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Introduction: COPD is a progressive disease, characterised by symptoms of 
dyspnoea, fatigue, exercise intolerance and reduced physical activity, 
resulting in impaired quality of life. Furthermore, the disease poses a 
significant burden on healthcare systems around the world. SPACE FOR 
COPD is a new self-management programme which aims to support 
individuals in acquiring the knowledge and skills required to optimise their 
emotional and medical well-being. 
 
Methods: This thesis describes a randomised controlled trial which aims to 
establish the effectiveness of a SPACE FOR COPD compared with usual care 
alone. 184 people with COPD were recruited from primary care. Individuals 
were randomly allocated to receive either the SPACE FOR COPD intervention 
or to continue with their usual care. The primary outcome was a measure of 
health-related quality of life (HRQoL), the Chronic Respiratory Questionnaire 
– Self Report (CRQ-SR) dyspnoea domain. Secondary measures included 
exercise performance, anxiety, depression, knowledge, self-efficacy and 
physical activity. Outcome measures were recorded at baseline, six weeks 
and six months. 
 
Results: There was no significant between-group difference in the change in 
dyspnoea at six months, therefore our hypothesis was rejected. In secondary 
outcomes, there were significant gains in HRQoL, exercise, performance, 
anxiety, knowledge and steps at six weeks, and at six months changes in 
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exercise performance and anxiety remained statistically significant. Correction 
for multiple comparisons, however, had not been made. 
 
Conclusions: SPACE FOR COPD did not result in improved dyspnoea, over 
and above usual care at six months. The programme may confer significant 
benefits in HRQoL, exercise performance, anxiety, knowledge and physical 
activity over and above usual care in the short-term, and gains in anxiety and 
exercise performance maintained at six months. Although these patients were 
relatively early within the course of their disease, physical activity was low, 
highlighting the need for a lifestyle intervention in this group of patients. 
Exploration of the potential benefit of additional on-going support, and delivery 
within group settings may of value in order to support the maintenance of 
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Chapter 1 Introduction 
 
1.1 Background 
Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of 
death worldwide, and poses significant financial burden on healthcare 
systems. In the UK direct costs were estimated at around £800 million per 
year (Department of Health 2004), although this is likely to have risen since. 
 
Historically healthcare has developed a reactive approach, designed on 
patient initiated contact in order to diagnose and treat threats to health. 
However, with people living longer the prevalence of chronic disease has 
risen. The needs of people living with long-term conditions are different from 
those with acute disease, and are not well met through this model of 
healthcare. The Chronic Care Model (CCM) suggests a shift away from the 
paternalistic approach, towards a more patient-centred style (Wagner 1998). 
 
Self-management is incorporated within the CCM as one of its central 
components. Self-management support aims to improve patients’ disease 
knowledge, self-efficacy and develop skills which will lead to health-enhancing 
behaviours and better patient outcomes (Bourbeau et al. 2004). Self-
management programmes for long-term conditions, such as diabetes and 
arthritis, are now well established in the clinical pathways of care. In COPD, 
however, the evidence is lacking (Barlow et al. 2002) and how self-
 26 
management should be provided is less clear. There is currently no 
standardised approach to self-management support for COPD in the UK. 
 
Some of the challenges in the current COPD self-management literature lie 
around the various interpretations of what self-management programmes 
should include, and when they should be provided. Many programmes have 
been initiated following hospitalisation for an exacerbation (Bourbeau et al. 
2003; Bucknall et al. 2012; Fan et al. 2012). This is quite far within the 
disease progression considering diabetes self-management is usually 
provided within a few weeks of diagnosis. While some self-management 
programmes have been as brief as an action plan or a single education 
session (McGeoch et al. 2006; Rice et al. 2010; Watson et al. 1997), others 
have been far more comprehensive and included supervised education and 
exercise for up to two years (Monninkhof et al. 2003). Drawing comparisons 
between these extremes makes it particularly challenging to review the 
literature and make recommendations. 
 
Despite recognition within the literature of the importance of self-management 
on health behaviour change, few studies have reported this. This may be 
because self-management of COPD requires mastery of such an extensive 
range of behaviours, including but not limited to: exercise, physical activity, 
smoking cessation, chest clearance, breathing control, energy conservation, 
inhaler technique, medication adherence, dietary intake and anxiety 
management. Some of these behaviours may be more easily measured than 
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others. This thesis focuses on health behaviours which have been shown to 
have the most important impact on clinical outcomes. 
 
Physical activity is one of these behaviours which will be more closely 
examined in this piece of work. Technological advances have increased the 
application of accelerometry to measure objectively physical activity. Recent 
studies have used accelerometers to demonstrate that people with COPD 
have reduced activity levels and this may be important to their long-term 
outcomes (Garcia-Aymerich et al. 2009; Garcia-Aymerich et al. 2003; 
Waschki et al. 2011). These activity monitor devices, however, provide 
enormous amounts of data, and there are deficits within the literature as to 
how best to use these data to make clinical inferences. 
 
1.2 Aims and objectives 
This thesis aims to address deficits in the current body of literature in self-
management for COPD. A Self-management Programme of Activity Coping 
and Education - SPACE FOR COPD- is a new self-management programme. 
This thesis evaluates the effectiveness of this programme in a randomised 
controlled trial (RCT) in primary care, compared with usual care alone. The 
primary outcome was pre-specified as Health Related Quality of Life 
(HRQoL), and was evaluated alongside a range of secondary measures used 




The hypothesis was that SPACE FOR COPD would confer greater gains in 
HRQoL when compared with usual care alone. 
 
Furthermore, the variety of outcome measures used in this trial permitted the 
opportunity to explore a number of other research objectives, which are: 
 
• To review and synthesize the literature and to propose a model of self-
management that can be used to inform future research and clinical 
practice. 
• To observe the impact of SPACE FOR COPD on exercise 
performance, psychological function, physical activity, knowledge and 
self-efficacy. 
• To explore physical activity characteristics in a population of people 
with COPD managed in primary care. 
• To examine factors that may be associated with a change in physical 
activity following SPACE FOR COPD. 
 
1.3 Structure and setting 
The work of this thesis is derived from a National Institute for Health Research 
for Patient Benefit (NIHR-RfPB) funded study. The grant was awarded to 
University Hospitals of Leicester (UHL) NHS Trust. The research was 
conducted between UHL alongside Leicester, Leicestershire and Rutland 
Primary Care Trusts and Coventry Teaching Primary Care Trust. The study 
was supported as one of the projects of the Leicestershire Northamptonshire 
and Rutland National Institute for Health Research Collaboration for Applied 
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Health Research and Care (LNR NIHR CLAHRC). Study recruitment was 
supported by the Primary Care Research Network (PCRN). 
 
The protocol of the study had been written prior to my participation in the 
study by Professor Sally Singh. I was employed by UHL under the RfPB grant 
as the lead researcher on the study. My role was to over-see the day-to day 
running of the trial, liaise with other bodies, screen, consent and perform 
baseline assessments of patients, randomise participants, provide the SPACE 
FOR COPD intervention to patients, and to arrange follow-up. Another 
physiotherapist, Vicki Warrington, also worked on the study, for whom I was 
responsible in supervising. Vicki Warrington also consented and assessed 
patients, and as a blinded assessor, performed all the follow-up assessments. 
 
The aims and objectives of this thesis are addressed in chapters 2 through 7. 
Chapter 2 is a review of the current literature in the area and outlines the gaps 
in knowledge. This identifies the rationale for this work and adds clarity to the 
literature. The methods of the trial are described in detail in chapter 3. 
Chapter 4 evaluates the short-term impact of SPACE FOR COPD at six 
weeks and chapter 5 evaluates the medium-term effects at six months. Both 
chapters 4 and 5 address the impact on HRQoL, exercise performance, 
psychological function, knowledge and self-efficacy. The physical activity 
characteristics of the population are examined in chapter 6, and chapter 7 
evaluates the impact of SPACE FOR COPD on physical activity and explores 
factors which may contribute to a change in physical activity. Finally, chapter 
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Chapter 2 Literature review 
  
2.1 Chronic Obstructive Pulmonary Disease 
Chronic Obstructive Pulmonary Disease (COPD) is a term which has been 
used to describe a group of diseases, including conditions known as chronic 
bronchitis and emphysema (Department of Health 2010). It is characterized 
by airflow obstruction which is usually progressive, not fully reversible and 
does not markedly change over a few months (National Institute for Clinical 
Excellence 2010). Diagnosis of COPD is based on a multi-dimensional 
assessment of a history of symptoms, physical examination and confirmation 
of the presence of airflow obstructive from spirometry (National Institute for 
Clinical Excellence 2010). Severity of the disease can be described by the 
degree of airflow limitation. The forced expiratory volume (FVC) and forced 
expiratory volume in one second (FEV1) are measures derived by spirometry 
that express airflow limitation. The Global Initiative for Chronic Obstructive 
Lung Disease (GOLD) has developed classifications of severity based on the 
FEV1 and FVC [table 2.1 (Global Initiative for Chronic Obstructive Lung 
Disease (GOLD) 2013)]. Chronic lower respiratory disease  was the fourth 
leading course of death for in 2010 in the UK (Office for National Statistics 
2011) and is expected to be the third leading cause of death by 2020 





Table 2.1 GOLD classification of COPD disease severity (Global Initiative for 
Chronic Obstructive Lung Disease (GOLD) 2013) 
 
 
2.1.2 Risk factors 
COPD is caused by exposure of the lungs to noxious agents, and it is 
accepted that smoking is the dominant risk factor (Department of Health 2010; 
Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013; National 
Institute for Clinical Excellence 2010). Exposure to other stimulants in 
industrial environments where hazardous agents can be inhaled has been 
acknowledged as a contributory factor (Blanc and Toren 2007). Those with an 
inherited pre-disposition of early onset of emphysema are also at risk, as well 
as people who have had a previous diagnosis of asthma (Department of 
Health 2010). Burning of biomass fuels, such as coal or straw, in poorly 
ventilated homes has also been identified as a global risk factor for 
developing COPD (Mannino and Buist 2007). 
This item has been removed due to 3rd Party Copyright. The unabridged version of the thesis can 
be viewed in the Lanchester Library Coventry University.
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2.1.3 Pathophysiology 
Pathological changes occur within individuals who have COPD, which include 
chronic airway inflammation, systemic inflammation and destruction of alveoli 
(Roth 2008; Willemse et al. 2005). It is believed these changes occur largely 
due to exposure to cigarette smoke (Bourdin et al. 2009; Roth 2008; 
Sutherland and Martin 2003), and are initiated long before symptoms are 
present (Sutherland & Martin 2003). Studies have established that smoking is 
associated with an increased infiltration of neutrophils and macrophages in 
the lung which are responsible for modulating behaviour of epithelial cells, 
fibroblasts and smooth muscle (Bourdin et al. 2009; Roth 2008). This initiates 
an increased inflammatory response which causes destruction of the elastic 
tissue in the alveoli and parenchyma, and results in loss of elastic recoil 
(Sutherland & Martin 2003). Although cigarette smoke is the primary cause, 
once the disease is established, the inflammatory process continues, even 
beyond smoking cessation (Willemse et al. 2005).  
 
2.1.4 Clinical features 
A spectrum of physical and psychological symptoms has been reported in 
people with COPD. The most common physiological symptoms are 
breathlessness, otherwise called dyspnoea, reduced exercise tolerance, 
cough, fatigue and production of phlegm (Department of Health 2010). In the 
early stages of the disease symptoms may be mild or even absent (National 
Institute for Clinical Excellence 2010) and there is usually a progression over 
time. Studies have shown that symptoms, particularly the level of dyspnoea, 
are more important for determining quality of life than the degree of airflow 
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obstruction (Bentsen et al. 2008; Hajiro et al. 1999). Health status is impaired 
in people with COPD (Wilke et al. 2012) and both physical and mental well-
being diminishes with increasing number of symptoms (Voll-Aanerud et al. 
2008). Symptoms may be variable on a day-to-day basis, and differ between 
individuals (Pauwels and Rabe 2004). 
 
Breathlessness is usually a symptom most commonly reported by the patient 
(National Institute for Clinical Excellence 2010), and is associated with anxiety 
and fear (Bailey 2004) which can lead to avoidance of activity and a 
progressive loss of cardiovascular fitness and skeletal muscle de-conditioning 
(National Institute for Clinical Excellence 2010). Although exercise intolerance 
may not be reported as often by the patient, it is an important clinical feature 
of the disease, and contributes significantly to the risk of mortality (Celli et al. 
2004). The severity of dyspnoea can be stratified by the Medical Research 
Council (MRC) Dyspnoea Scale [See table 2.2 (Fletcher et al. 1959)]. 
 
Table 2.2 Medical Research Council Dyspnoea Scale (Fletcher et al. 1959) 
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More recently GOLD has developed a model for patient stratification which 
incorporates both disease severity and symptoms (Global Initiative for Chronic 
Lung Disease (GOLD) 2011). Figure 2.1 illustrates the four possible 
classifications which combine either FEV1 or exacerbation frequency with 
dyspnoea score on the MRC scale or score from the COPD Assessment Tool 
(CAT), which is a measure of health status (Jones et al. 2009). 
 
Figure 2.1 GOLD 2011 disease severity classification [Global Initiative for 
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Acute exacerbation (AE) of COPD is an important event for an individual with 
COPD (National Institute for Clinical Excellence 2010). Definition of an AE is 
generally accepted as a sustained worsening of symptoms over and above 
day-to-day variation, is of acute onset, and may require additional treatment 
(Burge and Wedzicha 2003). Symptoms include cough, increased sputum and 
sputum purulence(Anthonisen et al. 1987). Those who have frequent 
exacerbations (≥ three per year) are likely to have a worse prognosis 
(National Institute for Clinical Excellence 2010; Suissa et al. 2012). Studies 
have shown that increased frequency of exacerbations is associated with an 
accelerated decline in lung function (Celli et al. 2008; Donaldson et al. 2002). 
Health related quality of life (HRQoL) is reduced during an AE and can take 
several months to improve, despite disease stabilisation (Spencer et al. 
2001). Decreased physical activity is a feature which may be present in the 
days prior to AE (Donaldson et al. 2005) and may remain below baseline 
levels a month later (Pitta et al. 2006). Severe exacerbations have been 
shown to have a negative impact on mortality (Soler-Cataluna et al. 2005). In 
the UK in 2008, 13.9% of people with COPD died within three months of a 
COPD-related hospitalisation, and it is thought that approximately 25% of 
those admitted to hospital will die within one year (The Royal College of 
Physicians, The British Thoracic Society and The British Lung Foundation 
2008; The Royal College of Physicians and the BritishThoracic Society 2004). 
 
2.1.5 Prevalence 
The precise number of people living in the UK with COPD varies between 
sources. COPD registers, which are kept by general practitioners, recorded 
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710,000 cases in 2009 (Department of Health 2009), however the accuracy of 
these documents is unknown. Previous reports estimate that approximately 
900,000 people living in the UK have a diagnosis of COPD (Healthcare 
Commission 2006).  Both of these figures are significantly lower than the 
suggested prevalence of three million which has been estimated from 
smoking rates (Stang et al. 2000). This implies that there may be around two 
million people in the UK with COPD who remain undiagnosed; these are 
known as the ‘missing millions’ (Department of Health 2010). 
 
Rates of COPD are associated with deprived communities, particularly in men 
working in the routine/manual sector (Department of Health 2004). It is 
thought this is due to higher smoking rates in this group (26% compared with 
15% in managerial/ professional trade), that smoking is taken up at an earlier 
age and that this group have an increased likelihood of exposure to 
environmental hazards (UK National Statistics 2007). 
 
2.1.6 Disease burden 
Burden to the individual 
The symptoms of COPD described in section 2.1.4 can lead to poor physical 
functioning (Braido et al. 2011), reduced daily physical activity (Pitta et al. 
2005b), social isolation and depression (Hanania et al. 2010; Omachi et al. 
2009). Health related quality of life is impaired for those with COPD, in 
comparison to healthy individuals (Schlenk et al. 1998). Increased disease 
severity is associated with higher levels of disability (Braido et al. 2011) and 
with poor quality of life (Ferrer et al. 1997). Disease severity, however, is not 
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an independent determinant of quality of life , and other factors including 
exercise performance, dyspnoea, self-reported disability and depression are 
also influential (Moy et al. 2009). 
 
Burden to the family 
The impact of the disease extends to the patients’ family, or ‘informal 
caregivers’ (Simpson et al. 2010). A shift in relational patterns and roles within 
the relationship can result in feelings of social isolation and a decreased 
ability to cope (Seamark et al. 2004; Simpson et al. 2010). Powerlessness, 
anger, grief, sadness, depression and shame have been identified as 
negative emotional reactions to the process of caring for a family member with 
COPD (Simpson et al. 2010). Spouses have identified that the burden of living 
with COPD are shared, and the marital relationship can become strained 
(Seamark et al. 2004). It has been argued that family who are responsible for 
caring for someone with COPD should be provided with social and 
professional support to address deficiencies in knowledge and to raise 
awareness of their potential roles (Spence et al. 2008). 
 
Burden to the healthcare system 
COPD poses a significant public health problem, and therefore the burden on 
the healthcare system is substantial. COPD is among the most costly 
conditions treated by the NHS (National Institute for Clinical Excellence 2010). 
In 2004 the Chief Medical Officer published a statement which reported 
annual direct costs of COPD of around £800 million (Department of Health 
2004). The impact on lost productivity was high with 24 million work days lost 
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each year, which accounted for indirect costs of approximately £2.7 billion 
(Department of Health 2004). Wouters (2003) studied the costs associated 
with COPD using data from the ‘Confronting COPD’ survey. Annual direct per 
patient costs of COPD in the UK were estimated at £833, which was the 
median cost among the range of countries (Wouters 2003). Costs associated 
with COPD escalate as the disease progresses, particularly in the most 
severe stage [See table 2.3 (Healthcare Commission 2006; National Institute 
for Clinical Excellence 2010)]. 
 
Table 2.3 Average costs per person for general management and 
management of an acute exacerbation of COPD (Healthcare Commission 
2006; National Institute for Clinical Excellence 2010) 
 
2.2 Physical activity 
2.2.1 Physical activity and COPD 
As previously discussed, physical activity is believed to be an important 
behaviour in individuals with COPD. Physical activity is reduced for those with 
COPD compared to healthy controls (Coronado et al. 2003; Hernandes et al. 
2009; Sandland et al. 2005; Waschki et al. 2012), in both duration and 
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intensity (Coronado et al. 2003;Hernandes et al. 2009;Pitta et al. 2005b). This 
decline is present in early stages, and significant reductions are seen even at 
GOLD stage II (Waschki et al. 2012; Watz et al. 2009). Activity levels decline 
further as disease severity, in terms of lung function, progresses (Waschki et 
al. 2012; Watz et al. 2009). 
 
A study by Garcia-Aymerich (2006) used activity questionnaires in 2,386 
patients with COPD, and found that individuals with ‘very low’ activity had an 
increased risk of respiratory related hospital admissions and mortality. This 
was supported by later findings by Waschki et al. (2011) who measured 
activity with accelerometers and found that the physical activity level (PAL) 
was the strongest predictor of all cause mortality. Physical inactivity has also 
been associated with worse quality of life (Esteban et al. 2010; Garcia-
Aymerich et al. 2004; McGlone et al. 2006), increased disability (Katz et al. 
2011) and higher exacerbation rates (Waschki 2012). 
 
The implementation of regular physical activity for the general population is 
endorsed by the UK government (Bull 2010) and the World Health 
Organisation (World Health Organisation 2010) due to its relationship with 
development of chronic diseases such cardio-respiratory disease, metabolic 
disease, cancers and mental health as well as all cause mortality. It is widely 
accepted that higher levels of physical activity are beneficial, and that these 
benefits can be significant. The guidelines from the American College of 
Sports Medicine (ACSM) are resoundingly accepted as the benchmark for the 
quota of physical activity required for a healthy lifestyle. The most recent 
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guidelines were produced for adults (Haskell et al. 2007) and replicated for 
older adults or adults with chronic illness (Nelson et al. 2007). The former 
recommends that adults should undertake at least 30 minutes of moderate 
intensity activity five times per week or 20 minutes of vigorous activity at least 
three times per week, or a combination of both. Moderate intensity is defined 
using metabolic equivalents (METs). One MET represents resting energy 
expenditure. A threshold of ≥3 METs <6 METs is used to define moderate 
activity and ≥6 METs for vigorous intensity. The guidelines for the older adult 
were updated to reflect the fact that what an older adult, or an adult living with 
a chronic condition considered to be ‘moderate’, may not be the same in 
absolute terms as what a young, healthy adult would consider ‘moderate’. 
These guidelines therefore recommend that on a zero to 10 Likert scale of 
effort, moderate activity would be scored around five to six, and vigorous 
around seven or eight. UK policy supports these guidelines, and recommends 
that 150 minutes of moderate or vigorous activity should be conducted per 
week (Department of Health 2013). 
 
2.2.2 Measuring physical activity 
Considering that physical activity may play an important role in the disease 
progression and outcomes for individuals for COPD, appropriate methods of 
measurement are required. One’s daily activity may be influenced by many 
individual factors including employment, health status, co-morbidities, 
weekday (Matthews et al. 2002), and time of the year (Sewell et al. 2010), and 




There have been many questionnaires developed which attempt to measure 
physical activity, and several have been validated in COPD. While some 
questionnaires (Sallis et al. 1985; Taylor et al. 1984) have been shown to 
correlate well with calorimetry, others have been used alongside monitoring 
devices with poor correlation found between the two (Donaire-Gonzalez et al. 
2011; Pitta et al. 2005a; Steele et al. 2000). Questionnaires have been used 
extensively, and several landmark studies in the field of physical activity have 
used this method of data collection (Garcia-Aymerich et al. 2003;Garcia-
Aymerich et al. 2006; Watz et al. 2009). Questionnaires are likely to be 
subject to re-call bias, and are likely to reflect the activity that the individual 
perceives they do, rather than what they actually do. When using physical 
activity questionnaires, or interpreting the data, it is important to remain aware 
of this discrepancy. 
 
Exercise tests 
While exercise tests may not actually measure daily physical activity, they 
may describe capacity for activity, and have long been referred to as 
surrogate markers for physical activity. A greater performance on exercise 
testing indicates a higher level of fitness, which might afford a greater ability to 
undertake more physically demanding tasks. It is important to recognise, 
however, that this may not always be the case, and that just because one has 
the ability to undertake activities does not mean that one does. There is a 
variety of exercise testing which are commonly employed. The gold standard 
of exercise tests is a cardiopulmonary exercise tests (CPET), which is usually 
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performed on a treadmill or cycle ergometer (Palange et al. 2007). Field tests 
have been developed which are considered more practical in a clinical setting. 
The ISWT (Singh et al. 1992) and the 6MWT (Butland et al. 1982) are the 
most well established of these tests in individuals with COPD. 
 
Activity monitors 
Over the past decade the development of devices for measuring activity has 
been attractive to researchers in COPD. However, with such a range of 
monitors available, and a variety of data output, there is currently no 
established best practice for their application. Devices range from simple 
pedometers which count steps, to complex multi-axial accelerometers which 
measure energy expenditure, vector magnitude units (VMU), or time spent in 
various positions or activities. There are a number of properties which need to 
be accounted for in selecting a monitor. 
 
Firstly, it should be considered if the output of the monitor is to be concealed 
from the individual wearing it. Devices which display data may not be 
appropriate when the monitor is to be used as an outcome measure, and may 
be more suitable as part of an intervention, such as using pedometers which 
display step counts. While some might argue that wearing a monitor may 
intervene in influencing physical activity, this has not been found to be the 
case when Sandland et al. (2005) documented no difference in activity level 
between those who knew why they wore a monitor and those who did not. 
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Another important feature of monitor selection is the nature of the data it 
provides. Step count is now commonly reported by many monitors. While the 
Mini-Mod (MM) and SenseWear Armband (SAB) monitors have been shown 
to report step count accurately, at slower speeds the validity of these monitors 
is less reliable (Furlanetto et al. 2010; Hill 2010a; Langer et al. 2009). This is 
important considering that people with COPD predominantly ambulate at 
slower speeds. It might also be considered that using step count to describe 
physical activity may be limited as it does not consider non-ambulatory 
activities. For example, some patients with COPD may find tasks such as 
getting dressed, washing, cooking or doing the gardening exert considerable 
energy, and would not be captured on step count information. 
 
There are several monitors that are able to provide estimates of energy 
expenditure. The SAB and MM measure this in terms of metabolic equivalents 
(METs), the Tritrac R3D, Actigraph and Actiwatch measure Vector Magnitude 
Units (VMU). The gold standard of measuring energy is through indirect 
calorimetry (IC) which measures gas exchange (Ferrannini 1988). The SAB 
has been validated against IC and has shown to be sensitive to detecting 
changes in energy expenditure across a range of tasks (Cavalheri et al. 2011; 
Hill et al. 2010a). Hill and colleagues (2010a) demonstrated that the difference 
between energy expenditure measured by SAB and IC was -0.2 METs 
(p=0.21, limits of agreement 1.3 METs) in a combination of slow and fast 
walking, standing, sitting and lying. Langer et al. (2009) also found the MM 
estimated energy expenditure well against IC, however it was not as sensitive 
as the SAB for detecting moderate energy expenditure. 
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A comparison of six of the most commonly used accelerometers was recently 
conducted (Van Remoortel et al. 2012). Patients with COPD were recruited 
across four sites and wore six activity monitors simultaneously: the Kenz 
Lifecorder, Actiwatch, RT3, Actigraph GT3X, Dynaport MiniMod and the 
SenseWear Armband. A protocol of tasks was completed, including walking, 
sitting, standing, lying and stairs, while wearing a portable device for 
measuring indirect calorimetry. The Dynaport MiniMod, Actigraph GT3X and 
SenseWear Armband were the most valid monitors during these tasks. 
 
In activity monitoring, other methodological factors must also be considered. 
The minimum duration an activity monitor should be worn for each day in 
order to be representative of an individual’s daily activity has not been 
ascertained. While several studies have deemed 12 hours to be adequate 
(Breyer et al. 2010; Pitta et al. 2008; Sewell et al. 2010), others report 
accepting data where the monitor has been worn for less (Coronado et al. 
2003; Mador et al. 2011). Additionally, if measurements are taken at more 
than one time point, it is necessary to consider whether a standardised time 
frame of measurement should be applied. In standardising the measurement 
period, e.g. 12 hours pre and post, we can be more confident that any 
observed change is as a result of an intervention. By having a standardised 
time frame, however, any activity undertaken outside of that period is not 




There has been more attention in the literature to establish the number of 
days required for accelerometry measurement in order to accurately represent 
average physical activity levels. In various COPD populations, this has been 
estimated from as little as two days up to 10 days (Hart et al. 2011; Hecht et 
al. 2009; Tudor-Locke et al. 2005). The overall message from these papers 
appears to be that the longer it is worn for the better (Hecht et al. 2009), but 
that a minimum of three days is required (Hart et al. 2011;Tudor-Locke et al. 
2005). 
 
2.3 General management of COPD 
It is recommended that a symptom based approach should be adopted in 
determining the management of each person with COPD (National Institute 
for Clinical Excellence 2010). Clinical features of the condition may be 
variable over time and the course of treatment should be modified in response 
to these changes. Currently, the most widely adopted strategies include 
smoking cessation, pharmacotherapy and pulmonary rehabilitation. 
 
2.3.1 Smoking cessation 
Exposure to cigarette smoke is the leading cause of COPD, triggering an 
inflammatory response in the lung tissue (Bourdin et al. 2009). Although 
increased inflammation continues after smoking cessation (Willemse et al. 
2005), stopping smoking slows the decline in FEV1 (Anthonisen 1989; 
Fletcher and Peto 1977; Hoogendoorn et al. 2010; Scanlon et al. 2000) and 
has a positive impact on symptoms (Kanner et al. 1999). Although mortality 
rates are still higher for ex-smokers than for never smokers, studies indicate 
 47 
that mortality declines progressively following smoking cessation 
(Godtfredsen et al. 2008). The current NICE guidelines  for COPD 
recommend that all COPD patients who are current smokers should be 
advised to quit, offered nicotine replacement therapy (NRT), Varenicline or 
Bupropion as appropriate, and should have a programme of support provided 
(National Institute for Clinical Excellence 2010). 
 
2.3.2. Pharmacotherapy 
Inhaled therapy is the forefront of pharmacological management for 
individuals with COPD, aiming to reduce obstruction through dilation of the 
narrowed airways (National Institute for Clinical Excellence 2010). Although 
the structural damage caused to the epithelial walls is largely irreversible, 
inhaled therapy may produce a small increase in FEV1 (National Institute for 
Clinical Excellence 2010). These drugs also appear to be effective in reducing 
both static and dynamic hyperinflation (National Institute for Clinical 
Excellence 2010), which may be important for exercise intolerance (O'Donnell 
et al. 2001). There are several types of inhaled therapy, which include; beta2 
agonists, anticholinergics and inhaled corticosteroids (ICS). Both beta2 
agonists and anticholinergics are often prescribed as either short-acting or 
long-acting. 
 
It is recommended that the first line of inhaled therapy is a short-acting beta2 
agonist [SABA (Global Initiative for Chronic Obstructive Lung Disease (GOLD) 
2013; National Institute for Clinical Excellence 2010)]. In the event that this is 
not effective at reducing dyspnoea, or if frequent exacerbations persist, and if 
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the FEV1 % predicted ≥ 50, then a long-acting muscarinic antagonist (LAMA) 
or a long-acting beta2 agonist (LABA) should be offered (Global Initiative for 
Chronic Obstructive Lung Disease (GOLD) 2013; National Institute for Clinical 
Excellence 2010). If breathlessness or frequent exacerbations persist, and if 
the FEV1 % predicted < 50, then  LAMA or LABA+ICS should be offered 
(Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013; National 
Institute for Clinical Excellence 2010). Both LAMA and LABA+ICS can be 
used together for individuals who remain breathless (National Institute for 
Clinical Excellence 2010). LABA+ICS cost around £33 to £41 per month, and 
a LAMA costs around £35 per month (British National Formulary 2013). Lung 
function, exercise tolerance, functional capacity, symptoms and side effects 
should all be monitored to examine the usefulness of the therapy on the 
individual (National Institute for Clinical Excellence 2010). 
 
2.3.3 Pulmonary rehabilitation 
Pulmonary rehabilitation is defined as an individualised programme of care 
which aims to improve physical activity, psychological functioning, enhance 
knowledge and improve self-management for those with respiratory 
impairment (Nici et al. 2006). It is echoed across guidelines that pulmonary 
rehabilitation should be an interdisciplinary activity and should recognise the 
needs of each individual (Global Initiative for Chronic Obstructive Lung 
Disease (GOLD) 2013 ; National Institute for Clinical Excellence 2010; Nici et 
al. 2006; Ries et al. 2007). 
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Pulmonary rehabilitation usually includes a programme of physical exercise 
training alongside a course of structured education. The exercise programme 
includes aerobic and strength training and aims to mediate the extra-
pulmonary effects of the disease by addressing muscle de-conditioning and 
exercise intolerance (Global Initiative for Chronic Obstructive Lung Disease 
(GOLD) 2013; National Institute for Clinical Excellence 2010). It is important to 
consider both strength and endurance training as it has been shown there is a 
cross-over effect of training (Spruit et al. 2002). In addition to physical training, 
education should be provided in order to equip the individual with the 
knowledge required to optimally manage their condition on a day-to-day basis. 
 
There may be some overlap between pulmonary rehabilitation and self-
management support. It could be argued that a good pulmonary rehabilitation 
programme is a form of self-management, in so far that it should provide 
education to assist in decision-making, support patients with the social and 
psychological ramifications of the disease and provide strategies for long-term 
behaviour change. This does not mean, however, that all self-management 
programmes qualify as pulmonary rehabilitation. Self-management has been 
provided through a spectrum of approaches, and this is discussed further in 
section 2.5. 
 
A Cochrane Review of pulmonary rehabilitation reviewed 31 RCTs and 
supported the inclusion of rehabilitation in the management of COPD due to 
its impact on dyspnoea, fatigue, emotional function and disease control 
(Lacasse et al. 2006). Exercise is the cornerstone of pulmonary rehabilitation 
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and gains in exercise capacity are of considerable interest, and are well 
documented (Griffiths et al. 2000; Pitta et al. 2008; Sewell et al. 2005; Sewell 
et al. 2006; Troosters et al. 2000). There are clear short-term gains from 
rehabilitation; however, improvements in HRQoL and exercise performance 
have been shown to diminish by six to 12 months (Egan et al. 2012; Griffiths 
et al. 2000; Sewell et al. 2006).  
 
In summary, there are a number of treatment approaches for people with 
COPD, which may improve lung function, HRQoL, physical function and 
psychological well-being. It is likely that all, or a combination of these 
strategies may need to be provided for any individual with COPD. It is 
common to prescribe inhaled therapy as a first line approach. However, what 
figure 2.2 shows is that inhaled therapy is more expensive per quality 
adjusted life year (QUALY) gained than influenza vaccination, smoking 
cessation and pulmonary rehabilitation. This highlights that although medical 
management is important, other approaches should not be ignored. 
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2.4 Chronic care and self-management 
2.4.1 Approach to management of chronic illness 
Having discussed the current treatments for COPD it is important to consider 
how the application of these strategies can be approached. In the earliest half 
of the twentieth century, healthcare systems around the world were developed 
when the primary threat to health was infectious disease (Creer and Holroyd 
2006; World Health Organisation 2002). In 1901 the average life expectancy 
was 47 years of age and by 1915 63% of the British population died before 
the age of 60 (Hicks 1999). Chronic diseases were not well understood, and 
their prevalence was low given that people were more likely to die at an early 
age (Creer & Holroyd 2006). Thus a paternalistic model of healthcare which 
was suitable in meeting the needs of acute illness was established and has 
been embedded in many healthcare systems since (Creer & Holroyd 2006). 
 
A paternalistic model of healthcare requires physician-led decisions about the 
management of an individual based on medical information (Creer & Holroyd 
2006). This model is focused on triage of patients, diagnosis and treatment of 
symptoms, reliance upon laboratory tests and prescriptions, short 
appointments, brief education and patient-initiated follow-up (Wagner 1998). It 
is a reactive form of health care in which the healthcare professional makes 
active decisions and the patient is a passive recipient of care. 
 
It is acknowledged that current healthcare provision does not reflect changes 
in society (Holman and Lorig 2004; Wagner 1998; World Health Organisation 
2002). The population is aging, with only 12% dying before the age of 60 
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(Hicks 1999) and the incidence of chronic disease rapidly increasing (World 
Health Organisation 2002). The characteristics of chronic disease are 
fundamentally different from acute illness (Holman and Lorig 2004). In 
contrast to acute conditions, chronic diseases are often of gradual onset, with 
an undulating course both physically and psychologically and ultimately are 
without cure (Holman & Lorig 2004). The needs of individuals and families 
living with chronic health conditions are not well met through the paternalistic 
model of care which many healthcare systems have adopted  (Wagner 1997). 
Acute care is discontinuous and fragmented (Holman & Lorig 2004), which 
does not lend itself to a long-term condition that cannot be cured. It seems 
inevitable, therefore, that healthcare systems which apply acute management 
strategies to the treatment of chronic disease will fail to meet the complex and 
on-going needs of long-term conditions (World Health Organisation 2002).  
 
2.4.2 Chronic Care Model 
Wagner and colleagues proposed an alternative approach to improve the 
management of chronic disease (Wagner 1998). The Chronic Care Model 
[CCM (Figure 2.3)] proposes that healthcare systems must be re-configured 
to meet the needs and improve outcomes for the chronically ill patient. The 
model suggests there are key elements required for effective management of 
chronic disease: self-management, decision support, delivery system design 
and clinical information systems. These components are based on a 
collaborative partnership between a prepared, proactive healthcare team and 
an informed, activated patient. 
 
 53 
Figure 2.3 The Chronic Care Model (Wagner 1998) 
 
 
2.4.3 Definition and principles of self-management 
Self-management has arisen as one of the key components of the CCM. For 
people living with a chronic condition, they are usually their own primary 
caregiver, therefore self-management is inevitable (Redman 2004). Lorig and 
Holman (2003) argue that when living with a chronic condition it is not 
possible to not self-manage, it is a question of how well one self-manages. 
The success of that course of management will determine health outcomes 
for that individual over their lifetime (Holman & Lorig 2004). Given the 
development of chronic diseases, and the increased burden they impose, it is 
unsurprising that interest in self-management has developed in recent years. 
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Defining what self-management is may be challenging. The term is used inter-
changeably with self-management support, self-management education, self-
care and disease management. This has led to broad interpretation and 
application as will be discussed later in section 2.5. It may be most useful to 
characterise self-management by considering what it involves, rather than 
what it is. 
 
Unravelling individual components which constitute successful self-
management and the processes by which it occurs has been attempted 
(Bourbeau 2008; Corbin & Strauss 1988; Lorig & Holman 2003). So far these 
concepts rely on theoretical models and clinical experience rather than 
evidence based trials. Corbin and Strauss (1988) identified three tasks that 
are necessary for undertaking self-management; i) medical management 
(such as taking medications or inhalers); ii) role management (adjusting 
lifestyle and behaviours) and emotional management (dealing with the 
emotional impacts such as anxiety or depression). These tasks have been 
widely accepted as important aims of self management (Lorig & Holman 
2003;Redman 2004). 
 
While the model of Corbin and Strauss considers what self-management 
strives to achieve, it does not consider the processes by which it occurs. Lorig 
et al. (Lorig & Holman 2003) identify five core self-management skills which 





Patients with long-term conditions should be taught problem-solving skills. 
The role of the healthcare professional is to teach the patient how to examine 
the problem, how to define it, deconstruct it and how to find a range of 
solutions. It is suggested patients finding their own solutions is preferential to 
them being offered by the professional. By equipping the patient with problem-
solving skills the individual is able to apply those skills and find solutions to 
any given problem they may face on a day-to-day basis. 
 
Decision-making 
Decision-making is a process undertaken by all individuals on a daily basis. 
These decisions may be better judged with access to enough and appropriate 
knowledge. The responsibility often lies with the healthcare professional to 
provide access to this knowledge. However, decisions are not usually made 
solely on disease-specific knowledge alone. Thorne and colleagues (Thorne 
et al. 2003) accumulated qualitative data from studies that were carried out 
among people with diabetes (Paterson and Thorne 2000), HIV and multiple 
sclerosis (Paterson et al. 2002). They conducted interviews with individuals 
who had lived with a chronic disease for many years and who believed they 
were effective in their decision-making abilities. Common across all 
individuals was the recognition that the disease was chronic and an 
understanding that disease outcomes would be directly related to self-care 
decisions was instrumental to the motivation to take control of their disease. 
Self-monitoring of symptoms, personal experience and understanding their 
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own circumstances were identified as being important to the decision making 
process. 
 
Utilisation of resources 
Self-management programmes should teach individuals how to find, select 
and use sources of help such as the internet, library services or programmes 
such as smoking cessation or support groups. To acquire this skill, self-
management programmes should not just tell people about resources but 
teach them how to use them. There may also be a requirement to teach 
people how to use several resources at once, rather than the common 
approach of using one at a time. 
 
Collaborative Partnership 
The fourth skill is formation of partnerships between the patient and 
healthcare professionals. This might also be referred to as collaborative or 
shared care, and features in the CCM. It suggests that there are two experts 
in the consultation room; the physician and the patient (Creer & Holroyd 
2006). The role of the physician as the decision-maker and of the patient as 
the passive recipient of care, as often seen in acute care management, 
should no longer apply (Holman & Lorig 2004). In collaborative care the 
physicians’ role is not to get patients to behave in the way they wish them to 
(Bodenheimer et al. 2002) but to add their medical knowledge to what patients 
already  know about their own capabilities and goals (Bodenheimer et al. 
2002) and to act as a teacher and provide guidance (Holman & Lorig 2004). 
This approach is based on addressing the perceived problems of the patient 
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and not what the healthcare professional perceives the problems to be 
(Bodenheimer et al. 2002). 
 
Taking Action 
Finally, taking action is identified as the fifth core skill. Schreurs and 
colleagues (2003) believe that disease-specific goals and patients’ own life 
goals may pose barriers to one another. Therefore, all goals should be made 
by the patient rather than the practitioner so that they are more likely to be 
realistic for the individual. There is evidence to suggest that goal-directed 
behaviour is enhanced when planning of the behaviour takes place (Gollwitzer 
1999). This is supported by planned behaviour theory, which suggests that 
individuals can plan for barriers that may threaten goal achievement 
(Schreurs et al. 2003).  
 
2.4.4 Mechanisms of self-management 
Self-efficacy is the cornerstone of many psychological behavioural 
frameworks (Ajzen 1991; Miller and Dollard 1941; Rosenstock 1966). Lorig 
and colleagues (2003) propose that self-efficacy is a mechanism by which 
effective self-management can be achieved. In his landmark paper Albert 
Bandura describes self-efficacy as the perception of one’s ability to perform a 
task or behaviour in any given situation, determines whether a behaviour will 
be initiated, how much effort will be spent and how long the behaviour will be 
sustained (Bandura 1977a). 
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Self-efficacy in relation to health behaviour change has been examined in a 
variety of healthcare contexts (Strecher et al. 1986). A review of studies which 
examined self-efficacy in smoking cessation, weight control, contraception, 
alcohol misuse and exercise was conducted by Stretcher et al. (Strecher et al. 
1986). They concluded that self-efficacy was a consistent predictor of both 
short-term and long-term success in behaviour change. As successful self-
management of chronic disease often requires changes in health behaviour, it 
is plausible that enhanced self-efficacy might strengthen this process. 
 







The framework from Bandura (Bandura 1977a) illustrated in figure 2.4 
suggests that behaviour change is a result of 1) efficacy expectations of one’s 
ability to perform a behaviour and 2) the expectations of the outcome of 
engaging in that behaviour. The model in figure 2.5 is similar to the process 
proposed by Bandura, insofar that self-efficacy supports behaviour change. 
However, the model by Bourbeau et al. (2004) suggests that the acquisition of 
knowledge and skills are important for supporting self-efficacy in the 
behaviour change process. Studies have demonstrated that education may 
improve disease knowledge (Hill et al. 2010b; White et al. 2006), although as 
This item has been removed due to 3rd Party Copyright. The 
unabridged version of the thesis can be viewed in the Lanchester 
Library Coventry University.
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yet there is no research in a COPD population to suggest that improved 
knowledge leads to behaviour change. 
 









Manipulation of self-efficacy may be possible and may improve adoption of 
health behaviours (Kaplan et al. 1984). The models by both Bandura and 
Bourbeau et al. suggest that several approaches can be used to enhance 
self-efficacy. Bandura’s model advocates that in order to improve self-efficacy, 
one’s confidence that they are able to achieve a particular behaviour and their 
confidence that in doing the behaviour will lead to a desirable outcome must 
be raised. Bourbeau’s suggests that building knowledge and skills are 
important. These models complement each other, as the combination of these 
strategies offers both psychological and practical approaches to enhance self-




This item has been removed due to 3rd Party Copyright. The unabridged 
version of the thesis can be viewed in the Lanchester Library Coventry 
University.
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2.4.5 Motivational Interviewing 
Motivational Interviewing (MI) is a counselling technique first described by 
Miller in 1983 (Miller 1983). It is a technique he conceptualized from his own 
experience, and from drawing on previous published theories, which focuses 
on an empathic, person-centred style and strengthening the clients’ own 
change talk, rather than the norm of confrontational style counselling (Miller 
1983). There are many features of MI which make it potentially useful in 
supporting self-management and behaviour change. 
 
The spirit of MI has been described as collaborative rather than 
confrontational, should evoke the individual’s motivation rather than to instil it 
and should preserve the individual’s autonomy. It can be directed towards 
people who are ambivalent or reluctant to change their behaviour, and the 
counselling style should help the individual to recognise their current problems 
and to develop solutions, with the overall aim of improving intrinsic motivation 
to change (Rubak et al. 2005). MI is based on four key principals of 
expressing empathy, developing discrepancy, rolling with resistance and 
supporting self-efficacy (Miller and Rollnick 2002). 
 
A systematic review in 2005 (Rubak et al. 2005) assessed 72 RCTs in which 
the MI intervention was deemed to be in congruence with the description of MI 
by Miller and Rollnick (Miller & Rollnick 2002). 47 of these studies were for 
addiction, while the remaining 25 were for physiological problems. Median 
duration of MI sessions was 60 minutes and the likelihood of gaining a 
treatment effect increased with number of encounters. Overall, a statistically 
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significant treatment effect was found in 74% of trials. The likelihood of a 
positive effect was enhanced by a prolonged follow up period. 
 
A second review also analysed 72 studies, however was not limited to RCTs 
(Hettema, Steele and Miller 2005). They found an effect size of 0.77 (95% CI: 
0.35-1.19) zero to one month post MI treatment. This diminished over time to 
0.11 (0.06-0.17) at follow-ups over 12 months. Success of treatment was not 
predicted by treatment duration, purity of the intervention, training or support. 
There were no detrimental effects reported from MI treatment in either review. 
Both of these reviews, however, were largely of studies of substance misuse 
and addiction. The application and effectiveness of MI in behaviour change, or 
lifestyle, interventions may differ and should be considered. 
 
Although the literature of MI in chronic disease health management is not as 
well developed as it is in substance misuse, there have been some studies. In 
a study of individuals at risk of chronic disease undergoing a self-selected opt-
in MI and education intervention, improved self-efficacy and health status was 
observed compared with individuals who chose not to opt-in to the treatment 
(Linden et al. 2010). It cannot be concluded, however, whether it was the MI 
or the education advice received that was responsible for these changes. 
Hawkins (2010) conducted an RCT of a diabetes self-management education 
programme (DSME) combined with MI compared with a control group who 
received healthy lifestyle advice. They found that the intervention group 
improved their glycaemic control and demonstrated significant improvements 
in self-efficacy and disease knowledge. Another study for diabetes showed 
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that the patients of GPs trained in MI showed significantly enhanced 
autonomy, increased motivation to change and reported having more 
information from their GPs than did a group of patients whose GP was not 
trained in MI (Rubak et al. 2009). A limitation of these studies is that it is not 
possible to establish whether it was the MI or the education that was 
responsible for the changes. 
 
A study in heart failure patients, however, conducted an RCT which compared 
three groups; MI; standard care and MI plus standard care, with the aim of 
improving physical activity (Brodie et al. 2008). Only those in the MI group and 
MI plus standard care group significantly improved their activity levels, 
suggesting that MI was the feature important in bringing about behaviour 
change.  
 
Although the evidence-base in chronic disease interventions is small, there is 
some indication that there may be additional benefits of supplementing care 
with MI. As yet, little research has been done on using MI to support 
behaviour change in self-management programmes for COPD. 
 
2.4.6 Outcomes of self-management 
Appropriate outcome measures which accurately reflect the aims self-






As previously described, appropriate knowledge is required in order to aid 
decision-making in self-management. Self-management programmes should 
therefore aim to promote education. Knowledge can be measured directly with 
questionnaires. The Bristol COPD Knowledge Questionnaire [BCKQ (White et 
al. 2006)] and the Lung Information Needs Questionnaire [LINQ (Hyland et al. 
2006)] have been validated in individuals with COPD. These questionnaires 
have both been used in pulmonary rehabilitation studies, and have shown to 
be sensitive to change (Jones et al. 2008; White 2006). As yet, these tools 
have not been used in any self-management studies. 
 
Health Behaviour 
There are a range of behaviours which reflect improved self-management in 
people with COPD. Smoking, physical activity and exercise are the most 
important behaviours, in terms of health outcomes. However, there may be a 
wealth of other behaviours and skills, such as chest clearance, breathing 
control, medication adherence, inhaler technique, diet and stress 
management which may be important for an individual. 
 
Quality of Life 
Quality of life is impaired in people with COPD (Spruit et al. 2007), and the 
aim of self-management support is to improve quality of life through positive 
health behaviour change. There are many tools available to measure quality 
of life, as both generic and disease specific measures. The choice about 
which to use might best be made based upon the population to which they are 
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being applied. This allows for disease-specific aspects of quality of life to be 
assessed. For individuals with COPD the two most common measures of 
HRQoL are the St. George’s Respiratory Questionnaire [SGRQ (Jones, Quirk 
and Baveystock 1991)] and the Chronic Respiratory Questionnaire [CRQ 
(Guyatt et al. 1987)]. Both of these measures have been validated and shown 
to be sensitive to change in a COPD population (van Rutten, Roos, & van 
Noord 1999). The SGRQ is comprised of four domains; symptoms, impact, 
activity and total. The range for each domain is zero to 100, with lower scores 
indicating a higher quality of life (Jones, Quirk, & Baveystock 1991). The CRQ 
is also comprised of four domains; dyspnoea, fatigue, emotion and mastery. 
Each domain is scored from one to seven, with higher scores indicating a 
higher quality of life (Guyatt et al. 1987). The questionnaire has also been 
developed in a self-report format (Williams 2001) which has been shown to be 
sensitive to change (Williams et al. 2003). The minimal clinical important 
difference (MCID) for this questionnaire has been estimated as 0.5 (Jaeschke 
et al. 1989). Several self-management programmes have used both the CRQ 
and the SGRQ (Bourbeau et al. 2003;Effing et al. 2011; Khdour et al. 2009), 
although neither tool has been found to be superior (van Rutten, Roos, & van 
Noord 1999) 
 
Anxiety and depression has a high prevalence in individuals with COPD 
(Janssen et al. 2010). It might be anticipated that if self-management 
strategies are adopted, and behaviour change is embraced, then symptoms of 
anxiety or depression may be reduced following a self-management 
programme. There are several tools available, however, the most commonly 
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used in people with COPD is the Hospital Anxiety and Depression Scale 
[HADS (Zigmond and Snaith 1983)]. The HADS is scored on a scale of zero 
to 21, and has two separate scores for both anxiety and depression. Scores 
within the range of eight to 10 signify a possible presence of anxiety/ 
depression and scores within the range 11-21 signify a probably presence of 
anxiety/ depression (Zigmond & Snaith 1983). The MCID of the HADS has 
been estimated at around 1.5 (Puhan et al. 2008). 
 
Healthcare utilisation 
It may be anticipated that improved disease knowledge will lead to behaviour 
change that will ultimately reduce patients’ healthcare utilisation. The 
expectation is that early identification of exacerbations followed by prompt 
initiation of treatment, such as antibiotics or steroids, will reduce the need to 
be admitted to hospital. This is a desirable outcome, particularly for 
commissioners, given the rising costs of COPD. 
 
2.5 Self-management and COPD 
2.5.1 Current self-management strategies for COPD 
The most recent Cochrane Review of self-management for COPD was 
published in 2007 (Effing et al. 2007). The review included 15 comparisons 
from 14 studies, and found that self-management was associated with a 
significant reduction in hospital admissions with no detrimental effects. There 
were statistically significant improvements in HRQoL, which did not reach the 
clinically significant threshold. No effects on number of exacerbations, lung 
function or exercise capacity were seen. While the authors concluded that 
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self-management should be recommended, there was significant 
heterogeneity in the interventions, outcome measures and time to follow-up, 
suggesting the need for further research. 
 
To date, there has been a variety of interventions aimed at promoting self-
management for individuals with COPD. While some of these strategies have 
openly adopted the title ‘self-management’ others fall under names such as 
education, home- rehabilitation or disease-management programmes. The 
name or title applied to an intervention can make the literature difficult to 
review. As discussed previously, pulmonary rehabilitation programmes may 
be a form of self-management but not all self-management programmes may 
qualify as pulmonary rehabilitation. A key distinction of pulmonary 
rehabilitation is that it should be interdisciplinary, suggesting that there should 
be some level of supervision from a multi-disciplinary team of healthcare 
professionals. Self-management may be supervised, but it may also be 
unsupervised, and there is no such requirement for an interdisciplinary 
approach. 
 
The Cochrane Review of self-management excluded all studies branded as 
‘pulmonary rehabilitation’. There are, however, many programmes which have 
been labelled as rehabilitation and yet are entirely home-based or 
unsupervised. Furthermore, the review included studies labelled as ‘self-
management’ which provided far more supervision and support than many 
pulmonary rehabilitation programmes. This following appraisal of the literature 
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attempts to evaluate studies based upon the contents of the programme 
rather than the label used to define it. 
 
Studies were included in this review if they were defined by the authors as 
‘self-management’. In addition, studies which evaluated an intervention which 
included education with an unsupervised exercise programme, regardless of 
what it was called, i.e. pulmonary rehabilitation or home-rehabilitation, were 
included. In an attempt to exclude studies which were more closely aligned 
with pulmonary rehabilitation than self-management, studies were excluded if 
they contained education with supervised exercise, unless it had been pre-
defined by the authors as a ‘self-management programme.’  
 
For search terms see Appendix 1. The review has been divided into three 
sections; education with supervised exercise; education with unsupervised 
exercise and education with no exercise. Study characteristics are 



























                 (SM)       (C)         (RM) 
Age:          66(12)    64(10)    66(8) 
FEV1%:     66(17)    67(18)    63(14) 
Male n(%):37(67)    28(51)    42(76) 
 
Stable, primary care 
Supervised 
education for 2-4 





Treatment difference at 
24mt: CRQ-total:-0.22 (-
0.49 to 0.042); 
CRQ(D):-0.16(-0.54 to 
0.21); (F): -0.17(-0.62 to 
0.27); (E):-0.31(-0.66 to 





















                   (SM)           (C) 
Age:           69.4(6.5)      69.6(7.4) 
FEV1:         1.00(0.33)    0.98(0.31) 
6MWT:       282(91)        280(90) 
Male n(%):  50(52)         56(59) 
 
Hospitalised within previous 12m 
Supervised 
exercise, one-to-
one home visits (1 






Treatment difference at 
12mt: 
Admission COPD -39.8 
(p=0.01), Other -57.1 
(p=0.01) 
 
SGRQ(T): at 4mt -4.2(-
7.7 to -0.2), at 12mt -2.0(-
















Australia 60 Parallel 
group 
RCT 
                       (SM)            (C) 
Age:              77.6(7.6)      75.8(8.1) 
FEV1:            0.79(0.33)    0.89(0.37) 
6MWT:         163(60)        148(62) 






to-one home visits 
over 12 weeks 
Change at 12mt(SM)v(C): 
6MWT:39 v 4.2 (-93.4 to -
7.3) p=0.023 
SGRQ(T):-5.8 v -1.4 (1.5 
to 16.4) p=0.020 
Respiratory admission 

















Country n= Design Patient characteristics Intervention Results Comments 
Bucknall 
(2012) 












visits for 2months 
(40 min. each) then 
every 6 weeks for 
10 months  
HR admission or death 
1.05 (95%CI 0.80 to 
1.38) p=0.73 
Treatment effect at 12t: 
SGRQ(T): -4.52(-9.07 
to 0.04) p=0.052; 
HADS-A -1.06(-2.08 to 
-0.03) p=0.044 

























                (SM)             (C) 
Age:         62.9(8.1)      63.9 (7.8) 
FEV1:       1.43(0.54)    1.40(0.53) 
ISWT:      388(164.5)    341(152.4) 
CRQ-D:   4.40(1.44)     4.52(1.38) 







3x week for 6mt 
2x week for 5mt 
Small groups 
 
Treatment effect at 
12mt: 
ISWT 35.1m (8.4-61.8), 
no p value 
ESWT 145.8 (-26.2-
317.8)m, NS 




All but 7 opted in 
for the additional 
5 months 
All patients had 




USA 426  Multi-
centre 
RCT 
                 (SM)             (C) 
Age:          66.2(8.4)       65.8(8.2) 
FEV1:        1.20(0.47)     1.21(0.49) 
Male n(%) 204(97.6)      209(96.3) 
 





1x week for 4weeks 




Mean fu= 250 days 
Deaths: 28 (SM) v 10 
(C), HR3.00(1.46-6.17), 
p=0.003 
AE treatment delay: 6.4 
days (SM) v 7.7 (C), 
p=0.48 
Terminated early 
due to higher 




































             (SM)             (C) 
Age:       66(8)           70(5) 
FEV1%:  33(10)         38(12) 
6MWT:   302(84)       315(104) 
 





sessions (one hour 
each) 
Home exercise 
programme, 1 hr 
per day, 5 days per 
week 
Twice monthly 
home visits for 2 
months, once 
monthly for 9 
months 
Change at 12mt (SM) v 
(C): 
6MWT 79m(p=0.0001) 
v 13m (ns) 
SGRQ(T): -

















Egypt 39             (SM)             (C) 
Age:   56.9(11.6)    56.4(9.03) 
FEV1: 0.80(0.35)    0.83(0.52) 
 







4x 1hr education 
while an IP 
Treatment effect at 2mt: 
6MWT: 58.15(11.23), 
p<0.001 
CRQ(D): 5.5(3.0 to 
9.0), p=0.003 
(F): 5.3(1.9 to 9.8), 
p=0.004 






Not powered to 




at baseline (n=25 
v n=14 for SM 
and C) 


























            (SM)             (C) 
Age:     65.6(10.1)   67.3(9.2) 
FEV1:    0.95(0.48)  1.10(0.50) 
Male %: 43.7          44.2 
SGRQ:   63.6          64.2 












Phone contact at 




Treatment effect at 6mt: 
SGRQ(T): -5.2, p=0.04 
(S): -7.8,p=0.01; (A) -1.8, 
ns; (I)-7.5,p=0.01 
Treatment effect at 12m: 
SGRQ(T): -3.8, p=0.17 
(S): -7.5,p=0.04; (A) -1.8, 
p=0.51; (I)-7.4,p=0.03 
Admission for AE 15 (SM) v 
34(C) at 6mt, p=0.01 
Admission for AE 26 (SM) v 















               (SM)             (PR) 
Age:       66(9)          66(9) 
FEV1:     1.13(0.34)  1.08(0.39) 
Male %:  57              54 








week, 4 weeks 





Between-group at 3mt: 
CRQ(D):0.05(-0.21 to 0.29), 
p=0.74; (F):-0.02(0.24 to 
0.20), p=0.85; (E): -0.10(-
0.36 to 0.16), p=0.46; (M): -
0.03(-0.23 to 0.17), p=0.75 
Between-group at 12mt: 
CRQ(D): 0.16(-0.08 to 
0.40), p=0.20; (F): 0.09(-
0.14 to 0.34), p=0.41; (E): 
0.18(-0.08 to 0.44), p=0.15; 
(M): 0.08(-0.12 to 0.28), 
p=0.45 
Change 6MWT at 12mt 
(SM) v (C): -3(-15 to 10) v -





























   
              (SM)             (C) 
Age:        69.8(11.6)    72.1(9.9) 
FEV1:      1.4(0.6)       1.4(0.5) 
Male %:   52               67 
SGRQ:    43.5(18.8)   36.8(17.6) 
HADSA:  6.2(4.2)       5.3(3.6) 
HADSD:  4.6(3.7)       4.1(2.9) 
 
Stable, from GP registers 
 
Action Plan 
Introduced by PN 
over 1hr. 
 
Change at 12mt (SM)v(C): 
SGRQ(T): 1.7(1.6) v -
0.43(1.6), p=0.58 
(S): -7.8(2.2) v -5.5 (2.7), 
p=0.52 
(A):1.1(1.8) v -0.92(2.3), 
p=0.47 



















Male (%): 76.5 
 







Home training 3x 
week for 3m 
Phone contact 
 
Change 6MWT at 3mt: 
73.2(50.2), p<0.05 within-
group 
Compared with OP-PR, 
change6MWT p=0.44 
 
Withdrawals: n=7 (SM) v 
n=19(OP-PR) 
Did not report 
change between 





















Country n= Design Patient characteristics Intervention Results Comments 
Monninkhof 
(2003) 
Netherlands 248 2 by 2 
RCT 
Age: 65 (7) 
FEV1%: 57 (15) 
Male (n): 169 
              (SM)             (C) 
SGRQ:  37.2(1.6)     38.1(1.5) 
6MWT:  428(91)       442(83) 
 




Education – 5x 
2h group 
Exercise – 1 or 
2x week for 2 
years 
Written info, AP 
Treatment effect at 12mt: 
SQRQ(T) -0.6(-2.8 to1.7), 
ns; (S)1.1(-2.5 to 4.8), ns; 
(A) -0.2(-3.2 to 2.8), ns; (I)-
1.4(-3.9 to 1.1), ns 
6MWT: -13(7)m (SM) vs. -










UK 27 Pilot, 
RCT 
              (SM)             (C) 
Age:    70(13)             70.5 
                              (57.5-78.15)                   
FEV1:   0.94                0.96 
         (0.66-1.17)    (0.77-1.31) 
Male n:   6                   4 
ISWT:    110(30-270)  160(45-85) 







Exercise – DVD 
led, 4x week 




Change at 7 weeks (SM) v 
(C): 
ISWT:45 v -15, p=0.013; 
CRQ(D): 0.5 v -0.1, 
p=0.042; (F): 1.7 v 0.0, 

























Country n= Design Patient characteristics Intervention Results Comments 
Ninot (2010) France 45 RCT              (SM)             (C) 
Age:     65(59.24)      61(56.65) 
FEV1:   1.69              1.52 
           (1.17-2.01)      (1.06-1.85) 
Male n:  18                 14 
SGRQ:  44(26.56)      41(27.51) 
6MWT:   450              397 




2x weekly, 4 
weeks 
Phone contact 
Change at 12mt (SM)v (C): 
ISWT 30(5to8)m v 12.5 
(15to48)m, p=0.15 
SGRQ(T): -7.6(-18to-1) v -
4.7(-11 to 4), p=0.15; (S): -
7(-19 to 1) v 3.7(-18 to 18), 
p=0.02; (A):-6.7(-16 to -5) v 
-6.7(-13 to o), p=0.61; (I): -
















69 RCT              (SM)             (C) 
Age:         68(10)       67(8) 
FEV1%:    37(14)      36(16) 
Male %:    62            67  






Change at 6mt (SM) v (C): 
SGRQ(T): -4 v 0, ns; (A); -2 
v 1, ns; (I): -3 v 1, ns; (S): -







SM=self-management, C=Control, T=total, S=symptoms, I=impact, A=Activity
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Education with supervised exercise programmes. 
There are four studies in this review which have been defined by the authors 
as self-management, and include a programme of education alongside 
supervised exercise training. 
 
One of the earlier studies evaluating the effects of a self-management 
programme for COPD was a Dutch study, COPE-I (Monninkhof  2003). This 
was an RCT design which recruited and randomised 248 participants [mean 
(SD) age 65(7) years; FEV1 % predicted 57(15); baseline 6MWT 428(91) 
metres and 442(83) metres for self-management (SM) and usual care (UC) 
respectively]. Branded as self-management, the intervention included five 
separate two-hour education sessions in small groups over the period of four 
months as well as one or two exercise training in small groups, weekly, for 
two years. Training consisted of cycling, walking, upper limb and lower limb 
strength training under supervision of a physiotherapist and was regularly 
adjusted with the patient to achieve goals. Education addressed medical, role 
and emotional management tasks and provided patients with knowledge and 
skills. 
 
Despite a complex and comprehensive intervention, the study failed to detect 
any difference between intervention and usual care groups in HRQoL, 
exercise capacity, symptoms, exacerbation frequency or self-confidence. The 
authors suggest that as the control group were medically optimised, shown 
inhaler technique and provided with smoking cessation which perhaps 
diminished the room for difference between groups. Additionally, they might 
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be considered quite a ‘well’ group of patients with high baseline scores in 
HRQoL [mean (SD) SGRQ Total 37.2 (1.6)] and exercise performance [mean 
(SD) 6MWD 428 (91) metres]. This may have created a ceiling effect whereby 
there was limited scope for improvement. Furthermore, this sample were 
relatively mild in terms of airflow obstruction, (FEV1 1.71 litres), and perhaps 
the patients were ‘too well’ for such a comprehensive intervention. 
 
More recently the effectiveness of a modified intervention, COPE-II, has been 
published (Effing et al. 2011). This was another Dutch study which recruited 
and randomised 159 participants [for SM and UC respectively, mean (SD) age 
62.9(8.1), 63.9(7.8) years; FEV1 1.43(0.54), 1.40(0.53) litres; baseline ISWT 
388(164.5), 341(152.4) metres]. The education was reduced to four sessions, 
but was supported with written material and phone calls at four, 13 and 26 
weeks. The content of the exercise training was similar to that described in 
COPE I, however it was carried out three times per week for the first six 
months and then twice weekly for an optional five months with one session 
per week being carried out at home. 
 
At the end of the study there were statistically significant between-group 
differences in the primary outcome of ISWT of mean (95% CI) 35.1 (8.4 to 
61.8) m, and CRQ dyspnoea 0.32 (-0.03 to 0.67), p =0.04 at 12 months, 
although neither of these differences breached the relative MCIDs. A 
significant difference of the number of steps [mean (95% CI) 1,190 (255 to 
2125)] measured by a pedometer was found in favour of the intervention at 12 
months. The usual care group in this study had a significant amount of  
77 
intervention, receiving the education, written information, phone calls, 
smoking cessation advice if needed and being allowed to access their normal 
physiotherapy exercise if it was part of their usual care. Although the authors 
argue this is likely to diminish the between-group effect, the between-group 
difference that was observed on the ISWT was largely accommodated for by 
the 24m decline in the usual care group rather than the 11m improvement in 
the self-management group. Even at an interim assessment at seven months 
there was only a 12m improvement in the intervention group, which after 
supervised exercise three times per week for six months, might be considered 
a small improvement. 
 
An optimal training threshold for individuals with COPD has been described at 
around 60-85% (Nici et al. 2006; Revill et al. 1999). Neither of the COPE 
studies described the intensity of training during the exercise component of 
their programmes, therefore it is not possible to evaluate whether training was 
optimally prescribed in these studies. It is also unfortunate that short-term 
measurements were not taken, such as at six or12 weeks from baseline as it 
has been shown in the literature that physical gains made in the short-term 
may diminish by 12 months (Bourbeau et al. 2003; Maltais et al. 2008). These 
studies, therefore, may have missed data collection when gains were at the 
optimum. 
 
Boxall et al. (2005) conducted an RCT in 60 people with COPD [mean (SD) 
age 77.6 (7.6), 75.8 (8.1) yrs, FEV1 0.79 (0.33), 0.89 (0.37) litres for SM and 
UC respectively] to test a self-management programme. It involved nine one-
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to-one home visits, with supervised education and exercise. Short-term 
outcome measures (12 weeks) were taken immediately post intervention, and 
documented a 34.9m change in exercise performance. Other significant 
between-group outcomes were HRQoL on SGRQ total and impact domains, 
which were also clinically significant. It was not possible to blind researchers 
or participants in this study and it was underpowered with analysis performed 
on only 60 participants, therefore results must be treated cautiously. It is, 
however, interesting that although less intensive than the COPE interventions 
the programme described in this study yielded greater benefits. Participants in 
this study were older, more severe and had a lower 6MWT distance at 
baseline. This may explain why Boxall et al. showed greater benefits than 
COPE, as those who are worse at baseline have the most to gain. 
 
Ninot et al. (2011) conducted an RCT in France, and recruited and 
randomised 45 people with COPD [mean (SD) age 65 (59.24), 61 (56.65) 
years; mean (95% CI) FEV1 1.69(1.17-2.010, 1.52(1.06-1.85) litres; baseline 
6MWT 450(385-505), 397(360-470) metres for SM and UC respectively]. 
Outpatient sessions of supervised education and exercise in small groups 
were provided twice weekly for four weeks. Exercise was based on a cycling 
programme but no details with regard to prescription were described.  The 
study demonstrated non-significant between-group difference of 17.5m 
(p=0.15) on 6MWD, and clinically significant improvements in all four domains 
of the SGRQ at 12 months. This study, however, only included 45 participants 
which resulted in uneven groups at baseline, and data was not normally 
distributed. Although the results on the SGRQ are significantly improved, the 
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study was not adequately powered to detect this change. A major limitation of 
this study is that no short-term outcome measures were performed at the end 
of the intervention period (four weeks). It is not possible to establish, 
therefore, whether the lack of change at 12 months is because the 
intervention failed to intervene, or whether a short-term effect was not 
maintained during the 12 month follow-up. 
 
Of these four studies, three demonstrated some impact on HRQoL and two 
demonstrated there were small gains in walking performance, which were 
statistically but not necessarily clinically significant. It is surprising that better 
results were not seen, given these studies included supervised exercise and 
education to a level which was comparable or more than that of many 
pulmonary rehabilitation programmes. With the exception of the study by 
Boxall et al. (2005), all others included patients with high FEV1 and baseline 
exercise capacity. The failure to observe larger improvements in these studies 
may be because they were relatively ‘well’ patients at baseline, there was less 
room for improvement and a ceiling effect on the tests occurred. Another 
possibility, however, is that the interventions in these studies were highly 
supervised and may have been too onerous for the well functioning patients. 
The COPE studies both required weekly attendance at hospital for up to a 
year (Effing et al. 2011; Monninkhof et al. 2003), which may have created 
dependence upon the healthcare team rather than fostering independence 
and establishing self-management skills. It is worth considering that the level 
of intervention should be appropriate for the severity of the patients, and 
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perhaps heavily supervised interventions for quite mild patients may not be 
the best way to direct resources. 
 
Education with unsupervised exercise 
Seven studies were found from the literature search which evaluated 
programmes of education with unsupervised exercise training. One of the 
most highly cited of these is the ‘Living Well with COPD’ programme 
(Bourbeau et al. 2003). It was a multi-centre RCT in Canada, and recruited 
patients who had been admitted to hospital due to COPD within the previous 
12 months. 191 individuals with COPD [mean (SD) age; 69.4(6.5), 69.6(7.4) 
years; FEV1 1.00(0.33), 0.98(0.31) litres; baseline 6MWT 282(91), 280(90) 
metres for SM and UC respectively] were randomised to either usual care or 
home-based self-management. The programme consisted of seven or eight 
individual home visits (one hour each) by a healthcare professional to conduct 
a comprehensive educational programme which addressed knowledge, 
respiratory skills, action planning for exacerbations and emotional support. 
Exercise was introduced at home and individuals were instructed to walk, 
cycle and climb stairs three times per week for 30-45 minutes per session. 
 
No significant between-group differences were found on the 6MWT. There 
were clinically significant between-group differences in the impact and total 
scores of the SGRQ at four months. Only the impact score remained clinically 
significant at 12 months (p=0.05). In the 12 months from baseline there was a 
39.8% reduction in admission from acute exacerbation, 51.7% reduction in 
admission for reasons other than exacerbation and a 41% reduction in 
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emergency department visits for exacerbation in the self-management group, 
compared with usual care. This was evaluated again after the second year 
and significant between-group differences remained (Gadoury et al. 2005). 
This is in contrast to results found from the study by Boxall et al. (2005) who 
found no significant difference on hospital admission. This may be because 
Bourbeau and colleagues only included patients who had had at least one 
hospitalisation in the preceding year, and as such they recruited a group of 
patients who were more likely to admit to hospital. It is likely that there was a 
greater occurrence rate of exacerbations in this group than those in the other 
studies. If the occurrence rate of an event is low, it can be difficult to find a 
difference and usually large numbers are needed. It is likely therefore that the 
study by Boxall et al., with just 60 patients, was insufficiently powered to 
detect a change in hospitalisation. 
 
In 2008 the ‘Living Well with COPD’ programme was evaluated again, with 
modifications, against conventional outpatient pulmonary rehabilitation 
(Maltais et al. 2008). This time the education was delivered in small groups, 
twice weekly for four weeks. The self-management groups were loaned 
exercise cycles for three months and were prescribed a training intensity of 
60% of their maximum that they achieved on a baseline cycle test, and were 
instructed to train for 40 minutes three times per week for eight weeks. A low 
intensity and long duration was deliberately prescribed so as to avoid severe 
dyspnoea on unsupervised exercise. Outcomes were performed at three and 
12 months. 252 people with COPD were recruited [mean (SD) age 66 (9), 66 
(9) years; FEV1 1.13 (0.34), 1.08 (0.39) litres; baseline 6MWT 370 (89), 368 
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(85) metres for SM and pulmonary rehabilitation (PR) groups respectively]. 
Again, HRQoL was found to improve clinically significantly in all four domains 
of the SGRQ at three months, and all but the activity domain remained so at 
12 months. CRQ dyspnoea also exceeded the MCID at 12 months. There was 
no improvement in 6MWD, however a statistically significant improvement in 
cycling endurance time was observed. A key finding from this study was that 
the self-management home-exercise programme was not inferior to the 
outpatient supervised exercise programme in terms of HRQoL. While the 
‘Living Well with COPD’ programme is detailed in its approach to promoting 
self-management, a concern with the delivery method is that participants were 
loaned exercise bikes which were then withdrawn and patients were 
encouraged to buy their own. Firstly this increases the expense and logistics 
of the programme, which restricts its implementation in the UK. It is may also 
have significant implications for exercise maintenance if participants are 
loaned equipment and then expected to buy their own. 
 
Very few studies which have been discussed have demonstrated significant 
impact on exercise performance, and none have convincingly evidenced 
improvements in walking exceeding the MCID. There are, however, a number 
of studies which have included unsupervised exercise which have shown 
more impressive results. Mendes et al. (2010), Moore et al. (2009), 
Fernandez et al. (2009), and Ghanem et al. ( 2010) all conducted studies 
which included an educational programme and a home-based, unsupervised 
training programme and found improvements in exercise tolerance which 
were either statistically significant or exceeded the MCID. 
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Mendes et al. (2010) conducted a three arm RCT in Brazil in 117 patients 
[mean (SD) age 69.2(8.7) years; FEV1 % predicted 46.5 (22.0)]. Patients were 
randomised to either usual care, pulmonary rehabilitation or a home-based 
self-management programme. Patients who received the self-management 
programme were advised to complete 30 minutes of walking at 60-80% 
maximal heart rate achieved on the 6MWT three times per week. They also 
received a group-based single education session and telephone support. After 
12 weeks a 73m improvement in 6MWD was documented in the self-
management group, however, the authors did not report how this compared 
with the usual care group. There were seven drop outs in the self-
management group compared with 19 in the rehabilitation group, which the 
authors suggest means self-management may be more acceptable for some 
patients. 
 
Moore and colleagues (2009) tested a novel DVD approach to home-based 
exercise programme, and although exercise was chair-based, patients were 
instructed to use the Borg breathlessness scale to train to a symptom limited 
intensity. Education was provided in written format from British Lung 
Foundation material. The study was based in the UK, and included a small 
sample of 27 [mean (SD or 95% CI) 70 (13), 70.5 (57.5-78.15) years; FEV1 
0.94 (0.66-1.17) litres, 0.96 (0.77-1.31); baseline ISWT 111 (30-270), 160 (45-
85) metres for SM and UC]. A 60m between-group difference on the ISWT 
was observed in the self-management group vs. usual care at six weeks. 
Statistically significant between-group differences were seen on the 
dyspnoea, fatigue and emotion domains of the CRQ. This was a small study, 
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and the non-normally distributed data suggests this may not be a 
representative sample. 
 
In the study by Fernandez et al. (2009) participants were advised to exercise 
for one hour per day, five days per week. Training included upper and lower 
limb resistance training and a walking programme prescribed at 90% of the 
peak velocity achieved on the 6MWT. The educational programme was 
conducted through twice monthly home visits for two months and once 
monthly visits for nine months. The study was conducted in Spain and 
recruited 50 people with COPD [mean (SD) 67 (8) years; FEV1 % predicted 
33(10), 38 (12) litres, baseline 6MWT 302 (84), 315 (104) metres for SM and 
UC respectively]. A between-group difference of 66m on 6MWT after 12 
months was documented, and clinically significant improvements in HRQoL 
were observed in all four domains of the SGRQ. No power calculation was 
reported, recruitment and randomisation procedure are not clear and it does 
not explain why there were 27 people in the self-management group and 14 in 
the usual care. 
 
Ghanem et al. (2010) conducted an RCT in Egypt. During hospitalisation for 
an exacerbation of COPD, 39 people with COPD were recruited and 
randomised [mean (SD) age 56.9 (11.6), 56.4 (9.03) years; FEV1 0.80 (0.35), 
0.83 (0.52) litres for SM and UC respectively]. It failed to describe any detail 
with regard to the prescription of the exercise training, other than that patients 
in the self-management arm were advised to carry out cycling, walking, 
respiratory muscle training and strength training every day at home. The 
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education programme was provided during the hospital stay during four one-
hour sessions. Significant between-group differences were found after two 
months on the 6MWT of 58.15 (11.23) metres, p<0.001, CRQ dyspnoea of 5.5 
(3.0 to 9.0), p=0.003, fatigue 5.3 (1.9 to 9.8) and emotion 8.7 (2.5 to 15.0). 
Despite being a young group they had a low FEV1, however this may reflect 
the fact that these patients were recruited in hospital. 
 
These four studies are the only programmes which have incorporated 
education with unsupervised exercise and shown a positive impact on 
exercise performance. In comparison with the studies of supervised exercise 
discussed earlier, the participants in these studies were more severe, in terms 
of baseline function and FEV1, therefore better improvements in exercise 
capacity may have been observed as these patients had more to gain. 
 
There are several issues with the quality of these studies. With the exception 
of the study by Mendes et al. (2010), all of these trials had small samples 
[n=50, n=39, n=27 for Fernandez et al. (2009), Ghanem et al. (2010) and 
Moore et al. (2009) respectively]. Having not reported a power calculation, it is 
likely that these studies are insufficiently powered. And while Mendes et al. 
did report a significant within-group change in exercise performance in the 
self-management group, they did not report a between-group comparison with 
the control group. Additionally, none of these studies reported using a blinded 
assessor, or using an intention to treat approach in the analysis. Both 
Fernandez et al (2009) and Ghanem et al. (2010) did not report how 
participants were recruited and both studies had uneven numbers in the self-
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management and usual care groups at baseline [self-management vs. usual 
care n=30 and n=20 (Fernandez et al.), n=25 and n=14 (Ghanem et al.)], 
which raises concerns about how randomisation was conducted. 
 
Despite the lack of rigour and lack of power in these studies, they suggest that 
exercise performance can be improved in people with COPD who follow an 
unsupervised programme of training. This is an important finding, but must be 
substantiated with more high quality research. 
 
Another study which included an unsupervised exercise programme alongside 
education to promote self-management was that by Khdour et al. (2009), 
although this study did not measure exercise capacity. The study was based 
in the UK and recruited 173 participants with COPD [mean (SD) age 65.6 
(10.1), 67.3 (9.2) years; FEV1 0.95 (0.48), 1.10 (0.50) litres for SM and UC 
respectively]. The intervention was pharmacist-led, and introduced 
participants individually to the programme in a one-hour session, which 
included knowledge on COPD and skills in inhalation technique, symptom 
management, relaxation and chest clearance. This was supported with written 
information, phone calls and re-enforced at clinical appointments. Exercise 
training was only advised, not prescribed. Interestingly this is one of the few 
studies that have reported using motivational interviewing as a technique to 
support the delivery of the programme. HRQoL significantly improved on the 
SGRQ at six months but had declined at 12 months [SGRQ-Total treatment 
effect at six months = -5.2 (p=0.04) and at 12 months= -3.8 (p=0.17)]. 
Supporting findings by Bourbeau et al. (2003), a 50% decrease in emergency 
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department visits, 59% decrease in hospitalisation and a 39% decrease in 
unscheduled GP visits was observed in the intervention group compared with 
usual care. Similar to the study by Bourbeau et al. (2003), this was a more 
severe group of patients. Although the study was not powered to detect 
change in healthcare utilisation and was not blinded, this is an interesting 
finding given that the level of additional support that the intervention required 
was a one-hour consultation, two phone calls and written information. This is 
considerably less intervention than the ‘Living Well with COPD’ programme, 
which achieved similar results, but required eight one-to-one home visits. This 
suggests that a ‘light touch’ approach is not only feasible, but may deliver 
similar results, in a similar population, compared with a more supervised 
programme. 
 
Self-management education – no formal exercise 
There are a number of programmes under the label of self-management with 
the primary aim of helping patients to self-manage their exacerbations. These 
approaches have usually focused on education specifically tailored around the 
exacerbation, often with the aim of prompting identification and early 
treatment of an exacerbation to minimise its impact and reduce the risk of 
hospitalisation.  
 
Two of these five studies evaluated the impact of a simple action plan. An 
action plan is a set of written instructions which aims to equip the patient with 
knowledge of how to identify the symptoms of an exacerbation, what course 
of treatment to take and to initiate it early. Watson et al. (1997) recruited and 
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randomised 69 participants with COPD in New Zealand [mean (SD) age 
68(10), 67(8) years; FEV1 % predicted 37(14), 36(16) litres for SM and UC 
respectively]. Participants in the self-management arm were introduced to the 
action plan by a practice nurse. No further advice or support was given. No 
significant between-group differences in HRQoL were observed [mean 
change at six months SGRQ total -4 vs. 0, activity -2 vs. 1, impact -3 vs. 1 and 
symptoms -8 vs. -2]. 
 
A similar study was conducted by McGeoch et al. (2006), also in New 
Zealand, with larger numbers. 159 patients were recruited and randomised 
[mean (SD) age 69.8(11.6), 72.1(9.9) years; FEV1 1.4 (0.6), 1.40 (0.5) litres 
for SM and UC respectively]. The intervention was also an introduction to the 
action plan without further support. Changes in HRQoL, anxiety or depression 
were neither statistically nor clinically significant [mean (SD) change, for SM 
and UC respectively, SGRQ total 1.7(1.6) vs. 0.43 (1.6), p=0.58; HADS-A -
0.15(0.7) vs. 0.01(0.03), p=0.87; HADS-D -0.29 (0.29) vs. 0.04 (0.32), 
p=0.57]. 
 
A Cochrane Review of the use of action plans without any formal patient 
education included a further three studies, and concluded that the use of 
action plans in isolation could not be recommended as there was no evidence 
of any benefit in either HRQoL or healthcare utilisation (Walters et al. 2010). 
While there may still be a place for action plans which are integrated into a 
broader self-management approach, used alone they appear to offer little 
clinical benefit. 
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One study published recently, embedded an action plan within a programme 
of patient education, which was based on the ‘Living Well with COPD’ course. 
Bischoff and colleagues (2012) recruited from primary care in the 
Netherlands. It was a three-group RCT, in which patients were randomised to 
self-management, routine monitoring or usual care. 165 people with COPD 
were recruited and randomised [mean (SD) age 66(12), 64(10), 66(8) years; 
FEV1 % predicted 66(17), 67(18), 63(14) for SM, UC and routine monitoring 
respectively]. Participants in the self-management group received a Dutch 
version of the programme, which included written modules and an action plan. 
It was delivered by the practice nurse in two to four one-hour sessions, 
although the precise number of sessions varied. The primary outcome was 
the CRQ total and there was no significant treatment effect at 24 months 
between self-management and usual care [mean change (95% CI) -0.22 (-
0.49 to 0.042]. There were no significant effects in any of the CRQ domains or 
in the self-efficacy scale at either six or 24 months.  In the second year of 
follow-up more exacerbations were managed with bronchodilator use [odds 
ratio (95%CI) 2.81 (1.16 to 6.82)] or with prednisalone, antibiotics or both 
[3.98 (1.10 to 15.58)] and there was also a tendency for more exacerbations 
to be reported in the self-management group compared with usual care.  
 
The lack of short-term follow-up in this study means it is difficult to identify 
whether the intervention failed to intervene, or whether improvements were 
made but not maintained. A short-term assessment is important to establish 
this. It is interesting, however, that despite being modelled on the same 
programme that was used by Bourbeau et al. (2003) and Maltais et al. (2008), 
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which documented significant improvements in HRQoL, this study showed 
little clinical impact. This may be because the patients in the Bischoff et al. 
study were recruited from primary care, and therefore may be a ‘better’ group 
of patients. Their baseline HRQoL scores were high, which may have created 
a ceiling effect. Another important difference is the absence of the exercise 
component of the programme. The authors have not explained why this 
element of the programme was withdrawn, although it may be because it was 
delivered by practice nurses in primary care. It is, however, possible that 
improvements in exercise capacity may be an important factor in minimising 
the impact of the disease symptoms and therefore improving quality of life. 
 
There have been a further two studies which evaluated the impact of a self-
management education intervention, which did not include any exercise. 
These final two studies aimed to specifically target patients who had 
previously been admitted to hospital due to an exacerbation of COPD. Firstly, 
the Glasgow Supported Self-management Trial (GSuST) was published last 
year (Bucknall et al. 2012). It recruited and randomised 464 people with 
COPD [mean (SD) age   69.1(9.3) years; FEV1% predicted 40.5(13.6); 
baseline SGRQ total 70.1(16.4)]. Those randomised to self-management 
received four forty-minute one-to-one sessions from the study nurse during 
the first two months, followed by home-visits every six weeks for another 10 
months. The self-management education was adapted from the ‘Living Well 
with COPD’ programme, however was specifically adapted to focus on 
exacerbation management. The primary endpoint was time to re-admission or 
death. 48% of the self-management group and 47% of the usual care group 
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reached the primary endpoint within 12 months. There was no significant 
difference between-groups in risk of re-admission or death [Hazard ratio (95% 
CI) 1.05(0.80 to 1.37) p=0.73]. There was a low response-rate on the 
questionnaire data, with baseline and at least one follow-up only available for 
61% of people. Of the data that was returned there was a significant treatment 
effect on some domains of HRQoL and anxiety on the HADS [treatment effect 
(95% CI) SGRQ-impact -6.89 (-12.40 to -1.39), p=0.015; HADS-A -1.06 (-2.08 
to -0.03), p=0.044]. There was no impact on other domains of the SGRQ, 
depression or self-efficacy.  
 
The study team attempted to identify ‘successful self-managers’ in this trial as 
those who initiated rescue medication appropriately following the onset of an 
exacerbation. A sub-group analysis was performed on this group, and there 
was a significant reduction in having more than one hospitalisation for COPD 
in the ‘successful self-manager’ group [hazard ratio (95%CI) 0.44 (0.25-0.76) 
p=0.003]. This is the first study to try to identify a target group in this way, and 
is important for future studies to consider who might be most appropriate for 
self-management. We should be cautious, however, to limit the ‘success’ of 
self-management to initiation of rescue medication. Other studies have 
documented improved medication adherence, however, this has not 
necessarily translated into any other markers of improved health status or 
reduced healthcare utilisation (Walters et al. 2010). 
 
The second study which targeted people following hospitalisation was an 
American study in a veteran affairs institute (Fan et al. 2012) 426 people with 
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COPD were recruited and randomised [mean (SD) age 66.2(8.4), 65.8(8.2) 
years; FEV1 1.20(0.47), 1.21(0.49) litres for SM and UC respectively]. 
Participants in the self-management group received a written action plan, had 
supervised education once a week for four weeks and received regular 
telephone contact for 12 months. The study aimed to recruit 960 patients, 
however, it was terminated prematurely because of safety concerns due to 
higher mortality in the self-management arm [deaths=28 vs. 10 for self-
management v usual care respectively, hazard ratio (95% CI) 3.00 (1.46 to 
6.17) p=0.003]. Among those who did complete the study there were no 
between-group differences in HRQoL. Furthermore, there was no between-
group difference in the delay between exacerbation onset and initiation of 
treatment [mean 6.4 days vs. 7.7 days for self-management and control, 
(p=0.48)], suggesting that the intervention had failed to intervene in the way in 
which it was intended. 
 
Despite best efforts, no clear reason for the difference in mortality was found. 
It could be argued that the study was underpowered as they did not meet the 
power calculation, and had the study achieved statistical power, this 
difference may not have existed. Additionally, it should be noted that as these 
patients had recently been hospitalised, the mortality rate of 13% in the 
intervention group might not actually be considered to be beyond what is 
expected for this population. 
 
Both the studies by Bucknall et al. (2012) and Fan et al. (2012) suggest that 
the timing of self-management may be important. A recent study which 
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evaluated the natural progression of COPD indicated that the first 
hospitalisation signals a progressive decline, and that subsequent 
exacerbations become more frequent and regular (Suissa, Dell'Aniello, and 
Ernst 2012). Initiating self-management support following hospitalisation may 
be too late in the disease process to have a significant impact on clinical 
outcomes. Self-management is a subtle intervention, and behaviour change 
may be more difficult to achieve once the disease is further advanced. 
On the whole, studies which have included written information without any 
formal exercise component have had very limited success. While some of 
these studies have recruited quite ‘well’ patients and may have experienced a 
ceiling effect, others have recruited more severe participants and still 
experienced little improvement. These studies have included a range of 
education programmes, from something as basic as an action plan through to 
one-to-one home visits for a year, and yet this seems to have little impact on 
the clinical effectiveness. The lack of an exercise programme may be 
important in understanding why these programmes have not had better 
outcomes. It seems intuitive that in order to for HRQoL to improve, an 
individual must experience an alleviation of either physical or emotional 
symptoms. Alleviation of the symptoms of dyspnoea, fatigue and exercise 
intolerance is largely achieved through improved exercise capacity. It seems 
pivotal, therefore, that exercise which is an important health behaviour, should 





2.5.2 Summary of self-management programmes for COPD 
This review of the literature on self-management for COPD is in keeping with 
the Cochrane Review of self-management which concluded that there is 
heterogeneity in the nature and content of the interventions, the outcome 
measures used and the time to follow-up (Effing et al. 2007). There are 
several key findings from the review which will be summarised below. 
 
The level of supervision required by a healthcare professional on a self-
management programme is important to consider in order to ensure safety 
and clinical effectiveness, but there are also financial and organisational 
implications of the level of support required. While it might be assumed that 
more support would lead to better outcomes, the findings from this review do 
not confirm this. Figure 2.6 and 2.7 represent all the studies included in this 
review on two grids. The x-axis represents the level of supervision provided in 
the education aspect of the programme while the y-axis represents the level 
of supervision provided in the exercise component. Names in red represent a 
statistically negative trial outcome and those in green a statistically positive 
trial outcome. Figure 2.6 shows the outcome on HRQoL and figure 2.7 shows 













































These figures illustrate that higher levels of supervision does not necessarily 
lead to better outcomes. Unsupervised approaches, such as that used by 
Khdour et al. (2009), had a better impact that more supervised programmes, 
such as Monninkhof and Ninot (Monninkhof  2003; Ninot et al. 2011). This 
may, in part, be due to disease severity which was worse in the Khdour et al. 
(2009) study which may allow for greater improvements. It may also be 
important, however, to ensure that the treatment approach is appropriate for 
the severity of the patients. For instance, Monninkhof et al. (2003) recruited 
mild patients to a highly structured programme, which may have been too 
restrictive for self-management skills to develop. 
 
Several studies included unsupervised exercise training, and demonstrated 
clinical effectiveness, in terms of HRQoL, exercise performance and reduced 
healthcare utilisation (Fernandez et al. 2009;Ghanem et al. 2010;Khdour et al. 
2009;Mendes et al. 2010; Moore et al. 2009). This suggests these 
programmes were effective in provoking changes in health behaviour. 
Improved exercise performance following unsupervised exercise training is an 
important finding, as supervised exercise training incurs significant financial 
and organisational costs. There is, however, a need for better quality research 
in this area which is adequately powered. 
 
What this review has highlighted, and can be seen in figure 2.6, is that some 
form of exercise component is important within a self-management 
programme in order to bring about changes in HRQoL. As previously 
discussed, exercise may be a crucial vehicle by which physiological and 
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emotional changes occur, which is important in bringing about changes in 
HRQoL. 
 
This review has also offered some insight in the importance of timing of self-
management provision within the course of the disease. The studies by Fan et 
al. (2012) and Bucknall et al. (2012) suggest that initiating self-management 
support once the disease is well established enough that the patient is being 
hospitalised for their condition may be too late to have any strong clinical 
benefit. This may, however, depend upon the nature of the intervention, as 
Bourbeau et al. (2003) also recruited people who had previously been 
hospitalised and did observe a positive impact. The papers in this review 
which have studied less severe patients, have on the whole, shown less 
clinical effectiveness than trials which have studied patients at the more 
severe end of the spectrum. As discussed previously, this may be due to a 
ceiling effect insofar that the ‘well’ patients have less room to improve. This 
does not mean, however, that self-management support is not effective in 
these people. Intuitively, self-management support aimed at improving health 
behaviours provided earlier within the course of the disease may have more 
of a preventative approach. It is possible, therefore, it may just take longer to 
see the benefits of self-management in these less sever patients. 
 
Some of the self-management programmes described are similar in structure 
and content to that of pulmonary rehabilitation in the UK. This may be in part 
due to mixed interpretations of ‘self-management’ and different systems of 
healthcare which operate various programmes of rehabilitation around the 
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globe. It is clear from the literature that there are different levels of self-
management support, and it may be that these can be applied in a tiered 
process. In order to move our understanding of self-management forward it is 
important to differentiate between the various skills and processes which are 
involved. The work reviewed so far has culminated in the production of a 
model of ‘A spectrum of self-management support’ (Wagg 2012).
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Figure 2.8 shows a layered approach to self-management. The most basic 
level is an ‘action plan’ through to the most advanced which is ‘integrated 
care.’ With the addition of each layer a new set of content and processes are 
involved. As previously discussed the lack of clear definition of terminology in 
self-management can be confusing, and using the descriptions in the model 
may help practitioners, researchers and those involved in the field to have a 
clearer understanding of the different stages. 
 
Another function of this model is to aid in the decision-making process for 
practitioners in terms of management of their patients. Practitioners often 
need to make difficult decisions about patient care, particularly in a healthcare 
climate where resources are constrained and interventions must be allocated 
carefully. While it may be desirable for all patients to receive the most 
comprehensive care available, this is not always possible. This model may 
help guide practitioners in allocation of self-management support in a tiered 
process; the most basic for those with milder disease and the most 
comprehensive for more severely compromised. The content and processes 
involved at each level can be used to decide upon treatment choice based on 
individual patient deficits and needs. 
 
Overall it is important that the approach taken is well suited to the model of 
healthcare for which it is intended. In the UK, the impetus on self-
management for COPD has been outlined in the Outcomes Strategy for 
COPD and asthma (Department of Health 2012a). While there is evidence of 
improved patient outcomes, the implication of being able to achieve these 
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benefits at low cost is necessary in order to tackle the growing burden of 
COPD. Highly supervised self-management courses have been more than or 
equally resource intensive as most pulmonary rehabilitation courses which 
have been implemented successfully for many years. There is scope to 
develop self-management programmes in the UK which aim to provide an 
effective treatment regime that adopts more of a ‘light-touch’ approach. 
 
2.6 Literature Summary 
COPD poses a significant burden on the individual, the family and the 
healthcare system. There are a range of general management approaches 
which can be employed, and include pharmacology, smoking cessation, and 
pulmonary rehabilitation. These therapies tend largely to be provided in a 
reactive response to disease deterioration. Many of the current global 
healthcare systems are challenged in how to appropriately manage chronic 
disease, and often attempt to apply strategies designed for acute care onto 
the management of COPD. This is usually an ill fit, as there are many 
differences in the characteristics and therapeutic goals of both acute and 
chronic illness. The Chronic Care Model proposes that healthcare provision 
must be reformed in order to meet the needs of people living with long-term 
conditions. The CCM identifies that treatment should be evidence-based, 
systems should be improved, performance should be monitored, regular 
planned follow-up included, patients should be included in decision-making, 
and self-management should be supported. 
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It is inevitable that all people living with COPD will self-manage their condition. 
By providing self-management support, the aim is to provide patients with the 
skills and knowledge that is required to enable them to make decisions that 
will optimise their medical and emotional well-being. To improve self-
management is to embrace behaviours which will have a positive impact on 
health. There are, however, many factors which might influence behaviour. In 
supporting self-management, skills in problem-solving, decision-making, 
recourse utilisation, collaborative partnerships and taking action should be 
promoted. For individuals with COPD, there are more disease specific skills 
and behaviours to be addressed, including but not limited to exercise, 
relaxation, smoking cessation, inhaler technique, breathing control, chest 
clearance and exacerbation management. 
 
There have been several studies of self-management programmes for COPD 
published from around the globe. The interpretation of the term ‘self-
management’ has led to the development of great variety between 
programmes. Some have been as simple as an action plan, while others have 
provided highly intensive supervised programmes of exercise and education 
over substantial durations. With the aim of bringing clarity to the literature, this 
variety has been interpreted as a tiered approach to self-management support 
(figure 2.8 and appendix 2). Using this spectrum may be useful for 
researchers to define where along the spectrum an intervention sits, and also 
for practitioners to guide therapy for their patients. It is clear from the 
literature, however, that as yet there is no consistent message with regards to 
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how, who and when self-management support should be provided for people 
with COPD.  
 
As yet, there is no standardised approach to self-management for COPD in 
the UK, and studies of programmes to date have either developed 
interventions which are not feasible for a UK model of healthcare, have failed 
to intervene or have had methodological flaws. With a need for evidence of a 
feasible self-management programme for COPD in the UK, this thesis 
describes the work of a study conducted to evaluate the impact of a new self-
management programme – a Self-management Programme of Activity, 
Coping and Education – SPACE FOR COPD. SPACE FOR COPD is an 
independently followed programme which incorporates exercise training and 
promotes knowledge and skill acquisition. The programme is described in 
more detail in chapter 3. The study used a variety of outcome measures in 
order to reflect the range of skills required to self-manage COPD and to allow 
for exploration of the data in terms of health behaviour change. It was 
anticipated that SPACE FOR COPD would lead to improvements in clinical 
outcomes, when compared with usual care. The hypothesis was the SPACE 
FOR COPD would confer greater gains in HRQoL at six months, compared 







Chapter 3 Methods 
 
3.1 Introduction 
This chapter describes the methods employed in chapters 4, 5, 6 and 7. 
These chapters explore the main components of the RCT described in this 
thesis. This includes evaluation of the effectiveness of a SPACE FOR COPD 
at six weeks and six months, and the impact on physical activity. This chapter 
will describe the study design, patient recruitment, outcome measures and 
provide detailed description of the SPACE FOR COPD intervention. It will also 
outline information on data storage and methods of statistical analyses 
employed in this thesis. 
 
3.2 Main study design 
This was a single blind RCT (figure 3.1). Patients were randomised to receive 
either usual care through their General Practitioner (GP) or to an intervention 
group that received SPACE FOR COPD in addition to their usual GP 
management. A further detailed description of the SPACE FOR COPD 
intervention can be found in section 3.6 and of the usual care in section 3.7 of 
this chapter. All participants were assessed at baseline prior to randomisation 
and re-assessed after six weeks of receiving their intervention and again after 









3.3 Randomisation and blinding 
A third party randomisation service was provided by the Leicester University 
Clinical Trials Unit (CTU). Simple randomisation was used and the CTU 
prepared a list of codes in a random order; either intervention or control. 
These codes were accessed by the research team via an internet-based log-
in system called ‘Sealed Envelope’. The research team able to access these 
codes were Katy Mitchell, Sally Singh and Samantha Harrison, all of whom 
were unblinded researchers. Upon entering the patient identification number 
on Sealed Envelope the researcher was provided with the next code in the 
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sequence. Participants randomised to ‘control’ received usual care and those 
randomised to ‘intervention’ received the SPACE FOR COPD intervention. 
Follow-up assessments at six weeks and six months were all performed by a 
blinded researcher (Vicki Warrington) who was unaware which group the 
participant had been allocated to. It was not possible to blind participants from 
which group they had been allocated. Participants were informed of the 
blinding procedure and were advised not to inform the blinded researcher of 
their randomisation. 
 
3.4 Patient recruitment details 
3.4.1 Ethical approval 
Ethical approval for the study described in this thesis was obtained from the 
Leicester, Leicestershire and Rutland Research Ethics Committee Nottingham 
2. Sponsorship was provided by University Hospitals of Leicester (UHL) NHS 
trust (appendix 3). Approval was also obtained from the Research and 
Development departments of Leicester City Primary Care Trust, 
Leicestershire County Primary Care Trust and Coventry Teaching Primary 
Care Trust. 
 
Subjects were provided with a written information sheet (appendix 4) and 
were given at least 48 hours to consider the information and to ask any 
questions. Informed written consent was provided by all participants (appendix 
5). It was made clear that refusal to take part or withdrawal from the study 
would not affect their current or future medical care. 
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The GPs of all participants were informed of their patients’ involvement with 
the trial and were sent a copy of the consent form, a patient information sheet, 
a copy of the protocol and a covering letter. A copy of the consent form, 
patient information sheet, GP covering letter and a copy of their initial reply 
slip was filed in the UHL medical notes. If the individual did not have medical 
notes a new set was created. Each participant was given a copy of the 
consent form and a copy was kept with an information sheet in a research file. 
Trial registration number: ISRCTN33482179. 
 
3.4.2 Recruitment 
Participants were recruited through 30 general practices in primary care in 
Leicester, Leicestershire, Rutland and Coventry. Practices were approached 
by the Primary Care Research Network (PCRN), and those interested in 
assisting in recruitment were put in contact with the study team. A mail out 
was conducted to all patients on each practice COPD register, which provided 
a patient information sheet. Patients who were interested in participating in the 
study were asked to complete the reply slip and send to the study team to 
arrange screening for suitability. 
 
3.4.3 Inclusion Criteria 
Subjects were eligible to participate and to be randomised in the trial if they 
had airflow obstruction diagnosed with spirometry (FEV1/ FVC ratio < 0.7) in 
accordance with the GOLD guidelines (Global Initiative for Chronic 
Obstructive Lung Disease (GOLD) 2013), a clinical picture of COPD and self-
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reported as MRC dyspnoea grade 2-5. They also had to be able to 
understand and read English to the level of an eight year old. 
 
3.4.4 Exclusion Criteria 
Subjects were excluded from participation if they had locomotive, neurological 
or cognitive impairment that would prevent engagement with the exercises 
provided by the SPACE FOR COPD intervention. They were also excluded if 
they had completed pulmonary rehabilitation within the previous 12 months. 
 
3.5 Outcome Measures 
Assessment of all outcome measures was performed at three time points: 
baseline prior to randomisation, six weeks from receiving the intervention and 
six months from receiving the intervention. The outcome measures can be 
divided into four main categories: exercise performance, patient reported 
outcome measures, healthcare utilisation and physical activity. 
 
Baseline Visit 
During the baseline visit general clerking information was collected. This 
included demographics, past medical history, smoking history, current 
respiratory-related symptoms, current medications, height, weight and social 
status. Resting Borg breathlessness, heart rate and oxygen saturations were 
recorded. Spirometry was performed in order to confirm the diagnosis of 
COPD. This was performed on a Vitelograph and was carried out according to 
the BTS guidelines (British Thoracic Society 2005). Participants that failed to 
show a diagnosis of COPD as previously described in section 3.3 were 
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withdrawn from the trial, no further data was collected and were referred back 
to their GP. These participants were not randomised to a study treatment 
group. 
 
(1) Exercise Performance 
(i) Incremental Shuttle Walking Test [ISWT (Singh et al. 1992)] 
This is a standardised and externally paced field walking test that is 
incremental and progressive. The test has been validated for use with 
individuals who have COPD and it compares favourably with peak oxygen 
uptake as measured by conventional laboratory maximal exercise tests in this 
population (Singh et al. 1994). Participants were asked to walk around a 10m 
course along a flat hospital corridor which was marked out by two cones 
placed nine metres apart to allow 0.5 metres at each end for turning. The 
speed of walking was dictated by audio signals from a CD player. The speed 
began slowly and increased after each minute. The test continued until the 
individual was either too breathless or fatigued to continue or until the speed 
could no longer be maintained. The test was operated according to the 
standardised instructions. The total number of shuttles completed was 
recorded as metres. Oxygen saturations and heart rate were recorded 
immediately on completion of the test using a pulse-oximeter. Borg 
Breathlessness and perceived exertion scores were obtained upon test 





(ii) Endurance Shuttle Walk Test [ESWT (Revill et al. 1999)] 
This is an externally paced constant speed walking test of endurance 
capacity. This was performed following the ISWT and after allowing for a long 
enough rest period for oxygen saturations and heart rate to return to baseline. 
Participants were asked to walk around the same 10m course as described 
for the ISWT. The speed was again dictated by audio signals from a CD 
player, and after approximately 100 seconds of warm up at the slower speed, 
a triple bleep denoted the start of the faster endurance speed which then 
remained constant until the test was complete. The speed at which the 
individual was required to walk during the ESWT was calibrated by using their 
ISWT distance in the regression equation described by Singh et al. (Singh et 
al. 1992) to estimate their peak oxygen consumption (VO2 peak). A speed 
was selected that related to the individual working at a rate of approximately 
85% of their peak VO2. The test was terminated either when the individual 
was too breathless or fatigued to continue or when the pace could no longer 
be maintained. The test was timed from the end of the warm up until 
completion. The maximal length of the test is 20 minutes. 
 
(2) Patient-reported outcome measures 
(i) Chronic Respiratory Questionnaire- Self Reported [CRQ-SR (Williams et al. 
2001)] 
This questionnaire is comprised of 20 questions which cover four domains; 
dyspnoea, fatigue, emotion and mastery (appendix 6). Questions are 
answered on a seven point Likert Scale. The dyspnoea domain is the only 
component which is tailored to the individual as the respondent is instructed to 
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self select activities which have elicited breathlessness in the past two weeks. 
This tool has been found to be valid in a COPD population and sensitive to 
change following a course of pulmonary rehabilitation (Williams et al. 2003). A 
change of 0.5 per domain has been defined as the minimal clinically 
significant difference for this group of individuals (Jaeschke et al. 1989). The 
questionnaire has been used extensively in people with COPD and takes 
about five to 10 minutes to complete. 
 
(ii) Hospital Anxiety and Depression Scale [HADS (Zigmond and Snaith 1983)] 
This is a short scale developed as a screening tool for the detection of states 
of anxiety and depression in a hospital or medical outpatient setting (appendix 
7). It is comprised of 14 questions, seven of which give a score for an anxiety 
subscale and seven of which give a score for a depression subscale. The 
authors state that total score per subscale of eight to 10 shows a borderline 
state of anxiety or depression and a score greater than 10 indicates a 
probable state of anxiety or depression. The questionnaire takes 
approximately three minutes to complete. 
 
(iii) Pulmonary Rehabilitation Adapted Index of Self-Efficacy [PRAISE (Vincent 
et al. 2011)] 
Adapted from the General Self-Efficacy Scale, the PRAISE includes the 
original 10-item questions alongside an additional five items which are 
disease specific (appendix 8). Individuals are instructed to reflect on each 
statement on a four point Likert type scale as to whether it is ‘not at all true’, 
‘hardly true’, ‘moderately true’ or ‘exactly true’. The score range per question 
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is one to four, giving a total score range of 15-60. A higher score indicates 
greater self-efficacy. It has been validated in a COPD population and has 
shown to be sensitive to change following pulmonary rehabilitation (Vincent et 
al. 2011). It takes around five minutes to complete. 
 
(iv) Bristol COPD Knowledge Questionnaire [BCKQ (White et al. 2006)] 
A measurement of knowledge, the BCKQ is a self-reported multiple choice 
questionnaire (appendix 9). It is divided into 13 topics; In COPD, COPD, 
symptoms, breathlessness, phlegm, chest infections/ exacerbations, exercise, 
smoking, vaccinations, inhaled bronchodilators, antibiotic treatment, steroid 
tablets for COPD and inhaled steroids. Each topic contains five statements 
and the respondent is instructed to indicate whether they think the statement 
is true, false or if they don’t know. A score of one is allocated for a correct 
answer and zero for an incorrect answer and for all answers marked as ‘don’t 
know’. The score range is zero to 65, and a higher score indicates better 
knowledge. The questionnaire has been validated in a COPD population, has 
shown to be sensitive to change following pulmonary rehabilitation (White et 
al. 2006) and takes around 10 minutes to complete. 
 
(3) Healthcare Utilisation 
Utilisation of both primary and secondary healthcare resources was captured 
by retrieving data directly from electronic records held by the participants’ GP 
practices and local hospitals. Participants were also asked to report their 
healthcare utilisation in order to capture data which may have been missed, 
such as any healthcare visits which might have occurred out of the area. Visits 
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to the GP, practice nurse, other healthcare professional, emergency 
department visits, hospital admissions were recorded for both respiratory and 
non-respiratory related causes. Courses of antibiotics and steroids were also 
recorded.  
 
(4) Physical Activity 
The SenseWear Armband (SAB) Pro3 (Bodymedia, Pittsburgh) physical 
activity monitor is a portable lightweight device which is worn on the upper 
right arm (figure 3.2) and provides a measure of ‘free living’ activity. It is a 
multi-axial accelerometer which uses specific algorithms to determine total 
energy expenditure, time and energy expenditure over a METs threshold and 
number of steps. It has been validated against a visual count of steps at 
various speeds in both healthy and COPD populations (Hill et al. 2010a). 
Reliability was found to weaken with slower walking speeds, however was still 
preferential to a conventional pedometer (Turner et al. 2012). Individuals were 
instructed to wear the SAB for seven consecutive days during all waking 
hours, other than when the monitor might get wet, such as taking a bath/ 
shower or going swimming. The monitor was worn for a seven-day period 



















3.6 The SPACE FOR COPD Intervention 
The SPACE FOR COPD manual is a 176 page workbook which is composed 
of information directed at providing individuals with COPD with knowledge and 
skills with which to manage their condition (figure 3.3). The main components 
are: drug management, symptom management, management of psychological 
consequences, lifestyle, social support, communication and incorporates goal 
setting and action plans. The manual is comprised of four stages, which aim 
to gradually introduce new topics to the individual over time. For a full list of 


















3.6.1 The SPACE FOR COPD manual introduction 
All participants who were randomised to ‘intervention’ received the SPACE 
FOR COPD manual. It was introduced to the participants by a healthcare 
professional (HCP) on a one-to-one basis at the individual’s home during a 
single 30-45 minute consultation. The purpose of this session was to 
introduce the individual to the contents of the manual, to identify learning 
needs and to employ motivational interviewing techniques to discuss the 
individual’s willingness to change. 
 
Introduction to the contents of the SPACE FOR COPD manual 
The aerobic training component of the manual advises individuals to 
participate in a daily timed walk, and is described in stage one of the manual. 
Initially this is broken down into manageable periods of walking as dictated by 
This item has been removed due to 3rd 
Party Copyright. The unabridged version of 
the thesis can be viewed in the Lanchester 
Library Coventry University.
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the individual’s level of dyspnoea, with the overall aim of achieving 30 minutes 
of exercise five times per week. The HCP completed sections in the manual 
which notified the speed and duration of walking that was achieved by the 
individual during the ESWT. Participants were advised to complete their daily 
walk at that pace which should feel ‘brisker than their normal and comfortable 
walking speed.’ The aim of the daily walk was to increase the duration by a 
few seconds each day. The manual contains a walking diary in which 
participants were instructed to record their longest walk of the day, their total 
walking time of the day (in the event they did more than one walk) and to use 
a zero to 10 scale of how hard they found the walk (appendix 11). It was 
advised that each walk should be terminated when the individual scored 
between four and six on this scale. 
 
Resistance training exercises are described in stage three of the manual. 
They were discussed during the introduction; however, individuals were 
informed not to commence this stage until a review had taken place two 
weeks later. For a description of the resistance training exercises see 
appendix 12. The manual provides instructions that each exercise should be 
carried out for three sets of eight repetitions, and should be carried out three 
days per week. Individuals were asked to complete a diary of resistance 
training, which details the weight used, the number of repetitions completed 
and the level of difficulty on a zero to 10 scale for each exercise. 
 
The action plan was also explained to the patient by the HCP during the initial 
introduction (appendix 13). Each person receiving the manual was asked 
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about their frequency and current management of infections or exacerbations. 
Patient details, current medications and emergency medications were 
completed on the form. Signs and symptoms of an exacerbation were 
highlighted by the HCP and forms of management were identified. The 
individual was directed to the pages in the manual which could be useful in 
the management of their exacerbations. 
 
Identification of learning needs 
The results from the baseline BCKQ were observed by the HCP, and any 
areas of deficit were highlighted and used to prompt the patients about 
possible learning needs. Participants were shown the contents page of the 
manual and asked to discuss topics of interest or areas which they felt 
inclined to know more about which helped to identify any other learning needs 
which had not been detected from the BCKQ. 
 
Motivational Interviewing (MI) 
A key aim of the manual is to support the individual in making changes in 
health behaviours which have led to or may alleviate the symptoms of COPD. 
This is largely done through a process of providing knowledge, promoting self-
efficacy and goal setting. It was also facilitated by the HCP through MI, with 
particular respect to commencing the exercise programme. The HCP 
conducting the introduction was trained in MI. The purpose of the MI 
discussion was to establish the individual’s willingness to participate in the 
exercise programme by exploring issues of confidence and importance, to 
discuss the pros and cons to change and to identify motivating factors and 
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possible barriers. The duration of MI varied dependent upon the individual’s 
response. The greater the ambivalence that was displayed the more time was 
spent on this discussion. 
 
Readiness to change was evaluated and discussed by using ‘readiness 
rulers’. Individuals were asked on a scale of one to 10 how important it was to 
them and how confident they were to undertake a daily walking programme. 
The individual’s responses to these questions were used to provoke further 
discussion, supporting self-efficacy to enhance motivation. Various forms of 
reflections and rolling with resistance were used by the HCP to reinforce 
change dialogue from the patient. Preserving the individual’s autonomy was 
an important aspect of the consultation, and goals which were set were made 
by the patient and not the HCP.  
 
3.6.2 Telephone support 
Each participant who received the SPACE FOR COPD manual received two 
phone calls from the HCP who had conducted the introduction. They took 
place two and four weeks following the 30-45 minute introduction. The 
purpose of the telephone calls was to monitor and review progress of the 
exercise programme, continue the use of MI and provide encouragement. 
Individuals were also given the opportunity to ask questions or discuss 
problems related to working through the manual. The consultation was 
expected to be approximately five minutes. A copy of the telephone contact 
schedule is provided in appendix 14. 
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3.7 Best usual care 
All participants maintained access to their best usual care provided by their 
GP. For those randomised to the ‘control’ group, this was the only form of 
management that was received. Participants were recruited from 25 GP sites 
therefore it was not possible to standardise for all participants. 
Pharmacological management and an annual review comprising spirometry, 
MRC dyspnoea grade assessment, smoking status are common features of 
usual care. No participants were referred to pulmonary rehabilitation as part of 
their usual care during that study period. 
 
3.8 Data storage 
Notes were kept in a locked filing cabinet and were identifiable only by the 
participant identification number. All electronic files containing individual data 
were kept on a network drive of UHL in a password protected file that was 
only accessible by the research team. A copy of the log of study visits and a 
copy of the outcome summary was filed in the patients’ hospital medical notes 
and distributed to the GP. All paperwork and electronic files will be kept for 15 
years in line with UHL policy. 
 
3.9. Sample size 
This study was powered on the primary outcome of the CRQ-SR dyspnoea 
domain at six months. To detect a between-group difference of mean (SD) 0.5 
(1.0) a sample size of 62 per group was required for 80% power, two-tailed 
tests (α0.05). In anticipation of up to a 30% attrition rate, the total sample size 
was increased to 184. 
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3.10 Statistical analysis 
Statistical support was provided by the trial statistician at the University of 
Leicester (JB). Data was predominantly analysed using Predictive Analytics 
Software [PASW previously known at Statistical Package for Social Science 
(SPSS)] version 18. STATA was used to carry out multiple imputations for 
missing data and Statistical Analysis Software (SAS) was used in the analysis 
of physical activity data in chapters 6 and 7. For the main outcomes at six 
months, an intention to treat approach was planned. The level of significance 
throughout was set at p<0.05. Data was screened for outliers. All data was 
assessed for normality so that appropriate parametric or non-parametric tests 
could be conducted. Normally distributed data are expressed as mean and 
standard deviation (SD) and non-normally distributed, or categorical data are 
expressed as median and inter-quartile (IQR) range or frequency and 
percentage. 
 
Between-group differences in baseline characteristics were compared with 
either independent t-tests for continuous data or chi square tests for 
categorical data. These tests were used again to test for differences between 
those who completed and those who did not complete the study. 
 
Between-group comparisons at six weeks were made using independent t-
tests and Mann-Whitney U tests for parametric and non-parametric data 
respectively. Within-group changes at six weeks were analysed with paired t-
tests or Wilcoxon tests for parametric and non-parametric data respectively. 
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To correct for baseline differences between groups, analysis of covariance 
(ANCOVA) was performed. 
 
At six months, an intention to treat (ITT) analysis was carried out. STATA was 
used to create 10 models of multiple imputations for missing data, according 
to a multiple imputations chained equations (MICE) technique (Azur et al. 
2011). To analyse between-group differences and within-group changes at six 
months, repeated measures analysis of variance (ANOVA) was employed. 
 
SAS was used to calculate bouts of baseline physical activity. A Kruskal-
Wallis test was used to test for differences in activity between MRC grades 
and GOLD stages, and a Mann Whitney U used for post hoc analyses. Bouts 
of activity were compared with total activity by using a Wilcoxon signed rank 
test. Linear regression was conducted in order to establish whether any 
characteristics or baseline variables were able to predict change in physical 


















There have been many studies published of self-management programmes 
for COPD, however, results of trials have been inconsistent. The literature 
gives no clear indication as to why some studies have had better 
improvements than others. Even with the publication of more self-
management studies since the Cochrane Review of self-management in 2007 
(Effing et al. 2007), the message that there is considerable heterogeneity 
between interventions, outcomes and follow-up remains. 
 
Time to follow-up is important to consider. Many studies initiated primary 
follow-up contact at anything between three months to seven or 12 months in 
the case of one study (Effing et al. 2011). A potential problem with not 
performing short-term follow-up is that treatment differences in this early 
period will not be detected. Self-management studies which have not 
performed outcome measures until seven months may have missed the 
opportunity to detect greater between-group differences and therefore fail to 
identify the need for any further support. The duration of the intervention 
should also be considered, as it may be supposed that programmes of longer 
duration would yield better results. The ‘intervention period’ of SPACE FOR 




This chapter will describe the short-term (six weeks) phase of the RCT 
described in chapter 3. Patients were recruited and randomised to receive 
usual care, or usual care plus SPACE FOR COPD. Patients were assessed at 
baseline and again six weeks later.  
 
4.2 Aims 
This chapter aims to explore the following: 
i) Between-group change in outcomes at six weeks 
 ii) Within-group response to treatment at six weeks 
 
4.3 Methods 
The methods for the study are described in detail in chapter 3. Please refer to 
this chapter for details related to recruitment, randomisation, blinding, 
outcome measures and a description of the intervention and usual care. The 










Figure 4.1 Study Design at six weeks 
Outcome Measures 
The outcome measures used in this study are described in detail in chapter 3. 
The outcome measures included were: 
 
Chronic Respiratory Questionnaire – Self Reported (CRQ-SR) dyspnoea, 
fatigue, emotion and mastery domains 
Hospital Anxiety and Depression Scale (HADS) 
Incremental Shuttle Walking Test (ISWT) 
Endurance Shuttle Walk Text (ESWT) 
Bristol COPD Knowledge Questionnaire (BCKQ) 
Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) 
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Power Calculation 
This study was powered to detect a between-group difference of mean (SD) 
0.5 (1.0) on the CRQ-SR dyspnoea domain at six months. For 80% power, 2-
tailed tests, 62 participants per group were required. Anticipating a 30% drop 




SPACE FOR COPD is an independent, individualised and standardised 
workbook for people with COPD, and is described in greater detail in chapter 
3. The aim of the programme is to support individuals in learning self-
management and disease specific skills that will enable them to improve 
health behaviours, such as exercise, smoking behaviour, stress management, 
breathing control and exacerbation management. Individuals randomised to 
the intervention arm of this study were introduced to the manual by a 
physiotherapist (KM). During this introduction motivational interviewing was 
used to discuss readiness to change, and the manual contents and the home 
exercise programme within SPACE FOR COPD was described to the patient. 
The exercise programme was to be conducted entirely at home, 
unsupervised, and consisted of daily walking and resistance training. Goal-
setting and problem solving strategies were embedded in the manual and 
supported by the therapist during the introduction. Patients then received two 
standardised phone calls from KM to assess progress, identify challenges and 
encourage progression. These occurred two weeks and four weeks from 
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initiation of the intervention, and example of the phone call pro forma is 
included in appendix 14. 
 
Usual care 
All participants continued to receive their usual care; however, patients 
randomised to the control group received no additional treatment. Usual care 
could not be standardised as it was embedded in clinical services, and 
withholding care would be considered unethical. Routine clinical care in the 
UK, however, usually consists of an annual review from their practice nurse 
which includes spirometry, and review of pharmacotherapy. No patients 
received any other self-management programme or pulmonary rehabilitation 
as part of their usual care. 
 
Statistical analysis 
Statistical analyses were completed using Predictive Analytics Software 
[previously known at Statistical Package for Social Science (SPSS)] version 
18. Baseline between-group differences were established with an 
independent t-test for continuous data and with chi square test for categorical 
data. The between-group differences in measures were compared using 
independent t-tests and Mann-Whitney U tests for parametric and non-
parametric data respectively. For within-group comparisons, paired t-tests or 
Wilcoxon tests were applied on parametric and non-parametric data 
respectively. Analysis of Covariance (ANCOVA) was used on measures 




184 patients were recruited and randomised to the study; 95 to usual care and 
89 to SPACE FOR COPD. 11 patients withdrew from the usual care group 
and 18 patients from the SPACE FOR COPD group. Reasons for withdrawal 
are outlined in table 4.1. The total missing data at six weeks was 29, or 
15.76%. Independent t-tests showed that there were no significant baseline 
differences between those who did and did not complete their six-week 
assessment (table 4.3). Baseline demographic data are described in table 4.2. 
Data are expressed as mean (SD) for continuous data and absolute values for 
categorical data. There were no significant differences between groups in 
baseline characteristics. 
 
Table 4.1 Reasons for study withdrawal 
Reason for withdrawal Usual care SPACE 
Co-morbidities 2 5 
Did not attend appointment 4 3 
Lost to follow up 1 4 
Intervention too difficult N/A 1 
Intervention too easy N/A 1 
Social 2 0 
Unable to attend appointment 2 3 
Work Commitments 0 3 




Table 4.2 Baseline characteristics of SPACE FOR COPD and usual care 
groups 





Age (yrs)  
[mean (SD)] 
69.9 (10.1) 69.0 (8.1) 0.502 
FEV1 (litres) 
[mean(SD)] 
1.45 (0.55) 1.45 (0.57) 0.973 
Male: Female 
[n (%)] 
47 (49) : 48 (51) 54 (61) : 35 (37) 0.127 
BMI 
[mean(SD)] 
27.09 (4.9) 28.05 (5.6) 0.217 
Age left education 
[mean(SD)] 

















































































69.2 (9.3) 0.851 
FEV1 (litres) 
[mean(SD)] 
1.46 (0.54) 1.39 (0.64) 0.550 
Male: Female 
[n (%)] 
84 (54) : 71 (46) 17 (59) :12 (41) 0.501 
BMI 
[mean(SD)] 
27.71 (5.27) 26.66 (5.16) 0.327 
Age left education 
[mean (SD)] 


































































Health-Related Quality of Life (HRQoL) 
The CRQ-SR is composed of four domains; dyspnoea, fatigue, emotion and 
mastery. The dyspnoea domain at six months is the primary outcome of this 
trial. There was a significant baseline between-group difference for CRQ-SR 
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dyspnoea domain. An ANCOVA was performed on the dyspnoea domain in 
order to adjust for this. Between-group differences in the change score from 
baseline to six weeks for all domains of the CRQ-SR are presented in table 
4.4 and figure 4.2. This shows that there were statistically significant between-
group differences in the change in dyspnoea, fatigue and emotion domain but 
not mastery. Baseline, six weeks, and within-group change scores for all 
domains for usual care and SPACE FOR COPD are presented in table 4.5. 
There were significant within-group changes in dyspnoea, fatigue and emotion 
domains in the SPACE group, and a significant within-group change in the 
dyspnoea domain in the usual care group. 
 
Table 4.4 Between-group differences in the change in CRQ-SR from baseline 
to six weeks 





0.33 (-0.001-0.665) 0.049 
Fatigue 
 
0.37 (0.08-0.66) 0.013 
Emotion 
 
0.35 (0.08-0.62) 0.011 
Mastery 
 









Table 4.5 CRQ-SR at baseline, six weeks and mean change for SPACE FOR 
COPD and usual care groups 





















































































































The between-group differences in HADS scores are presented in table 4.6 
and within-group changes are presented in table 4.7 and in figure 4.3. This 
showed significant between-group and within-group changes in the SPACE 
group in HADS anxiety, and no changes in depression. 
 
 
Table 4.6 Between-group differences in the change in HADS from baseline to 
six weeks 
 






-0.74 (-1.45 to -0.02) 0.044 
HADS 
Depression 


































Table 4.7 HADS baseline, six weeks and mean change scores for SPACE 
FOR COPD and usual care groups 



























































Given that HADS scores ≥8 suggest a possible or probably presence of 
anxiety or depression (Zigmond & Snaith 1983), a sub-group analysis was 
performed on those who had a baseline score of ≥8 in the anxiety domain 
(n=59) and ≥8 in the depression domain (n=38). There was no significant 




Between-group differences in ISWT and ESWT are presented in table 4.8 and 
figures 4.4 and 4.5, which show that there were statistically significant 
between-group differences in change in ISWT and ESWT. Within-group 
changes are presented in table 4.9. The within-group change in ESWT was 




Table 4.8 Between-group differences in the change in ISWT and ESWT from 
baseline to six weeks 






20.5 (3.8 to 37.2) 0.017 
ESWT (seconds) 
 






Table 4.9 ISWT and ESWT at baseline, six weeks and mean change for 
SPACE FOR COPD and usual care groups 
















































(32.4 to 138.8) 
0.002 
 


































Knowledge and Self-efficacy 
Between-group differences for the BCKQ scores and PRAISE scores are 
presented in table 4.10. Within-group changes are presented in table 4.11. 
There were significant between-group and within-group changes for the 
SPACE group in the change in BCKQ, and no change in the PRAISE. 
 
Table 4.10 Between-group differences in the change in knowledge and self-
efficacy from baseline to six weeks 






2.21 (0.09 to 4.33) 0.041 
PRAISE 
 







Table 4.11 Knowledge and self-efficacy at baseline, six weeks and mean 
change for SPACE FOR COPD and usual care groups 



























32.70 (9.80) 33.02 
(10.13) 












The data described in this chapter refers to the six-week outcomes of an RCT 
which aimed to test the effectiveness of SPACE FOR COPD. Measures of 
health related quality of life, exercise capacity, knowledge and self-efficacy 
are examined in order to establish the short-term impact of SPACE FOR 
COPD. The findings of this chapter will be discussed under the following 
headings; health-related quality of life, anxiety and depression, exercise 
performance, knowledge, self-efficacy, limitations and conclusions. 
 
Health Related Quality of Life (HRQoL) 
The results from this chapter demonstrate a statistically significant mean (95% 
CI) difference between the groups of 0.33 [-0.001 to 0.665 (p=0.049)] in the 
change in CRQ-SR dyspnoea domain. There were significant within-group 
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changes for both SPACE FOR COPD and usual care groups, however, only 
the SPACE FOR COPD group exceeded a mean change of ≥ 0.5, which is the 
MCID (Jaeschke, Singer, & Guyatt 1989). Statistically significant between-
group and within-group changes were also observed in the fatigue and 
emotion domains of the CRQ-SR. No changes were observed in the mastery 
domain. These findings suggest that SPACE FOR COPD confers greater 
benefits in HRQoL, compared with usual care, at six weeks. As previously 
discussed in chapter 2, other self-management programmes for COPD have 
had mixed success in their impact on HRQoL. It is worthwhile to consider how 
the findings from SPACE FOR COPD compare with the literature so far. 
 
Figure 4.6 has been adapted from figure 2.6 in chapter 2, with the SPACE 
FOR COPD study incorporated. SPACE FOR COPD is allied with the studies 
by Khdour et al. (2009) and Moore et al. (2009), insofar that it is based on 
unsupervised education and unsupervised exercise training. All three of these 
programmes have demonstrated a positive impact on HRQoL, suggesting that 
a ‘light-touch’ approach to self-management can be effective in promoting 
patient benefit. This is likely to be an important consideration for policy 
makers, who will want to provide effective programmes with as limited 














RED = no impact on HRQoL 
GREEN = significant impact on HRQoL 
While the study by Moore et al. (2009), with only 27 participants, was likely to 
be underpowered, the study by Khdour et al. (2009) was a large RCT. 
Interestingly this was also a manual-based programme, delivered during a 
one-hour consultation, supported by motivational interviewing (MI) and 
reinforcement through telephone contact. Although only the Khdour et al. 
study and the SPACE FOR COPD study have used this kind of approach, 
both have had a successful impact on HRQoL. MI has previously been 
identified as a useful technique for influencing behaviour change (Hettema et 
al. 2005). In an expert review (Effing et al. 2012) it was suggested that 
cognitive components such as cognitive behavioural therapy (CBT) or MI 
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should be considered as part of future self-management interventions. This 
may be important for changes in HRQoL. The success of these two studies 
suggests that for programmes adopting a light-touch approach, motivational 
interviewing may be a useful technique. 
 
Other self-management studies which have been successful in improving 
HRQoL, with the exception of COPE II, have mostly included more severe 
patients (Bourbeau et al. 2003; Boxall et al. 2005; Ghanem et al. 2010), 
whereas several unsuccessful studies have recruited milder patients (Bischoff 
et al. 2012; McGeoch et al. 2006). This may be as a result of a ceiling effect in 
those who are milder, whereby high baseline scores leaves little room for 
improvement. Patients who are more severe at baseline have more to gain, 
and therefore studies which have recruited more severe patients may have 
appeared to be more effective. However, both the SPACE FOR COPD study 
and COPE II (Effing et al. 2011) have recruited milder patients and have 
demonstrated significant improvements in HRQoL. A comparison of these 
studies requires further attention. 
 
Although the COPE II study population was slightly younger (mean age ~ 63 
yrs), their degree of airflow obstruction was similar to that of the patients in 
this study [1.43 litres (COPE II self-management) and 1.40 litres (COPE II 
usual care) vs. 1.4 litres SPACE FOR COPD intervention/usual care]. The 
COPE II intervention included six months of compulsory supervised exercise 
three times per week and an optional additional five months supervised 
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exercise twice weekly. In addition to this all patients had two hour small-group 
education sessions for four weeks and telephone support. COPE II was 
powered for ISWT and 142 patients were followed up. At the end of the 
intervention period (12 months) a mean (95% CI) between-group difference of 
0.32 [-0.03 to 0.67 (p=0.04)] for the dyspnoea domain of the CRQ-SR was 
observed. This is a remarkably similar between-group difference achieved in 
the present study after just six weeks.  For the other domains, mean (95%CI) 
differences for the COPE II group were 0.09 (-0.34 to 0.52), 0.10 (-0.22 to 
0.42) and 0.11 (-0.21 to 0.43) for fatigue, emotion and mastery respectively, 
none of which were statistically significant. This is contrast to SPACE FOR 
COPD where significant differences in both fatigue and emotion domains were 
observed. 
 
One similarity between the two studies is that the baseline values of the CRQ-
SR domains are all relatively high (mean baseline scores between 4.13-5.35 
for COPE II and 3.81-5.27 for SPACE FOR COPD) compared with other 
studies (Evans et al. 2010;Sewell et al. 2006). This may afford less 
opportunity for improvement. This may be particularly true for the mastery 
domain, which in the current study was the highest of all domains at baseline 
(5.27 for SPACE FOR COPD and 5.20 for usual care). It is possible that in 
this group of patients that there was little deficit in mastery on commencing 
the study, therefore the intervention would be unlikely to make a difference, as 
might have been anticipated prior to recruitment. 
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These studies both suggest that significant gains in HRQoL can be achieved 
in milder patients with higher baseline scores. It is interesting, however, that 
despite the intensity of the COPE II programme, and a similar population, 
gains in HRQoL were greater in the SPACE FOR COPD group after just six 
weeks than were achieved after either seven or 12 months on COPE II. As 
COPE II did not take measurements any sooner than seven months, it is not 
possible to understand whether between-group differences may have been 
greater earlier within the intervention period, and then began to decline by 
seven months. However, as a model of self-management support, it would be 
difficult to justify the costs of an intervention which requires the infrastructure 
of COPE II, given that the light-touch approach of SPACE FOR COPD 
appears to be just as, if not more, successful in improving HRQoL. 
 
Timing of outcome measures is important, and this is the first self-
management programme in stable outpatients to demonstrate significant 
changes in HRQoL are initiated over such a short period. Moore et al.(2009) 
demonstrated significant improvements at eight weeks, however as previously 
stated, this is likely to be underpowered. Ghanem et al.(2010) found 
significant improvements after two months, however this was in a post 
exacerbation population where the opportunity to recover may be greater. All 
other studies have documented changes between three and 12 months. 
 
Outcome measures were conducted at six weeks in the present study as this 
was considered to be the amount of time required for significant changes in 
health outcomes to occur. Other studies which have a longer intervention 
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period have conducted outcome measures at the end of their intervention 
periods. The findings from the present study are important because it 
demonstrates that significant changes in HRQoL can occur over a short 
duration, and suggests that perhaps self-management interventions do not 
necessarily need to be as long in duration as some other studies have 
provided. This information is useful for healthcare professionals who provide 
self-management support to patients, so that they can plan early follow-up 
and establish progress at an earlier stage. Furthermore, in financially 
constrained services, programmes of shorter duration are likely to be 
favourable. However, the medium- and longer-term maintenance of these 
outcomes must be considered. This will be evaluated in chapter 5. 
 
Anxiety and depression 
The HADS is a frequently employed measure of anxiety and depression, and 
as has been used across a spectrum of diseases. Pre-defined thresholds of 
zero to seven is normal, eight to 10 indicates possible presence 
anxiety/depression and ≥11 a probable presence of anxiety/depression 
(Zigmond & Snaith 1983). The MCID has been estimated at around 1.5 
(Puhan et al. 2008). 
 
The mean baseline scores in both groups for anxiety and depression were 
within the normal range. There was a statistically significant between-group 
difference in change in anxiety scores from baseline to six weeks of mean 
(95%CI) -0.74 (-1.45 to -0.02) p=0.044 (lower scores= improvement). A sub-
group of those who scored ≥8 at baseline (n=59) revealed no significant 
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between-group changes from baseline to six weeks (p=0.382). It has been 
documented that anxiety contributes significantly towards functional 
impairment for patients with COPD (Kim et al. 2000) and is associated with 
increased risk of exacerbations (Eisner et al. 2010). It is therefore considered 
an important health outcome. 
 
Despite the prevalence of anxiety (Harrison et al. 2012), only three self-
management programmes have evaluated the impact of self-management on 
anxiety. The COPE II study (Effing et al. 2011) used the HADS and found no 
difference between groups in anxiety at 12 months with a mean (95% CI) 
difference of 0.05 (-1.00 to 0.90). Similarly to the current population, baseline 
anxiety scores were also within normal range. In contrast to the intensive 
COPE II programme, the study by McGeoch et al. (2006) investigated the 
impact of an action plan for exacerbation management. The impact on HADS 
anxiety was a mean (SD) change of 0.15 (0.7) in the intervention group and 
0.01 (0.3) in the control (p=0.87 between groups). Most recently the Glasgow 
Supported Self-management Trial demonstrated a significant reduction in 
anxiety [treatment effect -1.06 (95%CI -2.08 to -0.03), p=0.44] at 12 months 
(Bucknall et al. 2012). These participants were quite a different group to the 
present study, recruited following hospital admission and more severe, with 
higher baseline scores [mean (SD) 9.7 (4.6)]. The poor response rate of the 
questionnaires (61%) in the Glasgow study might reflect a selection bias, 




It seems counterintuitive that for those who scored more than 8 on the HADS 
that anxiety or depression did not significantly improve. The SPACE FOR 
COPD manual includes several sections which are designed to deal with 
emotions and anxiety management, therefore it might be anticipated that, for 
those who are anxious, the availability of these techniques should reduce 
anxiety levels. There are several points to consider as to why, for those with 
high baseline scores, anxiety did not significantly improve. 
 
The unsupervised aspect of the SPACE FOR COPD programme, may not 
lend itself to improving anxiety for those who are most anxious. Bouts of 
exercise have been documented as precipitating panic attacks (Maurer et al. 
2008) and it has been shown that dyspnoea is strongly associated with 
anxiety (Cleland et al. 2007; Eisner et al. 2010; de Voogd et al. 2011). It is 
possible that the unsupervised exercise programme that patients are advised 
to do at home may stimulate feelings of anxiety in response to an increase in 
dyspnoea on exercise. Supervised exercise training, like pulmonary 
rehabilitation, has shown to reduce anxiety for those who score highly at 
baseline (Harrison et al. 2012). Monninkhof et al. (2004a) conducted a 
qualitative analysis on patients who attended their supervised self-
management programme. A key finding was that many patients felt safer from 
participating in the study, and found the presence and constant re-
assessment from the healthcare professional reassuring. The safety net of 
supervision from a healthcare professional may be important for those who 
have symptoms of anxiety in order to reduce fears and concerns around 
safety and the presence of dyspnoea. It is possible that for those with high 
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baseline anxiety scores, SPACE FOR COPD is too ‘light-touch’ and that these 
patients may require more supervised care from a healthcare professional in 
order to reduce anxiety. 
 
Furthermore, while we might anticipate that increased knowledge will reduce 
anxiety, this may not necessarily be the case. One study of people with COPD 
demonstrated that the patients who were highly anxious had better knowledge 
scores (Dowson et al. 2004). The authors suggest this is perhaps because 
people who panic are more motivated to seek information. However, they 
were more likely to catastrophise any threats to health (such as dyspnoea) 
which would inhibit appropriate behaviour. This study suggests that for those 
who are more highly anxious, education may be insufficient, and perhaps 
more comprehensive interventions are required. While SPACE FOR COPD is 
more than an education programme, and incorporates paper exercises for 
assisting patients to identify coping strategies, we have no measure of how 
well these aspects of the manual were used. Furthermore, these exercises 
may not be comprehensive enough for those who are most at risk of 
symptoms of anxiety. 
 
We should also consider whether the HADS is the most appropriate measure 
of anxiety in this population. The HADS measures general anxiety and 
depression, however, in people with COPD much of the anxiety people 
experience may be more disease-related. The HADS, therefore, may not be 




Finally, we must remain aware of the small numbers of people who scored 8 
or higher at baseline (n=59). It is likely that this sub-analysis is underpowered 
for detecting any significant change. 
 
The mean (95% CI) between-group difference in change in depression from 
baseline to six weeks was -0.62 (-1.36 to 0.12) p=0.102. Depression has only 
been reported by the same three self-management studies which examined 
anxiety. COPE II observed a mean (95%CI) between-group difference of -0.41 
(-1.31 to 0.49), which was not statistically significant (Effing et al. 2011). 
McGeoch et al. (2006) found a mean (SD) change of 0.29 (0.29) in the self-
management group and 0.04 (0.32) in the usual care group (p=0.57 between-
group difference). There was also no significant change in depression in the 
study by Bucknall et al. [treatment effect (95% CI) -0.27 (-1.13 to 0.59) 
p=0.538 (Bucknall et al. 2012)]. It is possible that, for those who are 
depressed, self-management support is too subtle an intervention to reduce 
depressive symptoms, particularly as self-management requires a degree of 
patient motivation. Perhaps depression should be targeted by more intensive 
treatments first, such as cognitive behavioural therapy (CBT). 
 
Exercise Performance 
Exercise performance was measured by the ISWT and ESWT. There was a 
statistically significant between-group difference in the change from baseline 
to six weeks for the ISWT of mean (95%CI) 20 (3.78 to 37.18) metres 
p=0.017, and for the ESWT of 133.99 (39.66 to 228.32) seconds (p=0.006). 
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This suggests that SPACE FOR COPD was more effective than usual care in 
improving exercise performance. 
 
Effing and colleagues found changes in ISWT of a similar magnitude as the 
present study; however this was after a 12 month period of supervised training 
(Effing et al. 2011). Other self-management studies have documented 
improvements in exercise performance, but no other adequately powered 
studies have performed outcome measures as early as six weeks. It is an 
important finding from SPACE FOR COPD that changes in exercise behaviour 
can be observed over such a short time frame. Understanding the course of 
self-management and when behaviour change occurs is important, so that 
expectations of our patients can be managed, and that outcome measures 
can be performed at appropriate time points in order to evaluate individual 
progression. Early evaluation also allows us to test whether the intervention 
works, and then to evaluate maintenance strategies to follow. 
 
An interesting feature of SPACE FOR COPD, which is not common to all self-
management programmes, is that the exercise was entirely unsupervised. 
Indeed, some self-management programmes include no exercise at all 
(Khdour et al. 2009; McGeoch et al. 2006; Watson et al. 1997) and have had 
rather limited success. While guidelines for pulmonary rehabilitation state that 
at least some exercise should be supervised (Nici et al. 2006), there are no 
such guidelines for self-management. There may be several possible benefits 
of supervised training, however, findings in this chapter suggest that entirely 
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unsupervised training is superior to usual care, and is able to yield a 
significant changes result over a six-week period. 
 
Given that training was unsupervised the magnitude of change in the ISWT 
and ESWT might not be as great as expected from a supervised regime over 
such a period. For endurance training, patients in the SPACE FOR COPD 
group were instructed to walk daily at a speed which was 85% of the maximal 
speed achieved on the ISWT performed on their baseline assessment. This 
speed was demonstrated when the manual was delivered, but otherwise 
patients received little indication through the training period as to whether they 
achieved the correct speed. It is possible that patients either underestimated 
or overestimated their walking speed, and therefore did not train at an optimal 
intensity. It is also possible that as patients trained and became fitter, some 
patients may have re-calibrated their speed, and started to walk more quickly 
as they felt they were able to. These patients may not have seen their walking 
times improve, and may have resulted in negative feelings towards training if 
the benefits were not apparent to the individual. The telephone contact at two 
and four weeks were designed to include this in the discussion. 
 
Knowledge 
This study showed a significant between- group difference in mean (95% CI) 
BCKQ scores 2.21 (-0.09 to 4.33) p=0.041. Curiously no other self-
management studies have used the BCKQ, although some have used other 
tools to assess knowledge, all of which have found significant improvements. 
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Knowledge is consistently identified as a key feature in the process of 
behaviour change (Bourbeau et al. 2003), and is widely accepted as 
fundamental to self-management. It is not possible from the data presented 
here to determine to what extent knowledge contributes to behaviour change, 
however this is discussed in chapter 7. 
 
The BCKQ has been used to assess change in knowledge following 
pulmonary rehabilitation (White et al. 2006), with between-group differences of 
around nine points, which is much higher than those observed in this study. 
With respect to this difference, there are two key points to consider. Firstly, 
the questions within the BCKQ may not be relevant knowledge for each 
patient, such as questions about SPACE FOR COPD, steroids or inhaled 
steroids. Patients who received SPACE FOR COPD were advised to prioritise 
reading information that was relevant for them. If an individual did not use a 
SPACE FOR COPD, or steroids or inhaled steroids, then this information was 
not relevant for them and it would not be expected that their knowledge on 
irrelevant questions would change. The second point is that the educational 
material of the manual was not tailored to the questionnaire, and therefore 
some of the questions within the BCKQ may not have been directly answered 
within the pages of the manual. In future studies it may be more useful to 







There were no significant between-group differences observed in PRAISE 
scores at six weeks. Self-efficacy has been described as an important factor 
for behaviour change to occur (Bourbeau, Nault, and Dang-Tan 2004), 
therefore it would seem integral to enhance self-efficacy in any self-
management programme. Why a change was not observed in these data is 
worthy of further consideration. 
 
As discussed earlier in chapter 2, self-efficacy is specific to any given situation 
or task (Bandura 1977a). It is possible, therefore, for an individual to have 
high self-efficacy for one task and low self-efficacy for another. In order to 
have high self-efficacy, an individual must believe that the task is important to 
carry out and that carrying out the task will lead to desirable outcomes. 
SPACE FOR COPD aimed to address this in a number of ways, including 
education, problem-solving activities, barrier identification and case studies. A 
difficulty with measuring self-efficacy is that it is likely to vary according to the 
task. Self-management is multi-faceted, and SPACE FOR COPD provided 
support for patients to improve their management by a number of strategies, 
therefore measuring self-efficacy of anything specific is challenging. The 
PRAISE was selected to measure self-efficacy in this study (Vincent et al. 
2011). The PRAISE was developed for those attending pulmonary 
rehabilitation, which is another form of supporting self-management. It was 
anticipated that the PRAISE would be the most specific measure of self-
efficacy that could be aligned to the task of self-management. It is possible, 
however, that this was still not specific enough to measure the variety of self-
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management support offered through SPACE FOR COPD. Upon reflection, 
the COPD Self-efficacy scale may have been a more appropriate measure 
(Wigal, Creer and Kotses 1991). 
 
One of the important findings in this chapter is how soon within the course of a 
self-management programme clinical improvements can be observed. Several 
self-management programmes have provided courses of longer duration, and 
have therefore not reported outcome measures until between three and seven 
months (Bischoff et al. 2012; Bucknall et al. 2012; Effing et al. 2011; 
Monninkhof et al. 2003; Ninot et al. 2010). Several of these studies have 
reported no or limited clinical benefit (Bischoff et al. 2012; Bucknall et al. 
2012; Monninkhof et al. 2003; Ninot et al. 2010). It is not possible to tell from 
these studies whether there were significant gains made in the short-term 
which were reduced by the time of follow-up, or whether the intervention just 
failed to intervene in the first place. What the present study offers, is the 
insight that important gains are made within the first few weeks of undertaking 
the SPACE FOR COPD course. It is, however, important now to understand 
how these changes are maintained in the medium- to longer-term. This will be 




The significant difference between the groups at baseline in the CRQ-SR 
dyspnoea domain was a limitation of this study, which could not have been 
foreseen. It is likely that this was a random occurrence, and on the whole the 
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two groups were well matched. It was possible to manage this limitation 
statistically by performing an ANCOVA. By using the baseline CRQ-SR 
dyspnoea score as a covariate, this test statistically adjusted for this 
difference and minimised the risk of bias this may have had on the findings. 
 
Interestingly both SPACE FOR COPD and usual care groups demonstrated 
statistically significant within-group improvements in the CRQ-SR dyspnoea 
score and ESWT. However, only the intervention group breached the 
threshold for the MCID in the CRQ0SR dyspnoea domain. Furthermore, in 
both measures there was also a significant between-group difference, 
suggesting that SPACE FOR COPD was superior to usual care. The 
statistically significant within-group change in the usual care group, however, 
was an interesting finding and one that deserves further exploration. The 
impact of attention, participation bias, or the conduct of exercise testing may 
all have potentially interfered with the data reported in this trial. These issues 
will be discussed further in chapter 8 of this thesis. 
 
The risk of type I error, whereby the null hypothesis is rejected although it is 
actually true, is increased by conducting a large number of comparisons. In 
this chapter many comparisons have been made therefore this risk may be 
increased. However, it should be made clear that the primary outcome of this 
study is the CRQ-SR dyspnoea domain at six months. It is upon this outcome, 
which is described and discussed in chapter 6, that the hypothesis of the 
study will be accepted or rejected. All other outcomes and comparisons are 
for exploratory purposes, and therefore the statistical significance of these 
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outcomes alone should be treated cautiously. It should be considered, 
however, that with the exception of self-efficacy, depression and mastery, all 
other outcomes have been significantly different between groups, suggesting 
that overall there is a beneficial effect of SPACE FOR COPD at six weeks. 
 
Finally, it has not been possible from this study design to establish how well, if 
at all, any of the patients engaged with the self-management programme. The 
results which have been found indicate that the programme has been used to 
some extent or else it would be unlikely so many differences between the 
groups would have occurred. Information regarding use of the manual, 
however, would be able to inform us whether there was a dose-response, or 
which aspects of the manual were most or least useful. Unfortunately the 
nature of the intervention does not allow for this information to be captured. In 
the future a web-based version of the SPACE FOR COPD manual will allow a 
detailed interrogation of which aspects of the programme are used most. 
 
Conclusions 
SPACE FOR COPD confers significant improvements HRQoL, anxiety, 
exercise performance and knowledge at six weeks, compared with usual acre 
alone. This is the first self-management RCT, which is adequately powered, 
that demonstrates significant changes over such a short duration. 
Understanding that these changes can occur over a short period is important 
so that expectations of what can be achieved on a course of self-management 
can be appreciated. 
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These findings have demonstrated that SPACE FOR COPD is effective in 
improving a range of clinical outcomes, including HRQoL, exercise 
performance, anxiety and knowledge. The impact on depression and self-
efficacy may be more limited. For those with more complex emotional needs, 
exploration of how better to support them on SPACE FOR COPD or other 
interventions which may be required is warranted. 
 
This is one of few self-management studies to document that a light-touch 
approach can have such an impact on important clinical outcomes. SPACE 
FOR COPD has shown improvements in outcomes which are equal to, or 
more than, those of studies with samples of similar patients. Other studies, 
however, have adopted more highly supervised approaches. The 
effectiveness of this light-touch approach will be attractive for policy makers 
and healthcare providers, who want to provide self-management support for 
their patients, yet are constrained by financial and organisational limitations. It 










Chapter 5 The effectiveness of SPACE FOR 




The short-term analysis (six weeks) of the effectiveness of SPACE FOR 
COPD in primary care has been discussed in chapter 4. These findings 
suggest that SPACE FOR COPD conferred significant improvements in health 
HRQoL, anxiety, exercise performance and disease knowledge within a six-
week period when compared with usual care alone. It is not yet known 
whether these benefits are maintained beyond this six-week period. 
 
The maintenance of these health outcomes is of considerable interest. 
Several self-management programmes have failed to assess outcomes once 
the intervention period is complete, which offers no insight into the 
maintenance of outcomes once the formal support is removed. Of studies 
which have conducted a follow-up assessment once formal support has been 
completed there is a trend for results to diminish, although not back to 
baseline (Bourbeau et al. 2003; Khdour et al. 2009; Maltais et al. 2008). It is 
important to establish how well and how long outcomes are maintained in 
order to establish whether and when any more formal support is required. 
 
This chapter examines outcomes in HRQoL, anxiety and depression, exercise 
performance, knowledge and self-efficacy at six months. This will provide an 
insight into the effectiveness of SPACE FOR COPD over a medium-term 
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period, and how well the gains made at six weeks were maintained without 
any on-going support. 
 
5.2 Hypothesis and Aim 
Hypothesis 
SPACE FOR COPD will confer a greater improvement in dyspnoea than usual 
care, at six months. 
 
Aim 
To test the effectiveness of SPACE FOR COPD compared with usual care, in 
primary care patients with COPD after six months. 
 
5.3 Methods 
This chapter describes the follow up period of a larger trial. For an overview of 
the study methods please refer to chapter 3 of this thesis. This section will 
describe the details of the methods for the follow-up period. 
 
Follow-up 
All participants who had not withdrawn from the study were invited to the 
hospital for an assessment six months after the baseline assessment had 
been completed. At this assessment blinded outcome measures were taken. 
Since the blinded outcome measures were taken at six weeks, no participants 
had had contact with any member of the research team, other than to arrange 
the appointment for assessment. Patients in the intervention arm had been 
able to keep the manual, and at the four week phone call had been advised to 
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continue working through the programme indefinitely. No other support for the 
intervention had been offered since the four week phone call. Patients in the 
usual care group were given no specified advice by the research team. 
 
Outcome measures 
Primary outcome measure: 
CRQ-SR dyspnoea domain 
Secondary outcome measures: 
 CRQ-SR fatigue, emotion and mastery domains 
Hospital Anxiety and Depression Scale (HADS) 
Incremental Shuttle Walking Test (ISWT) 
Endurance Shuttle Walk Text (ESWT) 
Bristol COPD Knowledge Questionnaire (BCKQ) 




All participants had been randomised to either usual care or intervention, the 
details of which are described in chapter 3. 
 
Sample Size 
The sample required to detect a between-group difference on the dyspnoea 
domain of the CRQ-SR is 62 per group. A 30% drop out rate had been 




In the analysis of RCTs there may be several reasons why data may be 
missing or excluded from analysis, including failure to start, non-compliance, 
false inclusions or missing response (Hollis and Campbell 1999). An intention 
to treat approach (ITT) compares patients in the groups to which they were 
originally assigned. It has been argued to be the superior approach as it is 
likely to reduce bias (Lee et al. 1991), and not performing ITT analysis may 
lead to overestimation of the clinical effectiveness (Akl et al. 2012). These 
data were analysed primarily with all available data, as randomised, but only 
in those with an outcome. Secondary analysis was ITT, with a sensitivity 
analysis using multiple imputations to impute missing values. This analysis 
was conducted in STATA. 10 models of imputation were created based on 10 
variables put into the model. 
 
All other analyses were completed using Predictive Analytics Software 
(PASW) v.18. Independent t tests were carried out on demographic data and 
baseline characteristics between those who completed the study and those 
who withdrew. Missing data analysis was conducted. Data was checked for 
normality and outliers. A repeated measure ANOVA was applied to analyse 
between-group comparisons in the primary outcome and all secondary 
outcome data. For variables with a significant test of sphericity the 
Greenhouse-Geisser test was used, and for variables without significant 
sphericity, the test of assumed sphericity was used. Differences between 




184 patients were recruited to the study, 95 were randomised to usual care 
and 89 to receive the SPACE FOR COPD intervention. There was no cross-
over of randomisation. Following a drop out rate of 15.7% between baseline 
and six weeks, there was a further drop out of five patients from the usual 
care group and six patients from the SPACE FOR COPD group between the 
six-week and six-month assessments. The total drop out rate from the study 
was 40 patients (21.7%). This means that the minimum of 62 patients per 
group required for adequate power was achieved. Figure 5.1 documents the 
















Figure 5.1 CONSORT flow diagram of patient recruitment, randomisation and 












As shown in table 5.1, there were no statistically significant differences in 
demographic characteristics or baseline outcome measures between those 
who completed the study and those who did not. 
 







SPACE: Usual care  
[n (%)] 
65 (45) : 79 (55) 24(60) :16 (40) 0.096 
Male: Female 
[n (%)] 
80(56) : 64 (44) 21 (53) :19 (47) 0.731 
Age years [mean (SD)] 
 
69.6 (9.3) 69.1 (9.0) 0.718 
FEV1 litres [mean (SD)] 
 
1.47 (0.55) 1.36 (0.60) 0.251 
BMI [mean (SD)] 
 
27.52 (5.17) 27.68 (5.64) 0.868 
Dyspnoea 
 
3.17 (1.19) 2.92 (1.16) 0.264 
Fatigue 
 
3.88 (1.27) 4.14 (1.04) 0.269 
Emotion 
 








5.25 (1.36) 5.14 (1.32) 0.650 
ISWT metres [mean 
(SD)] 
340.7 (152.4) 321.8 (176.6) 0.517 
ESWT seconds [mean 
(SD)] 
262.6 (177.8) 278.0 (198.1) 0.638 
Anxiety 
 




5.12 (3.17) 5.46 (3.45) 0.574 
Spouse 
 
86 (60) 26 (65) 
Alone 
 
33 (22) 7 (18) 
Family 
 












Intention to Treat 
A test for missing data was conducted on all variables. Estimates were non-
significant (p=0.686), therefore it is accepted that data is missing completely 
at random. 
 
There were no failures to start the intervention, no false inclusions in these 
data sets and compliance could not be measured. Therefore the only 
requirement to perform ITT analysis was to impute missing values. The 
imputed values for the primary outcome all fell within the expected range. 
 
The Primary Outcome 
Repeated measures showed Mauchly’s test of sphericity was significant 
(p=0.038) therefore the results of the Greenhouse-Geisser test were used to 
correct for this. Table 5.2 shows the results from the repeated measures 
ANOVA of the primary outcome, CRQ-SR dyspnoea score. 
 
Table 5.2 Significance levels of within-subject effects of time and time and 
intervention and between-subject effects for the CRQ-SR dyspnoea score 
 Within-subject effects Between-subject effects 











The mean CRQ-SR dyspnoea scores for both groups are displayed in table 
5.3. These data are plotted in figure 5.2 for all time points. 
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Table 5.3 Mean baseline, six weeks, six months and change scores for the 












2.95 (1.17) 3.31 (1.07) 0.36 
(-0.09 to 0.70) 
6 weeks 
 
3.38 (1.35) 4.02 (1.19) 0.64 
(0.23 to 1.09) 
6 months 
 
3.44 (1.40) 3.97 (1.37) 0.53 
(-0.06 to 0.88) 
Mean change 
(baseline to 6 
months) 
0.49 (1.27) 0.66 (1.07) 0.17 
(-0.29 to 0.52) 
 
 
Figure 5.2 Mean dyspnoea scores for SPACE FOR COPD and usual care 





The MCID of the CRQ-SR is 0.5. Using this value, the population was 
dissected into ‘responders’ (those who changed ≥0.5 on the CRQ-SR 
dyspnoea score) and ‘non-responders’ (those who changed <0.5 on the CRQ-
SR dyspnoea). The numbers of responders and non-responders per group is 
displayed in table 5.4. 
 
Table 5.4 Number of responders and non-responders in SPACE FOR COPD 








35 (56) 28 (44) 
Usual care 
 




These findings suggest that there were no significant differences between the 
groups of the impact on CRQ-SR dyspnoea domain. The significant between-
subjects effect from the ANOVA is likely to be due to the difference between 
the groups at baseline. As a group as a whole, only the SPACE FOR COPD 
group exceeded the change of ≥0.5, which is the MCID. 
 
Secondary Outcomes 
HRQoL was measured by the other three domains of the CRQ-SR; fatigue, 
emotion and mastery. Repeated measures Mauchly’s test of sphericity was 
significant for all three domains (p=0.041, 0.046 and 0.025 for fatigue, 
emotion and mastery respectively). Results from the repeated measures 
ANOVA are displayed in table 5.5 
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Table 5.5 Significance levels of within-subject effects of time and time and 




































The mean values for the CRQ-SR domains at baseline, six weeks, six months 
and mean changes from baseline to six months were calculated. These are 
displayed in table 5.6 and plotted on figures 5.3- 5.5. Overall, this suggests 
that absolute HRQoL scores were maintained between six weeks and six 









Table 5.6 Mean baseline, six weeks, six months and change scores for CRQ-
SR fatigue, emotion and mastery domains 










3.93 (1.23) 3.80 (1.32) 0.13 
(-0.31 to 0.53) 
6 weeks 
 
4.37 (1.15) 3.80 (1.47) 0.57 
(0.07 to 0.96) 
6 months 
 
4.12 (1.34) 3.70 (1.40) 0.42 









0.19 (1.09) -0.12 (0.77) 0.31 
(-0.12 to 0.53) 
Baseline 
 
4.86 (1.27) 4.83 (1.22) 0.03 
(-0.31 to 0.52) 
6 weeks 
 
5.20 (1.18) 4.75 (1.32) 0.45 
(0.00 to 0.83) 
6 months 
 
5.02 (1.32) 4.64 (1.43) 0.38 









0.16 (1.18) -0.19 (0.85) 0.35 
(-0.08 to 0.60) 
Baseline 
 
5.25 (1.32) 5.14 (1.40) 0.11 
(-0.34 to 0.56) 
6 weeks 
 
5.40 (1.17) 5.03 (1.49) 0.37 
(-0.14 to 0.76) 
6 months 
 
5.29 (1.37) 4.91 (1.52) 0.38 







baseline to  
months 
0.04 (1.03) -0.23 (1.05) 0.27 




Figure 5.3 Mean fatigue scores for SPACE FOR COPD and usual care at 














Figure 5.4 Mean emotion scores for SPACE FOR COPD and usual care at 











Figure 5.5 Mean mastery scores for SPACE FOR COPD and usual care at 














Exercise performance was measured by the ISWT and the ESWT. Mauchly’s 
test for sphericity was not significant for the ISWT (p= 0.217) and was 
significant for the ESWT (p<0.001). Results from the repeated measures are 
displayed in table 5.7. The findings suggest that between-group differences in 
maintenance of ISWT between six weeks and six months were not 







Table 5.7 Significance levels of within-subject effects of time and time and 

























The mean baseline, six weeks, six months and change scores for the ISWT 
and ESWT are displayed for both groups in table 5.8. 
 
Table 5.8 Mean baseline, six weeks, six months and change scores for the 
ISWT and ESWT 




































baseline to 6 
months 
10.5 (63.3) -5.7 (50) 16.2 





































(83.4 to 291.6) 
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The changes in ESWT over the three time points for both groups are 
displayed in figure 5.6. 
 
Figure 5.6 Mean ESWT scores for SPACE FOR COPD and usual care at 















Anxiety and depression was measured with the HADS. Anxiety was significant 
on Mauchly’s test of sphericity (p=0.028) while depression was not (p=0.246). 






Table 5.9 Significance levels of within-subject effects of time and time and 
intervention and between-subject effects for anxiety and depression 
 Within-subject effects Between-subject 
effects 


















Mean baseline, six weeks, six months and changes scores for anxiety and 
depression are displayed in table 5.10. Lower scores demonstrate lower 
levels of anxiety/ depression. 
 
Table 5.10 Mean baseline, six weeks, six months and change scores for 
anxiety and depression 










5.98 (3.94) 6.91 (4.06) -0.93 
(-2.45 to -0.20) 
 6 weeks 
 
5.26 (3.94) 7.03 (4.10) -1.77 
(-3.12 to 0.44) 
 6 months 
 
5.68 (4.10) 7.00 (4.19) -1.32 




-0.30 (2.98) 0.09 (2.39) -0.39 
(-1.22 to 0.57) 
Depression Baseline 
 
5.32 (3.22) 5.06 (3.10) 0.26 
(-1.03 to 1.08) 
 6 weeks 
 
4.82 (3.43) 5.29 (3.38) -0.47 
(-1.63 to 0.63) 
 6 months 
 
5.13 (3.41) 5.53 (3.67) -0.40 




-0.19 (2.68) 0.47 (2.14) -0.66 
(-1.34 to 0.31) 
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It has been suggested that a score of 8 or above on the HADS may be 
suggestive of a presence of anxiety and/ or depression (Zigmond & Snaith 
1983). Given that the mean baseline scores for the group as a whole fall 
below this threshold, a sub-group analysis of those with a baseline score of 8 
or above for each domain was performed. The mean scores for all three time 
points are displayed in table 5.11, and illustrated in figures 5.7 and 5.8. 
 
Table 5.11 Mean baseline, six weeks, six months and change scores for 
HADS anxiety and depression for a sub-group of participants with baseline 
scores more than or equal to 8 









10.50 (2.11) 10.67 (2.47) -0.17 
(-1.45 to 1.09) 
6 weeks 
 
9.50 (3.11) 10.30 (2.98) -0.80 
(-2.33 to 1.10) 
6 months 
 
9.36 (3.81) 10.18 (3.42) -0.82 









-1.14 (2.99) -0.52 (2.25) -0.62 
(-2.04 to 0.80) 
Baseline 
 
9.44 (1.38) 9.94 (1.77) -0.5 
(-1.56 to 0.57) 
6 weeks 
 
8.56 (3.24) 9.25 (3.53) -0.69 
(-2.79 to 1.90) 
6 months 
 
8.00 (2.87) 10.25 (3.79) -2.25 









-1.44 (2.43) 0.31 (2.94) -1.75 





Figure 5.7 Mean HADS anxiety scores at three time points for the sub-group 














Figure 5.8 Mean HADS depression at three time points for the sub-group with 












Knowledge and self-efficacy 
The results of the repeated measures ANOVA are presented in table 5.12. 
Mean scores for both the BCKQ and PRAISE at all three time points are 
displayed in table 5.13. Overall, this suggests that between-group changes in 
disease knowledge are maintained between six weeks and six months, 
although statistical significance is borderline. There were no significant 
changes in self-efficacy at six weeks or six months. 
 
Table 5.12 Significance levels of within-subject effects of time and time and 
intervention and between-subject effects for knowledge and self-efficacy 
 Within-subject effects Between-subject 
effects 




























Table 5.13 Mean baseline, six weeks, six months and change scores for 








































2.62 (6.74) 0.93 (4.90) 1.69 





45.17 (8.15) 0.83 





44.29 (8.11) 2.6 





44.69 (8.22) 2.41 





1.10 (5.38) -0.48 (6.78) 1.58 














Table 5.14 Healthcare utilisation for both SPACE and usual care groups 




82 70 1.19 
(0.77 to 1.86) 
Courses Steroids 
 
22 27 0.88 
(0.47 to 1.66) 
GP visits (R) 
 
78 73 1.15 
(0.75 to 1.78) 
GP visits (NR) 
 
196 172 1.22 
(0.86 to 1.75) 
PN visits (R) 
 
48 53 0.97 
(0.60 to 1.59) 
PN visits (NR) 
 
46 48 0.97 
(0.59 to 1.59) 
RN home visits 
 
10 26 0.41 
(0.19 to 0.91) 
ED visits (R) 
 
1 2 0.54 
(0.05 to 6.09) 
ED visits (NR) 
 
8 4 2.16 
(0.63 to 7.42) 
Admissions (R) 
 
2 5 0.43 
(0.08 to 2.28) 
Admissions (NR) 
 
15 21 0.77 
(0.37 to 1.59) 
 
5.5 Discussion 
Following the results of the short-term outcomes discussed in chapter 4, this 
chapter aimed to evaluate the medium-term impact, once the formal support 
of the programme was complete. The main trial design was powered to detect 
a difference between these groups in the dyspnoea domain of the CRQ-SR at 
six months, and it was upon this that the hypothesis was tested. The 
remainder of this chapter will discuss these findings within the context of other 




The primary outcome 
The repeated measures ANOVA shows there is no significant difference 
between the SPACE FOR COPD group and the usual care group over the six-
month follow-up (p= 0.16). Therefore, the hypothesis that SPACE FOR COPD 
would confer greater benefit on HRQoL at six months compared with usual 
care is rejected. The results also show a significant effect of time, regardless 
of randomisation (p<0.001). This means that both groups improved 
significantly over the six-month period. From baseline to six months the mean 
changes were 0.66 for the SPACE FOR COPD group and 0.49 for the usual 
care group. Of these mean group scores, only the SPACE FOR COPD group 
exceeds the MCID of 0.5. In addition, 56% of the SPACE FOR COPD group 
improve by at least 0.5 compared with 44% of the usual care group. 
 
Effing et al. (2011) is one of few other RCTs of a self-management 
intervention that has measured the CRQ-SR at a follow up. This study was 
powered on the change in ISWT rather than the CRQ-SR, although they did 
detect a significant between-group difference on the CRQ-SR dyspnoea 
domain at 12 months (p=0.04). However, the actual change score from 
baseline was less than half of that observed in the SPACE FOR COPD group, 
with a mean (SE)  improvement in their intervention group of 0.37 (0.13) at 
seven months which declined to 0.30 (0.13) at 12 months follow up. It is likely 
that although within-group change was less, this was statistically significant 
between-groups because this study did not observe an improvement in the 
usual care group. 
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Maltais et al. (2008) tested the effectiveness of the ‘Living Well with COPD’ 
programme as an alternative to conventional pulmonary rehabilitation. 
Although there was not a control group, the within-group change in the self-
management group in CRQ-SR dyspnoea was significant after three months 
(mean change 0.82, p<0.001) and, although declined, remained significant at 
one year (mean change 0.62, p<0.001). This intervention required twice 
weekly supervised education for four weeks and an unsupervised programme 
of home exercise, with the loan of cycle equipment provided in patients’ 
homes for three months. In contrast to both Effing et al. (2011) and Maltais et 
al. (2008), the SPACE FOR COPD intervention provided a single 30-45 
minute introduction and two telephone calls, with no supervised training or 
education. This highlights how important the within-group improvement in 
dyspnoea gained from SPACE FOR COPD is. This will be of interest to 
healthcare providers who will want to provide effective self-management with 
minimal cost. 
 
Bischoff more recently conducted a study in primary care in the Netherlands 
(Bischoff et al. 2012). It was a three arm parallel RCT comparing a self-
management programme, routine monitoring and usual care. Self-
management was based on the ‘Living Well with COPD’ programme again, 
supported by the practice nurse, although the exercise component of the 
programme was removed. There were no significant advantages on the CRQ-
SR of the self-management programme compared with usual care or routine 
monitoring. It is interesting, that despite also being in primary care and using 
material from a previously positive programme that more a significant change 
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was not observed. Some of the key differences between this and the SPACE 
FOR COPD study are that SPACE FOR COPD incorporated an exercise 
programme, which as previously discussed, may be important for driving 
changes in HRQoL. Additionally, in the Bischoff et al. study, the intervention 
was delivered by practice nurses, whereas SPACE FOR COPD was provided 
by a physiotherapist with expertise in COPD and skills in motivational 
interviewing. The level of training of the facilitator, in both disease specific 
knowledge and understanding of self-management and behaviour change, 
may be an important in determining the effectiveness of the intervention. If 
SPACE FOR COPD is to be delivered nationally in primary care, there may be 
several challenges around training which will need to be considered. 
 
Secondary outcomes 
Health-related quality of life 
Fatigue, emotion and mastery domains of the CRQ-SR are reported as other 
measures of HRQoL. The differences between groups at six months were not 
statistically significant for any of the three domains; fatigue [mean (95% CI) 
treatment effect 0.31 (-0.12 to 0.53) p=0.05; emotion 0.35 (-0.08 to 0.60) 
p=0.09; mastery 0.29 (-0.14 to 0.56) p=0.08]. 
 
Effing et al. (2011) documented mean (95% CI) between-group differences of 
0.09 (-0.34 to 0.52), 0.10 (-0.22 to 0.42) and 0.11 (-0.21 to 0.43) for fatigue, 
emotion and mastery respectively, none of which were statistically significantly 
different to usual care. Bischoff et al. (2012) also failed to document any 
significant improvements on these domains at either six or 12 months [mean 
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(95% CI) treatment effect at 12 months -0.17 (-0.62 to 0.27); -0.31 (-0.66 to 
0.039); -0.20 (-0.55 to 0.14) for fatigue, emotion and mastery respectively]. 
Maltais et al. (2008) demonstrated within-group changes in the self-
management group at three months [mean (95%CI) 0.36 (0.17 to 0.55) 
p<0.001,  0.35 (0.20 to 0.50) p<0.001 0.49 (0.32 to 0.66) p<0.001 for fatigue, 
emotion and mastery respectively] which all declined during the follow up at 
12 months [mean (95%CI) 0.25 (0.06 to 0.44) p=0.01, 0.28 (0.14 to 0.43) 
p<0.001, 0.39 (0.23 to 0.57) p<0.001]. 
 
Out of any of these studies, the changes in HRQoL after the follow-up period 
were greatest in the Maltais et al. programme. This population was a similar 
age to SPACE FOR COPD, although slightly more severe at baseline. As 
previously described, in the Maltais et al. study participants were provided 
with supervised education and were loaned exercise bikes for the first three 
months. One difference which may be fundamental to the maintenance of 
outcomes is that the Maltais et al. study included regular telephone contact 
every two months by a case manager. This kind of on-going support has been 
identified in the Chronic Care Model (CCM) as important to sit alongside self-
management (Wagner 1998). A systematic review found that the more 
components of the CCM that were present the better the outcomes would be 
(Adams et al. 2007). This suggests that on-going support, such as telephone 
contact, alongside self-management may be more effective. Methods of on-
going support will be discussed further in chapter 8. 
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While the changes in HRQoL were not necessarily statistically significant at 
six months, the absolute changes were still greater than those of the Effing 
and Bischoff studies. As previously discussed, the lack of an exercise 
programme and the delivery of the programme from a practice nurse may be 
important features of the lack of improvement in the Bischoff et al. study 
(2012). It is remarkable, however, that between-group differences in HRQoL 
in SPACE FOR COPD at six months were higher than those observed in 
COPE II (Effing et al. 2011), considering the COPE II programme provided 
much more supervised, directed support than SPACE FOR COPD. 
 
The gradients of the slopes observed in figures 5.3- 5.4 and the results 
reported in chapter 4, would suggest that the improvements in CRQ-SR 
fatigue and emotion domains, were achieved during the first six-week period. 
Figures 5.3- 5.5 suggest that the benefits begin to decline between six weeks 
and six months. This pattern is also seen in other self-management literature. 
Both Khdour et al. (2009) and Bourbeau et al. (2003) measured HRQoL with 
the SGRQ. Bourbeau et al. (2003) documented significant treatment 
differences in the impact and total domains after four months of a self-
management intervention compared with usual care. However, between the 
end of the four-month intervention period and the 12-month follow-up, there 
was a decline in treatment effect across all SGRQ domains, and only the 
impact subscale remained significant (-4.7, p=0.05). The study by Khdour et 
al. (2009) documented a similar effect. After significant treatment differences 
were initially observed in the symptoms, impact and total domains, between 
six and 12 months treatment effects were reduced across all domains, and 
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only symptoms and impact were significant at 12 months (p=0.04 and p=0.03 
respectively). As previously suggested, exploring various methods of on-going 
support may be of interest in order to establish how these outcomes can best 
be maintained. However, a trend across all self-management studies, is that 
regardless of the outcome measure used to assess quality of life, a gradual 
decline can be observed over time across all control groups. This suggests 
that, in the face of declining quality of life for patients with COPD who receive 




Maximal exercise capacity was measured by the ISWT, and sub-maximal 
capacity by the ESWT. There was no significant effect of time (p=0.893) or 
time and intervention (p=0.52) on the ISWT, with a mean between-group 
difference 16.2m at six months. There was a significant effect of both time 
(p<0.001) and time and intervention (p=0.03) on the ESWT, with a mean 
between-group difference of 184 seconds at six months. 
 
The change in ESWT between groups is an interesting finding. The MCID of 
the ESWT has been estimated at around 186 seconds following pulmonary 
rehabilitation, and around 65 seconds following bronchodilation therapy 
(Pepin et al. 2011). The mean between-group difference of 184 seconds 
approaches or exceeds these benchmarks, which suggests this difference 
may be meaningful to patients also. 
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The suggestion that SPACE FOR COPD may be effective in influencing sub-
maximal exercise performance but not maximal exercise performance may be 
reflective of the unsupervised nature of training. The exercise programme of 
SPACE FOR COPD was derived from a training schedule used for pulmonary 
rehabilitation (Calvert et al. 2011; Sewell et al. 2006) whereby a walking 
programme of 85% of maximal speed is prescribed. For participants in this 
study, the only opportunity to become familiarised with this speed was on the 
initial assessment, prior to randomisation, therefore patients were expected to 
remember what that speed was during their home training. 85% exceeds the 
minimal training intensity recommendation of >60 %of maximal exercise 
capacity for COPD (Nici et al. 2006) and although tolerable for patients (Revill 
et al. 1999), in rehabilitation, is usually re-enforced through supervised 
training (Sewell et al. 2006). Without supervision of the walking speed which 
patients select, given that the speed required is at their upper end, patients 
engaging in the SPACE FOR COPD exercise programme may be exercising 
sub-optimally, at a slower speed than prescribed. Sub-optimal training may 
explain why the improvements in sub-maximal exercise capacity were not 
translated into gains in maximal performance. 
 
There are many other self-management programmes which have 
demonstrated no impact on walking distance at all, despite the inclusion of an 
exercise component (Bourbeau et al. 2003; Maltais et al. 2008; Monninkhof et 
al. 2003). Although Bourbeau et al. (2003) provided eight weeks of one-to-one 
home visits, and Maltais et al. (2008) loaned out cycle equipment for patients 
to keep at home, neither showed any changes on the 6MWT [mean (95% CI) 
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within-group change 6MWT 8 (-1 to 18) metres at three months; 0(-13 to 12) 
metres at 12 months (Maltais et al. 2008)]. Monninkhof et al. (2003) provided 
once or twice weekly supervised exercise for two years, and yet found no 
between-group differences in the 6MWT [mean (SD) change at 12 months -13 
(7) vs. -2(5) for self-management and usual care groups respectively]. Despite 
these programmes providing a high level of support, no gains in walking were 
found. It is an important finding that despite less contact time provided on 
SPACE FOR COPD compared with these other studies, exercise performance 
was improved and maintained over six months. Therefore, not only is this 
‘light-touch’ approach effective in improving exercise performance, but is 
superior when compared with more highly supervised programmes. 
 
Both Boxall et al. (2005) and Fernandezet al. (2009) documented significant 
between-group differences in distance walked on the 6MWT (35m and 66m 
respectively). In the study by Fernandez et al. (2009), patients received 13 
home visits of one-to-one supervised time with a physiotherapist. Boxall et al. 
(2005) provided nine home visits over 12 weeks. While these studies have 
shown to be effective in improving exercise performance, both utilise 
considerably more time and resources than SPACE FOR COPD. In the UK 
this is an important consideration, given the current economic climate where 
financial and organisational resources are constrained. 
 
Figure 5.6 demonstrates that between six weeks and six months there was a 
trend for exercise performance to continue improving, or at least maintained, 
in the SPACE FOR COPD group. This is an important observation. Exercise 
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performance may be considered a surrogate marker of health behaviour 
change. This observation suggests that patients who receive SPACE FOR 
COPD engaged in health behaviours which were sustained over a six-month 
period. The question of how best to maintain gains from courses, such as 
pulmonary rehabilitation, has long been debated and there is no consensus of 
the optimal way of preventing decline over time. SPACE FOR COPD may be 
the most effective self-management programme available in sustained 
changes in exercise behaviour, without on-going support. 
 
Anxiety and depression 
As a group as a whole, there was a statistically significant reduction in anxiety 
in the SPACE FOR COPD group, compared with usual care [mean (95%CI) 
treatment effect -0.39 (-1.22 to 0.57) p=0.044]. There was no significant 
difference between groups in change in depression [mean (95% CI) treatment 
effect -0.66 (-1.34 to 0.31) p=0.147]. In the sub-group analyses of participants 
who scored ≥8 at baseline there was no significant between-group difference 
in anxiety [mean (95% CI) treatment effect -0.62 (-2.01 to 0.71)]. In the sub-
group of patients who scored ≥8 at baseline on depression the between-group 
difference was not statistically significant, but did exceed the MCID of 1.5 
[mean (95% CI) treatment effect -1.75 (-3.22 to 0.44)]. It is also worthwhile to 
observe that the data shown in figure 5.8 suggests that reduction in 
depression scores continues between six weeks and six months. 
 
Despite emotional management being a key task of self-management (Corbin 
& Strauss 1988), only three studies have measured the impact of self-
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management on anxiety and depression (Bucknall et al. 2012; Effing et al. 
2011; McGeoch et al. 2006). All studies found no significant change 
depression, and only Bucknall and colleagues documented a change in 
anxiety at 12 months [mean (95% CI) treatment effect -1.06 (-2.08 to -0.03) 
p=0.044]. Similarly to SPACE FOR COPD, both Effing et al. (2011) and 
McGeoch et al. (2006) had low baseline scores for anxiety and depression in 
theirs samples of patients, which as group means were below the threshold of 
≥8. This is in contrast to Bucknall et al. (2012) where baseline scores were 
much higher [mean (SD) baseline anxiety 9.7(4.6), depression 8.4 (4.0)]. It is 
possible that given the higher levels of anxiety and depression in the Bucknall 
et al. study, there was greater room for improvement in these patients. 
Furthermore, the patients studied by Bucknall et al. had all been admitted to 
hospital for their COPD and were a post exacerbation group of patients. 
Anxieties in patients who have been hospitalised through their condition may 
be quite different to the stable populations observed in the other studies. 
 
Although the change in depression in the sub-group of those who scored ≥8 at 
baseline is not statistically significant, it is clinically significant. As the 
reduction in depression is clinically meaningful, this is an interesting finding. It 
becomes more interesting when we see that, unlike many other of the 
outcome measures in this study where changes largely occurs within the first 
six weeks, the reduction in depression for those who are at risk continues 
between six weeks and six months. This may be because, even with 
treatment, the effects of depression can be long lasting and make time more 
time before changes are evident. However, as this was a sub-group and 
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included small numbers (n=35) it is unlikely to be adequately powered. As 




On the whole, there was no significant impact of SPACE FOR COPD on 
healthcare utilisation over the six month study period. While some other self-
management programmes have shown a reduction in healthcare utilisation, 
this was not seen in the present trial (Bourbeau et al. 2003; Kdhour et al. 
2009). An interesting comparison between the studies is that healthcare 
utilisation in the present trial is considerably lower than seen in the others. For 
example, there were only 7 respiratory related admissions within 6 months 
between all 184 participants of this trial. This is in contrast to the Bourbeau 
study which had 189 respiratory admissions with a year and the Khdour study 
which had 49 respiratory admissions over 6 months, with similar numbers of 
patients. It is likely that this reflects the recruitment source of the participants, 
with the present study having recruited from primary compared with other 
studies which recruited patients engaged in secondary care. 
 
It is also important to remember that if patients’ self-management improves, 
this may not necessarily lead to reduced healthcare utilisation. Effective self-
management means the patient engages with their healthcare team 
appropriately, and improved disease knowledge and self-monitoring may 




In the interpretation of these findings it is necessary to consider several 
limitations of this study. Firstly, as identified in the previous chapter, there was 
a significant improvement in the primary outcome in both the intervention and 
control groups of this study. At six months, the CRQ-SR dyspnoea domain 
was the only outcome which had improved in the usual care group. There may 
be several explanations of this observation, and these will be discussed 
further in chapter 8. 
 
Given that this sample was a relatively milder and less severe group of 
patients, the generalisability of these findings are restricted to a similar 
population. The impact of SPACE FOR COPD on more severe, more 
functionally impaired patients cannot be established from these data. It is 
possible that more severe patients have more room for improvement and 
therefore greater effectiveness may be observed. Alternatively, perhaps the 
‘light-touch’ approach of SPACE FOR COPD may not be suitable for more 
severe patients who may require more support in the development of their 
self-management skills. Evaluating SPACE FOR COPD in a group of more 
severe patients is warranted in the future. 
 
Given that randomisation occurred at the patient level, there is a possibility 
that there may have been some treatment contamination at the GP level. It is 
possible that some patients may have shown the SPACE FOR COPD manual 
to their GP, who in turn might have described some of its content or promoted 
it to patients on the study who were in the usual care arm. Given that overall 
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there were relatively few respiratory related GP visits, it is likely that this risk 
was low. However, if this did occur then it may have contributed to the 
improvement seen in the usual care group. In the future, a cluster based 
randomised controlled trial which randomises at the level of the GP will control 
for this risk. 
 
In evaluating the effectiveness of SPACE FOR COPD this chapter has 
focused on the quantitative aspects of the study. In order to appreciate the 
wider implications and impact of the programme both qualitative work and 
healthcare utilisation analysis are required. While these aspects of the study 
are being conducted, they did not fall within the remit of this thesis, which 
intended to address the impact on the clinical outcomes of the trial. 
 
Finally, while this has been a ‘proof of concept’ study to establish the 
effectiveness of SPACE FOR COPD, it has been confined to a research 
environment. This is to say that, SPACE FOR COPD delivered as part of a 
research trial may not perform the same as when delivered as part of routine 
clinical service. Firstly, this study is open to selection bias, whereby patients 
that have been included have self-selected to be part of the trial. They may, 
therefore, have been a more motivated group. In usual care, not all patients 
may be as motivated or willing to undertake the programme, which may have 
an important impact on outcomes given the nature of the intervention. 
Additionally, in this study SPACE FOR COPD was provided by a 
physiotherapist with expertise in COPD and skills in motivational interviewing. 
It would not be expected that in usual primary care in the UK that all 
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healthcare professionals would have the same degree of knowledge or skill. 
Training in how to deliver SPACE FOR COPD must be made available, and 
quality assurance that it is delivered to an appropriate standard in order to 
optimise the programme’s effectiveness as part of a normal part of clinical 
service. 
 
Areas for further research 
As already discussed, qualitative evaluation of this project is also in place and 
work on these is on-going. The findings of this evaluation will support the 
quantitative findings of this chapter. 
 
While the findings of this chapter suggest that some outcomes are 
maintained, others decline between six weeks and six months. As suggested 
in the CCM, it may be important to ally self-management with on-going 
support for an impact on long-term outcomes. Future research should 
investigate the impact of on-going regular contact with a healthcare 
professional in conjunction with SPACE FOR COPD on the maintenance of 
health outcomes. There may be several methods of providing support, and 
this will be discussed in more detail in chapter 8. 
 
Finally, an evaluation of SPACE FOR COPD delivered as part of routine 
clinical care is now warranted. These findings have given sufficient confidence 
that SPACE FOR COPD does confer significant benefits over and above 
usual care. The next stage is to deliver the programme to more patients, and 
within a clinical context and in less of a research trial environment. This will 
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allow us to establish the effectiveness of SPACE FOR COPD once selection 
bias of he patients is minimised and to evaluate how well it can be delivered 
by non-specialist healthcare professionals. A cluster-based RCT of General 
Practices, with training provided to practice nurses would be a suitable 
approach to take for such an evaluation. 
 
Conclusions 
This chapter presents and discusses the findings of an RCT to assess the 
effectiveness of SPACE FOR COPD compared with usual care in a population 
of patients with COPD in primary care. The hypothesis was that SPACE FOR 
COPD would confer greater gains in HRQoL at six months, compared with 
usual care alone. The CRQ-SR dyspnoea domain was the primary outcome, 
and was not significantly different between groups, therefore the hypothesis is 
rejected. 
 
A number of secondary measures were taken, including quality of life, 
exercise performance, anxiety and depression, knowledge and self-efficacy. 
Significant between-group differences were observed for ESWT and anxiety 
at six months. Furthermore, for those at risk of depression at baseline there 
was a non-significant between-group change which exceeded the MCID. 
While absolute changes were largely maintained between six weeks and six 
months in many outcomes, statistical significance was lost. These findings 
suggest that there is some impact of SPACE FOR COPD compared with 




A feature of SPACE FOR COPD that may be important for maintenance may 
be the ‘light-touch’ approach of the programme. If patients can learn how to 
self-manage their COPD independently at home, within the environment 
within which they are to continue, this may have important implications for the 
maintenance of outcomes such as exercise performance. Participants of other 
programmes which provide supervised training (Boxall et al. 2005; Effing et al. 
2011;Monninkhof et al. 2003), or loan exercise equipment (Maltais et al. 2008) 
have the disadvantage that once the method of training is removed, patients 
must find alternative means. Intuitively one might anticipate maintenance 
might be more easily achieved by commencing training by the same method 
by which it will be continued. Furthermore, independent learning may have a 
powerful impact on the empowerment of the individual which may encourage 













Chapter 6 Physical activity in a population of 







In the early 20th century, bed rest was prescribed as a frontline course of 
treatment for many health conditions. The perception that ‘rest was best’ was 
confronted in the landmark work carried out by Jerry Morris (Morris and 
Crawford 1958). He found that risk of cardiovascular disease was higher for 
the sedentary bus drivers than for their more physically active bus conductor 
counterparts (Morris and Crawford 1958). Since then an increasing interest in 
physical inactivity and health has developed. Physical inactivity is now 
recognised as a pandemic (Kohl et al. 2012). The effect of physical inactivity 
on non-communicable diseases may be responsible for around 5.3 million 
deaths per year, putting it in a similar risk bracket to smoking (Lee et al. 
2012). 
 
The evidence that physical activity is reduced in people with COPD is 
compelling. Watz et al. (2009) showed that physical activity declined with 
more severe airflow limitation. Extensive work by Garcia-Aymerich and 
colleagues has identified that physical inactivity is associated with increased 
risk of hospital admission and death (Garcia-Aymerich et al. 2006). 
Furthermore, they later showed that while being physically active is 
associated with reduced lung function decline and better functional status 
(Garcia-Aymerich et al. 2009). Whilst the symptoms of COPD suggest that 
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physical inactivity is a likely consequence of COPD, there has been debate in 
the literature as to whether poor physical activity may in fact be a driving force 
behind the onset of the disease (Hopkinson and Polkey 2010). The answer to 
this debate, as yet, remains unresolved. 
 
Many studies of activity in COPD have been of patients recruited through 
secondary care services. Until now, there have been no reports of physical 
activity in patients with COPD who are managed primarily in primary care. 
This group of patients may be unique insofar that they are disproportionately 
low users of healthcare, with relatively well preserved functional status given 
their level of airway obstruction. If it is possible to identify distinctive features 
of this group then it may help to explain why some patients maintain health 
status better than others in the face of similar airflow limitation. Given the 
associations between physical inactivity and health status previously 
identified, examining the activity levels of this population might be of particular 
value. 
 
As well as analysing the physical activity of a cohort of patients from primary 
care, it may be of interest to interrogate the data further by testing whether 
there are differences in activity across disease severity. Watz et al. (2009) 
have demonstrated that physical activity declines with GOLD stage and MRC 
grade in their sample of a research cohort. This, however, has not been tested 
in a primary care population before. 
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There are no standardised approaches to measuring or reporting physical 
activity. Accelerometers have been used for some time to assess activity 
across a variety of populations. Compared with self-report physical activity, an 
advantage of accelerometers is that they are an objective measure and 
therefore not prone to reporter bias. However, the data produced from these 
monitors may be difficult to interpret. Looking at mean values of the output is 
challenging, given the large standard deviations of the data (Ng 2012). Step 
count has been a traditional measure of physical activity, however a recent 
study has shown that although most people with COPD might walk more than 
30 minutes per day, this does not mean they are active, since less than 25% 
of their time is spent in moderate activity as measured by METs (Vitorasso et 
al. 2012). 
 
The ACSM guidelines recommend that adults should spend 30 minutes, five 
times per week in moderate activity, and each 30 minutes should be 
comprised of at least 10 minutes continuous bouts (Nelson et al. 2007). Many 
accelerometers are able to detect that 30 minutes throughout the day has 
been achieved, but establishing how this activity was accumulated, i.e. in 10 
minute bouts, is more challenging. A recent study which recruited patients 
from a tertiary hospital in Spain analysed bouts of light, moderate and intense 
activities in a sample of people with COPD [n=177 mean (SD) age 71(8) 
years; FEV1 % predicted 52(16)]. Moderate was defined as a threshold of 2.6 
METs, which was equivalent to 50% of the maximum oxygen consumption on 
an incremental test. The median number of bouts of moderate-intense activity 
per day was 2.6 and the median duration per bout was around 20 minutes. 
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Using 2.6 METs as the threshold for moderate activity, 61% of the sample met 
the criteria for the ACSM guidelines. When using the traditional 3 METs as the 
threshold for moderate activity, 50% of the population met the ACSM 
guidelines. This is the first study of this kind, and it necessary to perform a 
similar method of analysis in other populations to confirm these findings. 
Additionally, this study did not compare activity which was performed in ≥10 
minute bouts with activity that was performed in bouts <10 minutes. It would 
be useful to make this comparison in this population, as it is likely that for 




This chapter explores the baseline physical activity data from the trial 
described in chapter 3 of this thesis. There were two key aims of these 
analyses: 
ii) To describe the physical activity levels of a sample of people with 
COPD who are managed in primary care. 
iii) To use physical activity monitoring to establish adherence to the 
physical activity recommendations. 
 
6.3 Methods 
For a detailed account of the methodology used please refer to chapter 3. The 
data described in this chapter examined the demographics and outcome 
measures that were observed at baseline only. Physical activity at the six-
week and six-month time points is discussed in chapter 7. 
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Participants 
As this chapter only examined baseline data, all participants of the trial were 
eligible for analysis. 
 
Outcome measures and variables 
This chapter will primarily examine the physical activity measured at the 
baseline assessment of patients enrolled in the trial. Physical activity was 
measured with the SenseWear Pro3 ArmBand (SAB). Patients were asked to 
wear the monitor during waking hours for seven days. The monitor was only to 
be taken off at night and while showering, bathing or swimming. 
 
Activity over exercise prescription 
The monitor was also worn during the Endurance Shuttle Walking Test 
(ESWT) that was performed on the baseline study visit. The timestamp on the 
monitor was pressed at the start and end of the test. When the data from the 
device was analysed, the time-stamps allowed the activity data recorded 
during the test to be analysed. The average MET level achieved during this 
test identified the MET level required for an individual to exert themselves at 
85% of their maximum. Figure 6.1 shows the output downloaded from an 
activity monitor. Circle A shows that the time selected is between the time 
stamp 2a (demarking the start of the ESWT) and time stamp 2b (demarking 
the end of the ESWT). Circle B shows the average MET level achieved during 
















Using this level as a benchmark, it was possible to measure the time and 
energy expended that breeched this threshold over the following week of 
wear. These data are expressed in this chapter as ‘time over prescribed 
METs’ and ‘energy expenditure over prescribed METs’. 
 
Basic monitor variables 
With the basic level of SenseWear software the monitor produces several 
variables. These are: 
• Total daily energy expenditure [TEE (Kcals)] 
• Steps (n) 
• Time spent over predicted METs (minutes) 
• Energy expenditure (EE) over predicted METs (Kcals) 

















Moderate physical activity 
With advanced software for the SAB it is possible to explore how often and for 
how long a threshold of activity is breeched. Figure 6.3 shows an example of 
output for an individual during one day of wear. The bar which is highlighted, 
called ‘physical activity’ demarks every point in time when that individual has 
been active above a threshold of 3 METs. From this it is possible to observe 
how often and for what duration an individual exerted themselves over 3 
METs. These counts were made for each individual over all seven days, and 



















The Physical Activity Level 
The physical activity level (PAL), defined by the World Health Organisation, is 
another method of classifying physical activity. The PAL is calculated by the 
following equation: 
 
PAL = total daily energy expenditure 
basal metabolic rate 
 
The PAL was predicted for this population by using the total daily energy 
expenditure predicted by the SenseWear Armband and using the Harris-
Benedict equation to predict basal metabolic rate (Harris and Benedict 1918). 
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Thresholds of activity intensity for the PAL have been suggested and are 
described below (Food and Agriculture Organization 2001): 
 
• PAL <1.4 = Extremely sedentary 
• PAL 1.4 – 1.69 = Sedentary 
• PAL 1.70 – 1.99 = Moderate 
• PAL 2.00 – 2.40 = Vigorous 
• PAL >2.40 = Extremely vigorous 
 
Missing and excluded data 
Data were excluded under any of the following conditions: 
• Error message displayed while downloading monitor data 
• The monitor was worn < 3 days 
• Days were excluded when worn < 12 hours 
All other available data was included for analysis. No attempt to impute 
missing data was made. 
 
Statistical Analysis 
Baseline characteristics of the population were described, and differences 
between participants included in activity monitor analysis and those not 
included were checked using independent t tests for parametric data and chi 
square for non-normally distributed data. 
 
A Kruskal-Wallis test was used to test for significant differences in basic 
monitor variables across MRC grades and GOLD stages, and Mann-Whitney 
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U used for post hoc analysis. Total time spent above 3 METs and time above 
3 METs in bouts of at least 10 minutes were compared with a related samples 
Wilcoxon signed rank test. 
 
6.4 Results 
184 patients were eligible for analysis. There was no activity monitor data 
available for 12 patients as the monitor had not been worn. 10 participants 
were excluded from analysis because the monitor was worn for less than 
three days. 10 data sets were removed because of activity monitor failure on 
















Table 6.1 Baseline characteristics of participants included and not included in 








85 (56) : 67 (44) 16 (50) :16 (50) 0.541 
Age 
[mean (SD)] 
69.8 (9.4) 68.3 (8.1) 0.429 
FEV1 
[mean (SD)] 
1.47 (0.55) 1.36 (0.60) 0.325 
BMI 
[mean (SD)] 
27.44 (5.35) 28.10 (4.83) 0.524 
Dyspnoea 
 
3.17 (1.14) 2.86 (1.39) 0.195 
Fatigue 
 
3.98 (1.22) 3.74 (1.28) 0.339 
Emotion 
 








5.28 (1.32) 4.94 (1.46) 0.202 
ISWT m 
[mean (SD)] 
339.6 (152.8) 319.3 (180.4) 0.511 
ESWT seconds 
[mean (SD)] 
270.8 (174.2) 242.9 (216.9) 0.432 
Anxiety 
 




5.03 (3.14) 5.97 (3.54) 0.142 












































How does activity vary between disease and symptom severity? 
The median (IQR) values for the total daily energy expenditure, energy 
expenditure and time above the prescribed METs level, steps and PAL for 
each MRC grade are displayed in table 6.2, along with the result of the 
Kruskal-Wallis. Post hoc tests were only performed on the measures which 
had a significant result from the Kruskal-Wallis. The results of the post-hoc 
Man Whitney U tests are displayed in figures 6.4 and 6.5. Only significant 
differences are highlighted in the figures, and unless otherwise stated, 
differences between grades should be assumed to be non-significant. 
 
Table 6.2 Basic monitor variables across the MRC grades 




















































































































The total daily energy expenditure, energy expenditure and time above the 
prescribed METs level, steps and PAL for each GOLD stage are displayed in 
figures 6.3 and 6.4. The median (IQR) values and the results of the Kruskal-
Wallis are described in table 6.3. The results of the post-hoc Man Whitney U 
tests are displayed in figures 6.6 and 6.7. Only significant differences are 
highlighted in the figures, and unless otherwise stated, differences between 
grades should be assumed to be non-significant. 
 
Table 6.3 Basic monitor variables across the GOLD stages 


























































































































How active is a cohort of patients in primary care? 
The total daily energy expenditure, energy expenditure and time above the 
prescribed METs level, steps and PAL are described in table 6.4. 
 
Table 6.4 Basic monitor variables for the population at baseline 





















Figure 6.8 displays the proportion of the sample that fall within the five 
categories of the PAL. 
 











Does the label of ‘active’ depend on what measure of activity is used? 
128 participants had available data for seven days and were eligible for the 
following analysis. For this analysis, a single bout of physical activity was 
considered any activity performed over 3 METs. There was such little activity 
that is considered ‘vigorous’ or ‘very vigorous’ (6-9 METs or above 9 METs 
respectively) that all activity over 3 METs was amalgamated. For all 128 
participants, every bout of continuous physical activity was catalogued for 
duration and frequency over the seven-day period, ranging from one minute to 
85 minutes. This was transformed into total time spent in bouts of various 
durations for the week. This was cumulated for the whole sample of 128, and 
data is displayed in figure 6.9. For example, we can see from this figure that 
for the whole group (n=128) over a seven-day period, approximately 12,000 
minutes were spent in one-minute bouts of physical activity, 7,800 minutes 
spent in two-minute bouts of continuous physical activity, 5,900 minutes spent 
in three-minute bouts of continuous physical activity, etc. The dashed line on 
figure 6.9 represents the threshold of 10 minutes, which is recommended by 
the ACSM as the minimal duration of continuous physical activity that has a 
known clinical benefit when contributing towards a weekly target of >150 
minutes of physical activity. This graph shows that most physical activity over 









A Wilcoxon signed rank test was performed on total time spent over 3 METs 
during one week and time spent over 3 METs in bouts that were of at least 10 
minutes duration. Results are displayed in figure 6.10. The dashed line in the 
figure represents the recommendation for physical activity of 150 minutes. 
 
Table 6.5 shows the number and percentage of the sample which are labelled 
as ‘active’ according to physical activity guidelines by using 3 different 
measures; total time spent over 3 METs, time spent over 3 METs in at least 
10 minute bouts and steps.  
 
The relationship between steps and energy expenditure over 3 METs in at 
least 10 minute bouts is displayed in figure 6.11. The dashed lines demark the 
thresholds of the activity guidelines for each measure. 
 
Table 6.5 Activity classification by three different variables 
Active 150 minutes spent 
over 3 METs 
n (%) 
150 minutes spent over 
3 METs in ≥ 10 minute 





103 (80.47) 32 (25) 15 (11.72) 
No 
 


































The aim of this chapter was to use the baseline activity monitor data from the 
trial described in chapter 3 to explore the activity levels of a sample of people 
with COPD who were managed in primary care. Using accelerometers, a 
range of measures were used from the SAB to describe the physical activity 
levels of the sample. Data were interrogated to establish if physical activity in 
this primary care population varied by disease or symptoms severity, as has 
been established in other research cohorts. Finally, the baseline physical 
activity monitor data of those who had worn the monitor for a whole week 
were evaluated to establish adherence to physical activity recommendations. 
 
Physical activity in primary care 
Physical activity of people with COPD managed in primary care has not 
previously been examined. The participants of this study had minimal contact 
with secondary care health services, despite relatively moderate lung function 
impairment (mean FEV1 1.45 litres). It is not well understood why some 
patients manage in primary care while others require frequent use of 
secondary care services. While we might expect that increased utilisation of 
secondary care is required as the disease progresses, the moderately 
impaired lung function of these patients suggests that use of secondary care 
services is not solely associated with airflow obstruction. There may be a host 
of factors which influence an individual’s ability to cope in primary care with 
their disease. This study provided the first opportunity to analyse a large 
sample of activity monitor data from people with COPD managed in primary 
care. It was anticipated that examination of their physical activity levels might 
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offer a unique perspective of the COPD patient, and may develop our 
understanding of why some patients seem to manage in primary care better 
than others. If activity levels in these patients were higher than in patients who 
engage with secondary care services, this could have generated a hypothesis 
that physical activity may be important associated with how patients cope with 
their COPD. This may have informed future research to test this hypothesis 
further. 
 
Participants in this study had a mean step count of 5174 (SD 3129) and mean 
PAL of 1.76 (SD 0.78). This is marginally higher than findings from a study by 
Waschki et al. (2011) which recruited 170 patients, of a similar disease 
severity to the present study (mean FEV1% predicted 58.8%), through a 
secondary care research database in Germany. The average step count of 
the sample was around 4,716 and the mean PAL 1.41. Troosters et al. (2010) 
recruited 70 people with COPD [mean (SD) FEV1 1.48 (0.66) litres] from 
secondary care centres in Italy, Belgium and the USA. The total mean (SD) 
step count was 5584 (3360), which is slightly higher than in the present study. 
A small study of 17 participants post rehabilitation, in secondary care, with a 
mean FEV1 of 1.1 litres had a mean step count of 5,646 (SD 3,471), which 
was slightly higher than that observed in the present study (Nguyen et al. 
2011). It is possible, however, that activity levels were marginally higher 
because these patients had been recruited following rehabilitation which might 
have improved activity, although this was not confirmed by the study. 
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The findings of this chapter, within context of these three studies, suggest that 
despite being managed in primary care and appearing to cope well with their 
disease, the activity levels of the participants in the present study were similar 
to those observed in patients engaged in secondary care. Therefore, there is 
no indication to suggest that physical activity is associated with patients’ 
ability to cope better in primary care. It should be noted, however, that the 
studies of patients managed in secondary care which have been described 
are all from non-UK centres. Referral into secondary care services may occur 
at different stages of the disease between different healthcare settings around 
the world, and therefore physical activity of patients managed in secondary 
care in other countries may be different to that of patients managed in 
secondary care in the UK. As yet there have been no direct comparisons 
made of physical activity in patients managed in primary and secondary care 
in the UK, and the question of whether any differences between these two 
populations exists remains. 
 
Studies of healthy age matched controls have described average step counts 
of around 9,000 [n=30 (Troosters et al. 2010)], 10,000 [n=22 (Waschki et al. 
2012)] to 11,000 [n=60 (Nguyen et al. 2011)] steps per day. Compared with 
the present study, this suggests that physical activity in people with COPD 
managed in primary care is low. However, the mean PAL of the healthy 
elderly described by Waschki et al. (2012) was lower than in the present study 
[mean (SD) 1.66 (0.19) vs. 1.76 (0.78) respectively], although this might be 
because the numbers of healthy controls was low (n=22) and may not be 
representative. Alternatively, this might reflect a difference between 
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ambulatory and non-ambulatory physical activity. Step count in the present 
study is reduced compared with studies of healthy controls, suggesting that 
ambulatory physical activity is impaired. However, the PAL, which 
incorporates any kind of physical activity, was slightly higher. This suggests 
the possibility that non-ambulatory activities may not be impaired in this 
sample, compared with healthy controls. This may be supported by work by 
Pitta et al. (2005b), which identified that patients spent a greater proportion of 
their time in lower intensity activities, such as sitting or lying, and less time in 
more moderate activities, such as standing or walking. Perhaps in people with 
COPD more attention to non-ambulatory activities should be paid in 
evaluation of physical activity in the future. To confirm this hypothesis future 
work could integrate physical activity monitoring alongside activity diaries to 
not only establish the intensity and duration of activity, but also the type of 
activity undertaken. This would be a novel area of research as the difference 
in ambulatory and non-ambulatory daily physical activity in people with COPD 
has not been explored. 
 
Furthermore, the PAL was calculated by two different methods in the present 
study and that of Waschki et al. (2012). Waschki et al. used night-time energy 
expenditure from the SAB to estimate the basal metabolic rate, whereas the 
present study used the Harris-Benedict equation (Harris and Benedict 1918). 
There is no reason to suggest that either method is superior, however, this 
may be another reason why the PAL of the patients in the present study was 
similar to that of the healthy controls in the Waschki study. 
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Activity has previously been dissected by GOLD stage and MRC grade in a 
secondary care research population of patients with COPD (Watz et al. 2009). 
Watz and colleagues (2009) found that physical activity reduced with higher 
MRC scores and GOLD stage. This kind of analysis, however, has not been 
replicated in a primary care population before. Exercise capacity reduces 
between MRC grades 2 to 5 (Meijer et al. 2001; Spruit et al. 2007), therefore 
we might anticipate that the capacity for physical activity may also decline. 
Considering that with increased disease severity, in terms of airflow 
obstruction, activities of daily living require a greater proportion of one’s 
aerobic capacity (Vaes et al. 2011) we might also assume that daily physical 
activity declines with higher GOLD stages. It is important to test these 
assumptions in order to understand how physical activity may change through 
the course of the disease, and therefore at what stage various interventions to 
target physical activity may be indicated. 
 
The analyses in this chapter showed that while average step count varied 
between MRC grades, the PAL, energy expenditure and time over prescribed 
METs did not change between MRC dyspnoea grades 2 to 4. This suggests 
that daily physical activity might be broadly maintained between those who 
are MRC 2 to MRC 4. Physical activity, particularly in terms of the PAL and 
time over prescribed METs, declined sharply in those who were MRC grade 5. 
Watz et al. (2009) studied the physical activity of 170 patients recruited from a 
secondary care centre in Germany. Both step count and PAL demonstrated a 
gradual decline between MRC grades 2 and 5. The findings in the present 
study suggest that the decrease between MRC grades may not be as gradual, 
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particularly in the PAL. It is not immediately clear why the findings from these 
studies differ as the two samples were of a similar age and disease severity. It 
is possible that in the present study where patients were recruited from 
primary care, physical activity is better preserved in MRC grades 2 through 4 
compared with patients managed in secondary care. Neither study, however, 
was adequately powered to detect differences between MRC grade, and 
therefore this may be natural variation. Additionally, the distribution of patients 
across the MRC grades may have different between the studies. While the 
Watz study does not report the number of patients in each MRC category, in 
the present study over half the sample were MRC grade 2 and only 10 were 
MRC 5. This is a more unusual distribution of patients than is usually seen in 
secondary care studies. This does highlights the need for more adequately 
powered research to understand how physical activity may change depending 
upon functional impairment. 
 
There were significant differences in step count between GOLD stages II and 
III, and II and IV, and significant differences in the PAL between GOLD stages 
II and IV. Interestingly, however, is that those who were GOLD stage IV had a 
higher PAL than GOLD stage II [median (IQR) 2.05 (1.36 to 2.91) vs. 1.41 
(1.15 to 2.12)]. This may be due to low numbers within each of the sub-
groups, as this study was not adequately powered to detect this difference. It 
may also, however, highlight the difference between using a measure of 
functional impairment (like the MRC scale) compared with a measure of 
obstruction (like GOLD stage) to evaluate the impact of COPD on an 
individual’s functional status. Evaluation of physical activity using the new 
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GOLD assessment of lung function or exacerbation history combined with 
health status measured by the CAT or MRC should be explored in the future. 
 
Interestingly, these findings show that even those who are MRC grade 2 or 
GOLD stage I have reduced physical activity levels, compared with studies of 
healthy controls (Nguyen et al. 2011; Waschki et al. 2012). This is consistent 
with previous literature (Watz et al. 2009). This suggests that physical activity 
is modified early within the disease, if not prior to the onset of the disease 
(Hopkinson and Polkey 2010). The data reported in this chapter justifies the 
requirement for interventions aimed to improve physical activity early within 
the disease in patients managed in primary care. 
 
Adherence to physical activity recommendations 
Physical activity guidelines have proposed that older adults should carry out 
around 150 minutes of moderates intensity (>3 METs) activity per week 
(Nelson et al. 2007), or around 10,000 steps per day (Le Masurier et al. 
2003). Historically, physical activity has been measured as self-report, 
however more recently the development of objective devices such as 
pedometers and accelerometers has initiated a wealth of studies which have 
measured activity by these means. While the use of these devices addresses 
the issue of subjective bias from self-report data, there are still difficulties with 
handling and interpreting the data they produce. 
 
The SAB produces several measures from its basic output, including TEE, 
steps, and time/ energy expenditure over a defined threshold. From this 
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output it is possible to derive other variables, such as the PAL. The advanced 
function of the monitor allows further interrogation of a minute-by-minute 
account of energy expenditure which allows for calculation of the duration of 
bouts of physical activity. The data presented in this chapter, particularly that 
shown in figure 6.10 and in table 6.5 demonstrates the disparity between the 
different measures. Depending on the measure used, anything between 11% 
and 80% of the sample may be described as meeting the guidelines for 
physical activity. In reporting the prevalence of inactivity in a given population, 
this highlights the importance of selecting appropriate measures produced by 
these devices. 
 
Some studies have reported total time spent above 3 METs, although have 
not reported time spent over 3 METs in at least 10 minute bouts (Troosters et 
al. 2010; Watz et al. 2009). The recommendations for physical activity state 
that 150 minutes of moderate activity per week should be accumulated 
through bouts of at least 10 minutes. The findings from this chapter show 
there is a significant difference between the total activity over 3 METs and 
activity over 3 METs accumulated through at least 10 minute bouts [median 
(IQR) 327 (167.75-573.50) minutes vs. 38 10.00-121.25) minutes]. The health 
benefits of bouts of activity less than 10 minutes are unclear, and do not fulfil 
the criteria of the current guidelines (Nelson et al. 2007). To avoid 
overestimation of adherence to physical activity guidance it would be 
recommended that time spent over 3 METs in at least 10 minute bouts should 
be reported. For some patients, however, bouts of 10 minutes at moderate 
intensity might not ever be achievable, even through regular physical training. 
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If measuring activity at several time-points, in order to ensure changes in 
physical activity are not missed in these patients, total time spent over 3 
METs should still be reported. 
 
Step count is another variable that can be used to report on adherence to 
physical activity guidelines, with a target of 10,000 steps per day. Figure 6.11 
shows that although there is a relationship between moderate activity and 
steps, there is not always agreement between the two measures as to which 
patients meet physical activity guidelines. All scatter points within the top right 
hand quarter of the graph represent patients who meet physical activity 
criteria by both methods of assessment, where as those in the top left and 
bottom right quarters represent patients who met one criteria but not the 
other. This disagreement suggests the need for using more than one variable 
to describe physical activity levels. If just one of these measures is selected 
then we may underestimate the proportion of patients that meet physical 
activity recommendations. 
 
The only other study which has assessed bouts of activity was published 
recently (Donaire-Gonzalez et al. 2012). It was a Spanish study which 
recruited patients from a tertiary hospital. This study used two difference 
thresholds for moderate physical activity. A value of 2.6 METs was derived as 
50% of maximal oxygen uptake on performing an incremental test. The 
second value used was the traditional application of 3 METs to denote 
moderate intensity activity. When using 2.6 METs, 61% of the sample (n=177) 
were considered to meet the guidelines, whereas using 3 METs, 50% of the 
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sample met the guidelines. This is considerably higher than the 25% of the 
sample in this study which met the criteria of ≥150 minutes of moderate 
activity per week in at least 10 minute bouts. 
 
It is not clear why the difference in these findings exists. A similar 
methodological approach was applied to both studies, and both used the 
SAB. The groups were similarly matched for age and FEV1, although the 
physical function of the Spanish cohort was quite high, with a mean (SD) 
6MWD of 407 (96) m. It may be that physical activity is highly variable across 
different cultures, climates, socio-economic backgrounds and between 
different hospital settings (Meijer et al. 2001; Pitta et al. 2009), and has also 
shown seasonal variation (Sewell et al. 2010). There is also likely to be 
natural variation in physical activity that could account for some of the 
difference between studies. 
 
Other non-COPD studies of adult populations have found that around 28-48% 
of the general adult population meets the ACSM criteria for physical activity 
(Martin et al. 2000; Meseguer et al. 2009 ; Rydwik et al. 2012). Given these 
estimates in the general healthy population, the findings by Donaire-Gonzalez 
et al. (2012) that suggest 50-60% of those with COPD meet the ACSM criteria 
seems high. This highlights that physical inactivity is not a problem restricted 






This was a cross-sectional observation of physical activity during a single 
snapshot during a seven-day period. This study has evaluated people at 
different stages of the disease process and attempted to interpret this to 
predict how physical activity may progress. Repeated measures of activity 
over a long follow-up are required to develop our understanding of how 
physical activity actually changes through the life span of individuals with 
COPD. There is presently a lack of literature which measures physical activity 
longitudinally, most likely because this kind of research is challenging to 
conduct. 
 
Another limitation of this study is that only one measure of physical activity, 
the SAB, was used. While the SAB is a well validated device for objectively 
capturing physical movement, it offers no insight into the actual purpose of the 
activity. For example, it is possible to see that movement has occurred, but 
we cannot tell whether that was for getting dressed, going for a walk, doing 
the shopping, etc. Some monitors, such as the Dynaport, are able to record 
time in different positions, such as lying, sitting, standing or walking, which 
may offer greater insight into the type of activity conducted. Additionally, the 
conjunction of accelerometry and physical activity diaries might provide more 
understanding of why activity is undertaken, e.g. for leisure, work or ADLs. 
 
Areas for future research 
Thus far, only this and the Spanish study have evaluated bouts of activity in 
line with recommendations. Differences between these countries exist in 
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terms of culture, climate, terrain, and the healthcare systems. It is likely be 
valuable to explore this further in other cultures also, as this may have a 
significant bearing on the findings. 
 
It is likely that there are a number of people with COPD who will never be able 
to achieve bouts of 10 minutes of moderate activity. There may still be value 
in performing physical activity in bouts of less than 10 minutes as this may be 
a measure of exercise, however at present this has not been verified. The 
value of activity in shorter bouts should be explored further in order to 
adequately prescribe recommendations for those who operate at a lower 
threshold. 
 
Finally, this study has demonstrated the importance of making the distinction 
of measuring moderate physical in bouts of 10 minutes. It is not yet known 
whether this measure can be improved following an intervention aimed to 
improve physical activity. This is explored in chapter 7 of this thesis, however 
should also be addressed in other fields, such as pulmonary rehabilitation. 
 
Conclusions 
The measurement of physical activity is complex. Even with the advent of 
sophisticated accelerometers, issues around reporting of variables exist. It is 
apparent from the body of literature, that although there may be large 
variability in physical activity data, physical activity in patients with COPD is 
low. This study of patients managed in primary care aimed to explore the 
physical activity levels of a sample of patients who are relatively low users of 
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healthcare, compared with much of the literature so far which have 
documented physical activity in patients in secondary care who are more 
likely to be high users of healthcare. The findings in this chapter suggest that 
physical activity of the patients in this study are similar to other samples of 
patients recruited from secondary and tertiary health services in other studies, 
and lower than studies of healthy controls. Even patients who might be 
considered mild, in terms of MRC grade or GOLD stage, have low levels of 
activity. These findings highlight the need for interventions to improve physical 
activity in all patients with COPD in primary care, regardless of their level of 
functional disability or airflow limitation. 
 
So far, studies have used accelerometers to report time spent in moderate 
physical activity. The ACSM guidelines recommend that 150 minutes per 
week of activity over 3 METs is required for a healthy lifestyle, however this 
activity should be accumulated in bouts of at least 10 minutes. The data 
presented in this chapter shows a significant difference between total activity 
over 3 METs and activity over 3 METs accumulated in at least 10 minute 
bouts. This has important implications for how these data are interpreted and 
the clinical meaningfulness of the measure. More than half of total activity 
over 3 METs was accumulated in less than 10 minute bouts, the clinical 
relevance of which is not known. In the future, research measuring moderate 
physical activity through accelerometry should report duration accumulated 
through at least 10 minute bouts, and studies aiming to promote a healthier 
physically active lifestyle should use this as an outcome. 
 
227 
Chapter 7 Physical activity following SPACE 







In chapter 6 of this thesis, methodological and practical difficulties around 
activity monitoring were considered. A number of approaches were used to 
analyse and describe baseline accelerometer data from all participants of the 
trial. In meeting the ACSM guidelines for physical activity, the average amount 
of activity conducted in the group was low. Only 25% of the current population 
met the minimum criteria of 150 minutes of moderate activity accumulated in 
bouts of at least 10 minutes, and only 12% met the recommended 10,000 
steps per day. 
 
Physical activity is a health behaviour which has important clinical implications 
for people with COPD, and has been associated with several poor long-term 
outcomes (Garcia-Aymerich et al. 2003; Garcia-Aymerich et al. 2006; 
Waschki et al. 2011). Self-management aims to promote positive changes in 
health behaviour, and SPACE FOR COPD has placed a particular emphasis 
on improving physical activity and exercise performance. As discussed in the 
previous chapter, it is challenging to predict how physical activity may change. 
This chapter will therefore use a range of measures produced by the 
SenseWear Armband from data collected over the study period to explore the 
impact of SPACE FOR COPD on physical activity. This will then be discussed 
within the context of other study findings. 
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7.2 Aims 
The aims of this chapter are: 
i) to evaluate the impact of SPACE FOR COPD on physical 
activity 
ii) to establish which, if any, characteristics can predict physical 
activity 
7.3 Methods 
The main trial design is described in more detail in chapter 3. Section 6.2 in 
chapter 6 describes in detail how the different variables, which will also be 
used in this chapter, were derived from the SenseWear Armband. 
 
Participants 
All participants in the study were eligible for inclusion in this analysis. If 
participants did not attend follow up, or did not wear the activity monitor for 
any of their three visits then these participants were excluded. 
As in the previous chapter, days were excluded if the monitor was worn for 
less than 12 hours. Participants were also excluded from analysis if there 
were less than three days available at each time point. 
 
Outcome measures 
Participants were asked to wear the SenseWear Pro3 ArmBand (SAB) for 
seven whole days following their baseline, six-week and six-month 
assessments. The monitor automatically provides several measures, such as 
total energy expenditure and steps. It is also possible to derive further 
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variables by using the professional advanced software. The variables which 
were derived from the monitor and used in this analysis were: 
• Total energy expenditure (TEE), expressed as Kilocalories (Kcals) 
• Steps 
• Energy expenditure over prescribed METs 
• Time over prescribed METs 
• Time over 3 METs in at least 10 minute bouts 
• Physical Activity Level (PAL) 
 
In order to standardise outcome measures over three time points only the first 
12 hours of each day’s data were recorded. This controlled for time in the 
calculation of any change in the amount of activity undertaken, and this 12-
hour period has been used by several other studies in the evaluation of 
physical activity (Breyer et al. 2010; Pitta et al. 2008). 
 
Analysis 
Data was checked for normality and outliers. Baseline differences between 
those included and those not included in the activity monitor study were 
examined with independent t-tests for parametric data and chi square for non-
parametric data. Of those included in this analysis, baseline differences 
between intervention and control were calculated using the same tests. 
Between-group differences from baseline to six weeks were tested for with 
independent t-tests. Between-group differences over time at six months were 
tested for by repeated measures analysis of variance (ANOVA). The number 
of participants achieving more than 150 minutes over 3 METs at each time 
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point were calculated using SAS and compared by using a Kruskal-Wallis 
test. Linear regression analyses were performed in the attempt to produce a 
model which could predict those more likely to increase their physical activity 
levels. All analyses were carried out on PASW version 18. 
 
7.4 Results 
The baseline differences between those included and not included in this 
aspect of the study are reported in table 7.1. Tables 7.2 and 7.3 present the 
baseline data of SPACE FOR COPD and usual care groups of those included 
in the study. Data was missing for 15 participants because there was an error 
upon downloading activity monitor data. 35 sets of data were missing due to 
withdrawal from the trial, 25 participants had not worn the monitor for long 
enough at one of their time points and there was a further 26 participants who 













Table 7.1 Baseline characteristics of those included and not included in 









43 (51.80) : 40 
(48.20) 





69.2 (9.4) 69.8 (9.0) 0.916 
FEV1 (litres) 
[mean (SD)] 
1.44 (0.55) 1.46 (0.57) 0.833 
BMI 
[mean (SD)] 
26.85 (4.81) 28.21 (5.59) 0.080 
Dyspnoea 
 
3.16 (1.12) 3.08 (1.25) 0.636 
Fatigue 
 
3.99 (1.18) 3.88 (1.28) 0.550 
Emotion 
 









5.33 (1.29) 5.13 (1.40) 0.325 
ISWT (m) 
[mean (SD)] 
346.4 (132.7) 327.6 (175.7) 0.073 
ESWT (seconds) 
[mean (SD)] 
257.2 (170.3) 273.2 (191.6) 0.768 
Anxiety 
 






4.69 (2.97) 5.67 (3.39) 0.042 
Bristol Knowledge 
COPD Questionnaire  
[mean (SD)] 
34.85 (8.74) 32.56 (8.33) 0.108 









































Table 7.2 Baseline characteristics of SPACE FOR COPD and usual care 
















67.5 (7.5) 70.6 (10.7) 0.136 
FEV1 (litres) 
[mean (SD)] 
1.45 (0.62) 1.48 (0.47) 0.767 
BMI  
[mean (SD)] 
27.60 (5.56) 26.69 (4.38) 0.405 
Dyspnoea 
 
3.31 (1.03) 3.00 (1.11) 0.973 
Fatigue 
 
4.06 (1.30) 3.84 (1.08) 0.189 
Emotion 
 









5.38 (1.38) 5.32 (1.26) 0.819 
ISWT (m)  
[mean (SD)] 
346.9 (126.4) 345.9 (139.4) 0.973 
ESWT (seconds)  
 
244.6 (174.0) 268.2 (168.2) 0.531 
Anxiety 
 






4.90 (3.51) 5.89 (2.44) 0.987 
Bristol Knowledge 
COPD Questionnaire  
[mean (SD)] 
36.55 (7.32) 34.61 (10.23) 0.368 








































Table 7.3 Baseline activity monitor data of SPACE FOR COPD and usual 
care groups 















Energy Expenditure over 
prescribed METs (Kcals)  
[median (IQR)] 
81.4 
(45.1 to 187.9) 
61.0 
(13.4 to 132.1) 
0.383 




(7.4 to 34.5) 
10.1 









Time over 3 METs in ≥ 10 
















The median (IQR) number of days the activity monitor was worn for was 7 (7-
7) at baseline, 7(7-7) at six weeks and 7(7-7) at six months. The output of the 
six activity monitor variables at all three time points are described in table 7.4. 
Results from the independent t-tests showed that there was a significant 
between-group difference in change in steps at six weeks (p=0.047). All other 
between-group differences were not statistically significant. The results of the 
repeated measures ANOVA are displayed in table 7.5. Change in time over 3 
METs in at least 10 minutes bouts, physical activity level and steps are 





Table 7.4 Activity monitor output at three time points for SPACE FOR COPD 
and usual care groups 

















































































































































Time over 3 









































Table 7.5 Significance levels of within-subject effects of time and intervention 















Total Daily Energy 
Expenditure 
(Kcals) 









0.691 0.304 0.802 
Steps (number) 0.670 0.609 0.898 
Time over 3 METs 
in ≥ 10 minute 
bouts (minutes) 




0.455 0.600 0.603 
 
This indicates that there were no effects of either time or intervention on 
physical activity. There were therefore no between-group differences in any of 







Figure 7.1 Time spent over 3 METs in at least 10 minute bouts at all time 















Figure 7.2 Physical Activity Level at three time points for both SPACE FOR 






















Figure 7.3 Number of steps at all time points for both SPACE FOR COPD 














Number of patients achieving physical activity guidelines 
In order to evaluate the number of people achieving the ACSM guidelines only 
those who had seven full days of data at all three time points were included in 
this analysis. There were 55 participants who fulfilled this criteria, n=29 in 
usual care and n=26 in the SPACE FOR COPD group. Table 7.6 describes 
the number of participants at each time point in each group who were 
compliant with the ACSM guidelines of at least 150 minutes of activity over 3 
METs in bouts of at least 10 minutes. The results of the Kruskal-Wallis test 
are also shown in this table. 
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0.422 0.585 0.854 
 
 
Overall there was no statistically significant between-group difference in the 
numbers of patients who achieved the recommendations for physical activity 
over the six months. There was, however, a non-significant increase of 15% 
more patients achieving the guidelines at six weeks.  
 
Predicting change in physical activity 
Although not statistically significant, figure 7.1 suggests there may a trend for 
increased time spent over 3 METs in ≥ 10 minute bouts in the SPACE FOR 
COPD group at six weeks. In order to predict who might be most likely to 
improve in this outcome at six weeks, linear regression analysis was 
performed. Baseline characteristics of; age, FEV1, FVC, BMI, gender, 
baseline ISWT distance, baseline ESWT distance, baseline BCKQ, baseline 
PRAISE, change ISWT, change ESWT, change BCKQ and change PRAISE 
were used in a backward stepwise linear regression model to predict change 
in time spent over 3 METs in ≥ 10 minute bouts in the SPACE FOR COPD 
group from baseline to six weeks. The only significant predictor was baseline 
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MRC grade which was able to predict 10% of the variability in change in time 
spent in activity over 3 METs in ≥ 10 minute bouts in the SPACE FOR COPD 
group at six weeks. 
 
7.3 Discussion 
These data suggest that there is some improvement in physical activity at six 
weeks in the SPACE FOR COPD group, however this is not maintained at six 
months. It was not, however, possible to predict who was most likely to 
increase physical activity with the variables that had been collected. 
 
Given the high variation in most measures of activity, achieving adequate 
power to detect a difference is likely to require large numbers of patients. This 
study was not adequately powered to detect a change in activity levels. The 
examination of these data, therefore, was for exploratory purposes to signal 
where and what changes might occur. This may assist us in generating 
hypotheses, which could be tested in future work. 
 
Meeting physical activity guidelines 
The guidelines for physical activity recommend that at least 150 minutes per 
week should be spent in moderate intensity activities which should be 
accumulated in bouts of at least 10 minutes duration (Haskell et al. 2007). At 
baseline, the median length of time in both groups did not meet this 
requirement at 45 and 38 minutes for SPACE FOR COPD and usual care 
respectively. After six weeks however there was a change of 51 minutes in 
the SPACE FOR COPD group and only a 1 minute change in usual care. This 
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means that for those on SPACE FOR COPD, on average, activity that 
contributed towards meeting the ACSM guideline was more than doubled 
during the first six weeks. While the lack of statistical significance suggests 
this could have occurred by chance, the size of this change suggests it may 
still be worth considering the implications. 
 
This is the first study of a COPD primary care population to scrutinize physical 
activity in this way. The effect of an intervention on adherence to physical 
activity guidelines has not previously been described. While as yet there are 
no studies which show a cause and effect that improving the physical activity 
levels of people with COPD will lead to improved survival, the widening body 
of literature suggests there is an association between the two (Garcia-
Aymerich et al. 2006; Waschki et al. 2011). We therefore make an assumption 
that improving activity is beneficial, and that meeting the guidelines should be 
the overall aim. 
 
There was not a significant change in the number of people who met the 
criteria of 150 minutes over 3 METs in at least 10 minute bouts overall. 
However, given that the average baseline time was only around one quarter 
of the recommended amount, most patients were far from achieving the 150 
minutes. Perhaps for many people with COPD, 150 minutes over 3 METs in 
10 minute bouts is more challenging than for most, or perhaps an unrealistic 
target altogether. Using time as a continuous variable rather than 
dichotomising below and above 150 minutes may therefore be a more useful 
measure in this population.  
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Only one other self-management study has previously attempted to report 
changes in physical activity in patients with COPD. COPE II (Effing et al. 
2011) used a Yamax digiwalker 200 pedometer to count steps, which patients 
wore for seven days at baseline, seven months and 12 months. Over the 
treatment period (12 months) there was a net improvement of 1,190 steps per 
day, which was approximately an 18% improvement on baseline activity and 
was statistically significant (p=0.028). This change was only weak-moderately 
correlated with change in ISWT (r=0.47) and ESWT [r=0.38) (Zwerink et al. 
2012)]. These data suggest that physical activity and exercise performance 
are not well associated, and supports the discussion in the previous chapter, 
which suggested that what one can do and what one does may be quite 
different. 
 
A key difference between COPE II and SPACE FOR COPD is the intensity 
and duration of the interventions. COPE II required patients to attend 
supervised exercise two to three times per week for up to one year, whereas 
SPACE FOR COPD was an entirely unsupervised programme which only 
provided planned support for the first four weeks. Perhaps the sustained 
support in COPE II was important for maintaining longer-term behaviour 
change. The short-term support in SPACE FOR COPD may explain why 
physical activity appears to show signs of improvement during the first six 
weeks, but returns to baseline after the withdrawal of formal support by six 
months. The point is worthy of consideration in planning for future research 
studies and implementation of SPACE FOR COPD in a clinical context. 
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Although the improvement in steps in COPE II was significant, there are 
drawbacks with the design. Pedometers have been found to be less reliable 
than accelerometers at detecting slow speeds on walking (Turner et al. 2012), 
therefore not all walking may have been captured by the device. Additionally, 
step count alone is a rather crude insight into physical activity. It gives no 
information about either intensity or duration of activity. It is not possible, 
therefore, from the COPE II study to establish the level of adherence of the 
population to the ACSM guidelines. The data from the SPACE FOR COPD 
trial offers a more meaningful insight into using a range of physical activity 
parameters. 
 
Predicting change in physical activity 
This is the first study which has attempted to establish whether any other 
variables can predict change in activity. A linear regression model was used 
to evaluate whether any of the characteristics of this population could predict 
the change in moderate activity performed in bouts between baseline and six 
weeks. Of all the variables entered into the model, only baseline MRC score 
was found to be a significant predictor, which was able to predict around 10% 
of the variance of the change in time spent over 3 METs. This suggests that 
with the variables collected in this study, it is not possible to predict change in 
physical activity. 
 
It is interesting that neither baseline nor change in either knowledge or self-
efficacy were significant predictors of change in physical activity behaviour. It 
has been previously postulated that a self-management intervention which 
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enhances knowledge, skills and self-efficacy results in behaviour change and 
impacts on healthcare utilisation and health status [Figure 7.4 (Bourbeau, 
Nault, and Dang-Tan 2004)]. While the author acknowledges this is a simple 
model, the data and analysis in this chapter does not support this theory. 
 










measure self-efficacy, knowledge and behaviour change were not 
appropriate, and using different measures may have produced an alternative 
result. All the measures used however (BCKQ for knowledge, PRAISE for 
self-efficacy and the SAB for physical activity) have been validated in COPD 
populations. While the BCKQ and PRAISE were originally designed for 
pulmonary rehabilitation populations, there is a lack of choice of other tools 
validated in people with COPD. It is also worth noting that this is the first self-
management study to measure knowledge, self-efficacy and behaviour 
This item has been removed due to 3rd Party Copyright. The unabridged version of the 
thesis can be viewed in the Lanchester Library Coventry University.
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change to test any relationship between the three constructs, and is the first 
time the theory proposed in figure 7.4 has been tested by objective measures. 
As recognised by the author himself (Bourbeau, Nault, & Dang-Tan 2004), it is 
likely that this model is an overly simplistic concept of behaviour change. 
Previously it was discussed that just because people have greater exercise 
capacity, it does not necessarily translate into physical activity behaviour 
change. There are parallels here insofar that having the knowledge and self-
efficacy to do more, also does not necessarily mean that people actually will 
do more. Figure 7.5 is modelled on the work by Bourbeau, Nault and Dang-
Tan (2004), but illustrates that there is likely to be a host of internal factors, 
external factors as well as symptoms, which contribute to the complexity of 
people’s choice around undertaking physical activity. It is possible that some 
of these factors may be influenced by programmes such as self-management; 
however others may be very difficult to manipulate. Behaviour change, in 
terms of physical activity, remains therefore a very unclear area of our 
























There are still no clear guidelines on measuring physical activity, and 
methodologies in the current literature are varied. Several methodological 
decisions were made which will have had implications for the findings of this 
chapter. The decision to only include the first 12 waking hours of data from 
each participant was taken to ensure standardisation, so that comparisons 
could be made in the knowledge that a like for like time-frame was used at 
each time-point. This does, however, come at the expense of not using data 
where the monitor was worn for longer than 12 hours. This study may 
therefore have underestimated physical activity levels in some participants, 
and this is accepted as a drawback of this methodology. By using the first 12 
waking hours, however, it was anticipated that this would capture the majority 
of patients’ ‘most active’ time of day. It was decided to use 12 hours on the 
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basis of previous studies which have assessed physical activity (Breyer et al. 
2010; Pitta et al. 2009; Pitta et al. 2008). However, data may still be a valid 
reflection of activity for periods of less than 12 hours (Hill et al. 2012). This 
would have been excluded in this study. At present we do not know the 
minimum number of hours required in order to be accurately representative of 
an individual’s daily activity levels. This is an area for further research in order 
to inform future studies. 
 
A further issue with the measurement and reporting of physical activity in this 
study is that with accelerometry alone, it is not possible to understand neither 
the nature nor purpose of the movement that the monitor has detected. This 
chapter has moved the literature forward by analysing adherence to physical 
activity guidelines for the first time by looking at both intensity and duration of 
activity. However, it is still not possible to tell how this activity was 
accumulated, for example cycling or walking. Physical activity questionnaires 
or diaries, although criticised for being prone to subject bias, are able to 
provide more detail regarding the purpose of activity. A combination of both 
questionnaires and accelerometry perhaps provide the best overall picture of 
the actual amount, nature and purpose of physical activity, and should be 
considered in future work. 
 
Future Recommendations 
It is clear that there needs to be more studies that inform choice regarding 
methodological decisions about measuring physical activity. Optimum daily 
wearing of activity monitors required for accurate measurement, the selection 
247 
of appropriate variables produced by monitors and the application of 
combined accelerometry and self-report are all worthy of further exploration. 
 
These data, alongside that of other studies, raise the question of whether 
longer-term support during an intervention is likely to lead to greater 
improvements in physical activity. In the current trial, SPACE FOR COPD was 
only formally supported for the first four weeks. Additionally to trends 
observed in physical activity, there were changes in other outcomes which 
were significant at six weeks but not by six months. Therefore it may be 
worthwhile for future work in SPACE FOR COPD to test the effectiveness of 
longer-term follow-up support. 
 
The measurement of time spent over 3 METs in at least 10 minute bouts is a 
novel approach to measuring and reporting physical activity monitor data in 
COPD studies. It permits for the interpretation of how well a population 
adheres to the recommended weekly amount of physical activity. The data 
from this trial suggests that 150 minutes may be unachievable for many 
people with COPD. There may be some value in future research establishing 
an optimum amount of activity for this population. 
 
Conclusions 
There were significant improvements in step count at six weeks, however no 
statistically significant changes in physical activity were maintained at six 
months. This finding is in keeping with several other trial outcomes (chapters 
4 and 5). Overall this may suggest that SPACE FOR COPD was most 
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effective during the first six weeks, when planned support was provided. 
Deducing who is likely to improve in physical activity was not possible with the 
data that was available from this study. Interestingly, however, exercise 
capacity, knowledge or self-efficacy were not significant in a model to predict 




































Chapter 8 General Discussion 
 
The aim of this thesis was to conduct an RCT to test the effectiveness of 
SPACE FOR COPD in primary care in the UK. SPACE FOR COPD is a new 
programme of self-management which aims to support core self-management 
skills and teach disease specific tasks which enables the individual to improve 
their quality of life as a result of changing health promoting behaviours. 
 
The hypothesis was that SPACE FOR COPD would confer a greater benefit 
on HRQoL when compared with usual care alone. In addition to HRQoL, we 
also sought to explore the impact of SPACE FOR COPD on knowledge, self-
efficacy, exercise performance, psychological function and physical activity. 
The discussion will be divided into main findings, study limitations, future work 
and final conclusions. 
 
8.1 Main Findings 
The hypothesis that SPACE FOR COPD would improve dyspnoea 
significantly more than usual care at six months was not supported by the 
data in this trial. Dyspnoea in both the intervention and control groups 
improved at six months (chapter 5). Upon reflection, it might have been more 
appropriate to appoint the primary outcome as the change in CRQ-SR 
dyspnoea at six weeks rather than six months. It is well documented that 
changes in HRQoL following pulmonary rehabilitation improves over the short-
term of six to eight weeks, but can diminish during the follow-up period at six 
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months (Egan et al. 2012; Sewell et al. 2006). Six weeks was considered to 
be the ‘intervention period’ of SPACE FOR COPD and the minimum amount 
of time required for changes in clinical outcomes to take place. A primary 
outcome of the intervention period would have been more appropriate, with 
secondary outcomes at six months to evaluate the maintenance period. 
 
There were short-term advantages in the SPACE FOR COPD group in 
HRQoL, anxiety, exercise performance knowledge and step count (chapters 4 
and 7). This is the first study to document changes in such an array of 
outcomes over such a short time frame. This has implications for recognising 
the variety of outcomes which need to be measured and how early changes 
can occur following initiation of self-management support. 
 
In the medium-term, significant improvements in endurance exercise 
performance and anxiety were maintained at six months (chapter 5). For 
those at risk of depression, depression scores on the HADS showed 
continued improvement in the SPACE FOR COPD group, and at six months 
the mean difference between groups exceeded the MCID, although this was 
not statistically significant. This is the first self-management study to 
demonstrate maintenance of exercise performance over such a period 
following an unsupervised programme of exercise training, and is also the first 
self-management study to document changes in depression of this 
magnitude. Maintenance of improvements in walking performance and 
emotional status are important clinical outcomes for people living with COPD. 
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The patients recruited to this study were largely managed in primary care. 
COPD patients in primary care are substantially under researched, compared 
with those managed in secondary or tertiary care. This thesis, therefore, has 
added a novel insight into a population of people with COPD that we currently 
have a lack of understanding of. It might have been anticipated that because 
these patients seem to manage better by avoiding the need for secondary 
care contact that physical activity levels may have been relatively well 
preserved. However, compared with other studies of healthy populations, 
physical activity levels in this population are low (chapter 6). Given the 
association of low activity and poor health outcomes, this highlights the need 
for an intervention aimed at improving physical activity in these patients. 
 
In this thesis the opportunity was taken, as the first UK-based study, to 
evaluate the adherence of a sample of COPD patients to the guidelines for 
physical activity (chapter 6). This provides insight into the magnitude of the 
problem of physical inactivity in COPD and highlights important 
methodological issues in physical activity monitoring. Moreover, this is the first 
self-management study to measure physical activity in response to an 
intervention by using validated and reliable accelerometers (chapter 7). This is 
an important advance in the field, given that behaviour change is a key aim of 
self-management, and that physical activity is an important behaviour in 
COPD and the focus of many sophisticated interventions. 
 
There are several implications and caveats to these findings which will be 
discussed within relation the population and the intervention. 
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8.1.1 The Population 
This is one of only two self-management studies globally, which have 
specifically targeted an intervention to patients managed in primary care. The 
other study evaluated a practice nurse-led education intervention, with no 
exercise and found no significant impact on either the primary measure of 
CRQ-SR or secondary measures of self-efficacy and healthcare utilisation 
(Bischoff et al. 2012). The present study, therefore, is the first study of a self-
management programme in primary care which has show significant clinical 
benefits. In this study, it is likely that targeting SPACE FOR COPD towards a 
primary care population in the UK has had several implications on the 
findings. 
 
The delivery of SPACE FOR COPD early within the course of the disease 
may be important in understanding what differentiates SPACE FOR COPD 
from other studies. Many studies have targeted self-management support 
towards patients who have previously been hospitalised with a COPD related 
admission (Bourbeau et al. 2003; Bucknall et al. 2012; Fan et al. 2012; Rice et 
al. 2010). Two such studies published recently have had poor outcomes, with 
one study showing no impact of the self-management programme at all 
(Bucknall et al. 2012), while the other was stopped prematurely due to safety 
concerns due to higher mortality in the treatment arm (Fan et al. 2012). There 
may be several reasons why self-management post-exacerbation has not 
been more successful. 
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The rationale that self-management support for those who have been 
hospitalised for their COPD should be effective is based in theory. The Health 
Belief Model (Becker 1974) and the Protection Motivation Theory (Rogers 
1975) dictate that people will not be motivated to change behaviour unless 
they feel a direct threat. In COPD, this is likely to be an acute event, such 
hospitalisation due to exacerbation. People who have been admitted to 
hospital due to COPD may feel at their most vulnerable at this time, and may 
be more motivated to change negative health behaviours, such as smoking 
and physical inactivity. However, in this instance, the increased threat of the 
exacerbation is usually only temporary, and once the symptoms of the 
exacerbation are relieved, motivation levels may decline. 
 
A recent study reported the natural history of COPD in a Canadian population 
and identified the importance of the negative impact of hospitalisation on 
disease progression (Suissa, Dell'Aniello, and Ernst 2012). The paper 
proposed from their data that there was around a five year lag between the 
first and second hospitalisation, and after the second, hospitalisations for 
COPD became more frequent and regular. Self-management strategies may 
be too subtle to make a significant impact in patients who are already 
entrenched within the spiral of disability associated with frequent 
hospitalisations. Self-management support aims to address behaviours to 
optimise medical and emotional well-being. These behaviours may be 
modified more readily in individuals who are earlier within the disease process 
and less burdened by frequent exacerbations and disease symptoms which 
may make it difficult to sustain behaviour change. 
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The present study recruited patients who were largely managed in primary 
care, and were mostly MRC grade 2. In contrast to some other programmes, 
SPACE FOR COPD may have been more effective as it was directed towards 
patients who were less functionally impaired and entrenched within the spiral 
of disability. These patients, therefore, may have found it easier to adopt new 
skills and tasks. Furthermore, having predominantly only been managed 
within primary healthcare for their COPD, these patients were perhaps likely 
to be have less knowledge about COPD and many self-management 
strategies. Usually, other than inhaled therapy, primary care offers little further 
treatment options for COPD, particularly early in the disease. These patients, 
therefore, were likely to have the most to gain from SPACE FOR COPD, 
given that previous input or advice was likely to be low. 
 
It may, however, still not be early enough. In other disease self-management 
programmes, such as diabetes, self-management support is routinely 
delivered soon after diagnosis (Davies et al. 2008). One study in diabetes 
self-management reported time since diagnosis was the most important factor 
for predicting a positive outcome (Ko et al. 2012). This suggests that the 
sooner self-management was delivered within the course of the disease the 
more likely changes in behaviour would be adopted. While the present study 
aimed to target individuals early within the disease, we did not seek to recruit 
newly diagnosed patients. The literature from the diabetes studies suggests 
that there may be additional benefits from initiating self-management support 
even earlier than in this study, and perhaps soon after the point of diagnosis.  
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The argument for self-management support for those earlier within the course 
of their disease is strengthened when considering the data presented in 
chapter 6, which showed that that physical activity levels were impaired in this 
population, in comparison with healthy counterparts. This suggests that 
although patients who are MRC grade 2 might be considered to be at the 
‘better’ end of the COPD spectrum, they may already have adjusted their 
behaviour in response to their COPD. This highlights the need for an 
intervention to promote positive behaviour change in patients who are less 
disabled by their disease. Particular consideration should be given to this 
when we consider that pulmonary rehabilitation, which is the only form of self-
management support regularly provided in the UK, is only usually offered for 
those who score 3 or higher on the MRC scale. SPACE FOR COPD may be a 
suitable self-management approach to be delivered to patients earlier within 
the course of their disease, in order to provide behaviour change support to 
those who would otherwise have had nothing. 
 
The importance of early intervention is amplified when we consider the 
progressive decline in functional capacity and health outcomes over time, 
which have been well documented in people with COPD (Agarwal et al. 2012; 
Casanova et al. 2007). In the face of an incurable disease, prevention of 
further decline may be the most hopeful option. Preservation of the status 
quo, in terms of health status, may be considered a positive outcome in light 
of the progressive disease burden. Negative health behaviours, namely 
smoking, exercise intolerance and physical inactivity, are significantly 
associated with worse health outcomes (Celli et al. 2004; Godtfredson et al. 
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2008; Waschki et al. 2011). SPACE FOR COPD aims to have a positive 
impact on these behaviours, and the results from this trial suggest that the 
intervention is successful in improving some of these changes. However, a 
positive result from a behavioural intervention may not be improvement, but 
may be maintenance instead. Preservation of health status may therefore be 
the ultimate aim of SPACE FOR COPD. Longer-term follow-up is required in 
order to evaluate how well and how long outcomes are maintained following 
SPACE FOR COPD, in the face of a disease which progressively 
deteriorates. 
 
While initiation of self-management support early within the course of the 
disease may be preferable, it may be a challenging ambition given the high 
prevalence of undiagnosed COPD (Bastin et al. 2010). A recent study in the 
UK suggested that around 34% of people admitted to a general district 
hospital due to COPD had not previously been diagnosed with the disease 
(Bastin et al. 2010). Moreover, the mean (SD) FEV1 of these patients was 
severe at 1.02 (0.32) litres. This highlights that people with COPD do not 
present early, and may not even be identified in primary care. In order to 
provide self-management support early within the disease, screening or case 
finding programmes must be employed, as outlined in the UK government’s 
agenda (Department of Health 2012b). 
 
8.1.2 The Intervention 
The NHS outcomes framework has identified in domain 2 that one of the key 
topics on the political health agenda for 2013/14 in the UK is enhancing 
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quality of life for people with long-term conditions (Department of Health 
2012b), and that self-management will play a role in meeting this aim 
(Department of Health 2012a). One of the challenges of providing self-
management support to a whole population of people with COPD is to 
develop an intervention which is both effective yet capable of being able to 
meet the demand. Given there may be around three million people in the UK 
with COPD, this presents a considerable challenge (Stang et al. 2000). Some 
self-management programmes to date have provided heavily supervised 
programmes, with one-to-one home visits (Bourbeau et al. 2003; Boxall et al. 
2005), loaning exercise equipment (Maltais et al. 2008), or supervised 
physical training for up to two years (Monninkhof et al. 2003). In the current 
financial and political climate in the UK it is not feasible to implement these 
kinds of programmes to the breadth of the COPD population, and they are 
therefore unlikely to be commissioned. At the other end of the spectrum, the 
simplest form of self-management is the provision of an action plan or brief 
education. There is, however, little evidence that these programmes have any 
clinical benefit (McGeoch et al. 2006; Watson et al. 1997). SPACE FOR 
COPD adopts a light-touch approach which would be feasible to roll out 
nationwide, although the content is comprehensive and encompasses all core 
self-management skills. SPACE FOR COPD is therefore not only an effective 
programme of self-management, but has potential to be deliverable on a 
larger scale than other models of self-management. 
 
We might suppose that light-touch interventions may be less effective than 
more heavily supervised approaches. There might be an assumption that self-
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management skills may be learned more easily if practiced under the 
supervision of a healthcare professional, and that there may be a dose-
response between the level of support provided and the outcome of the 
intervention. However the findings from this study, in comparison with other 
self-management programmes, do not support this hypothesis. There may be 
a number of explanations why the light-touch approach of SPACE FOR 
COPD challenges these assumptions. 
 
Individuals on SPACE FOR COPD were required to learn self-management 
skills in a self-directed manner, within their own home environment. Learning 
within one’s own environment may enable individuals to develop skills and 
practice them in the way in which they mean to continue using them. We 
might anticipate that this would more easily allow for maintenance of skills and 
therefore sustained behaviour change. This is in contrast to supervised 
courses, whereby individuals learn skills within a foreign environment and 
have the option rely upon a healthcare professional for support. In a 
supervised environment it may be easier to revert to more traditional, 
paternalistic patient healthcare professional roles. 
 
It is important to consider the participants’ expectations of those undertaking 
the SPACE FOR COPD intervention. Patients undergoing a supervised 
course expect a course which lasts for a specified duration and has an end 
point. Conversely, on SPACE FOR COPD, patients are encouraged to think of 
it as lifestyle intervention, and no end point of the programme is predefined. 
This may mediate patient expectations from the start and may influence 
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attitudes as to how long behaviour changes are to be maintained. From the 
outset, patients may therefore anticipate that these are lifestyle changes, 
rather than changes to be made solely for the duration of a course. 
 
Although the qualitative data from this trial has not been reported in this 
thesis, a key finding from patients who were interviewed that had used the 
manual was that patients felt that the telephone support was considerably 
reassuring. A qualitative study of telephone support reported many 
advantages to regular telephone contact (Walters et al. 2012). Patients 
reported that it acted as a ‘regular reminder’ and reinforced health behaviours, 
it helped to create a partnership with the healthcare professional and patients 
developed a sense of responsibility to them. Patients also identified that the 
knowledge that they would be receiving a call was a motivating factor and 
reassuring. While it is not possible to evaluate to what extent the phone 
contact contributed to the positive impact of the intervention, in the absence of 
any direct face-to-face healthcare supervision, the telephone contact might 
have been a valuable feature. The lack of contact between six weeks and six 
months may, in part, be a reason for the lack of maintenance in some of the 
outcomes in this trial. This might be addressed in further research. 
 
One of the challenges in making comparisons between the present study and 
others is the different duration of interventions and the different time to follow-
up. Other studies have had longer intervention periods and have therefore not 
conducted assessments until between three and seven months (Bourbeau et 
al. 2003; Effing et al. 2011; Monninkhof et al. 2003). If the intervention period 
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and time to follow-up is longer then the opportunity to measure the potentially 
greater, short-term response is missed. This means it is difficult to identify 
whether greater changes were made that then declined, and whether 
strategies to support maintenance should be employed. 
 
8.2 Study Limitations 
The data presented in chapters 4 and 5 demonstrates that there was a 
significant improvement in the CRQ-SR dyspnoea domain in both the 
intervention and usual care groups. This change in the usual care group was 
not anticipated. While no additions were made to usual care, the significant 
improvements in dyspnoea suggest that some impact had occurred in this 
group as a result of participating in the trial. Firstly, there is the impact of 
receiving attention, which is a well-known effect and is often referred to as the 
Hawthorne effect after the famous Hawthorne experiments (Landsberger 
1958). Secondly, the actual completion of maximal exercise tests may also 
have a significant impact on the patient (van Sluijs et al. 2006). In other 
disease populations, the performance of exercise tests has been shown to 
improve mood (Ewart et al. 1983) and increase confidence in undertaking 
physical tasks (O’Connor et al. 1995). For individuals with COPD, performing 
a maximal exercise test with a healthcare professional may be a liberating 
experience, as individuals experience exertion beyond what they previously 
though possible, without any detrimental effects. 
 
This raises the debate of to what extent is does the assessment itself become 
part of the intervention? In this study, given that the participants were 
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managed in primary care and had previously received little attention for their 
COPD, the impact of the assessment itself might have been considerable.  
Each assessment took between one and two hours, and was conducted in a 
hospital, by a physiotherapist who specialises in COPD. While every effort 
was made to minimise the potential impact of these assessments, it seems 
likely that these patients who had been relatively naïve to their condition and 
had sought to enrol in a research study for their disease, gained some 
positive effect of the assessments. 
 
In future work, this issue may be difficult to navigate if we wish to establish the 
effect on exercise performance. The Solomon-4 design trial has been 
described to manage this problem (McCambridge et al. 2011). It requires a 
four-group design whereby each randomised group is randomised a second 
time to either undergo or no undergo an assessment. This allows the effects 
of the intervention to be distinguished from the effects of assessment. If this 
design had been used in this study, it might have been easier to evaluate the 
real between-group difference between intervention and usual care. The 
Solomon-4 design, however, has not been used frequently and does require a 
larger sample size, which may pose difficulties. Conduct of the exercise tests 
by a technician, rather than a specialist, may also help to minimise the impact 
of the walking tests. 
 
Additionally, the term ‘demand characteristics’ has been applied to the 
phenomenon whereby participants are aware of the research aims, 
anticipating the findings and what this implies for how they are expected to 
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behave (McCambridge et al. 2012). In the present study, all participants were 
aware that investigators were testing the impact of a self-management 
manual which included education and exercise training on HRQoL, exercise 
performance and physical activity. It was clear to participants from the patient 
information sheet (appendix 4) that the investigators anticipated a positive 
impact. It is therefore possible that participants randomised to usual care who 
did not receive SPACE FOR COPD may have sought their own education and 
exercise regime, in the understanding that would have a positive impact. 
Demand characteristics may be challenging to negotiate around, however one 
possibility is the opportunity to carry out concealed consent. This method of 
consent withholds the purpose or aims of the study from participants until after 
the trial has finished, therefore reducing the risk of this effect. This has been 
seldom reported, however, and may have significant ethical implications. 
 
When we consider the transtheoretical model of change (figure 8.1), we can 
see that relapse is a part of the process of change (Prochaska and 
DiClemente 1983). It should be expected, therefore, that sustained behaviour 
change will not be achieved by all. In this study, the lack of contact following 
the four-week phone call meant that there was no opportunity to support 
patients who entered the relapse phase. A recent study evaluated a 
counselling intervention whereby GPs provided a single motivational 
interviewing consultation aimed at provoking behaviour change in smoking, 
drinking, unhealthy eating or physical inactivity ((Butler et al. 2013). The study 
showed that there was no beneficial outcome at 3 months, and suggested that 
behaviour change was unlikely to occur after a single consultation. The study 
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did show that there was an improvement in attempts to change and the 
patients’ perceptions of having made a change at three months. The SPACE 
FOR COPD study did not evaluate attempts to change, which may have been 
insightful information. Furthermore, the findings from Butler et al. suggest that 
one MI consultation may not be enough. Regular contact from the supporting 
healthcare professional would allow better support for patients who relapse, 
permitting the opportunity to use MI again to continue along the cycle. 
 














In this study SPACE FOR COPD was delivered as part of a research process, 
and as usual, subject selection bias whereby the participants recruited were 
likely to be the more motivated and willing patients. In routine practice not all 
This item has been removed due to 3rd Party Copyright. The unabridged 
version of the thesis can be viewed in the Lanchester Library Coventry 
University.
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patients will be as motivated. Given the self-directed nature of the intervention 
this may mean that SPACE FOR COPD is not beneficial for all people with 
COPD. It will be important in future work to identify who is most likely to 
benefit from SPACE FOR COPD and treatment options can therefore better 
be directed. Ultimately, chronic disease care should be personalised to the 
individual rather than a ‘one size fits all’ approach, therefore it is unlikely 
SPACE FOR COPD will suit everyone. SPACE FOR COPD, however, adds to 
the menu of treatment options available, which up until now have been 
limited. 
 
SPACE FOR COPD is a multifaceted, complex intervention, and is comprised 
of the SPACE FOR COPD manual, the interaction between the patient and 
the healthcare professional, motivational interviewing and telephone support. 
It is not possible to derive from this study which aspects of the intervention 
were the most helpful and which were the least. Furthermore, it was not 
possible to explore how well the programme was followed by any of the 
participants. The engagement required by the patients could not be either 
demanded or measured. It is therefore not possible to tell whether some 
patients ‘took the pill’ as it were. This means it is not possible to evaluate 
whether there was a dose response, or to re-evaluate the programme and 
revise it based on how well it is used. In this particular model of SPACE FOR 
COPD this may continue to be difficult to measure. However, as the SPACE 
FOR COPD programme is remodelled onto a website 
(www.spaceforcopd.co.uk), the data obtained from this will give us far more 
insight into how much the programme is used and which aspects are used. 
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The website will offer a more sophisticated, technology-based solution to self-
management for COPD, broadening the modes of delivery suited to different 
learning styles. 
 
Co-morbidities in COPD are common (van der Molen 2010), and have been 
associated with worse quality of life and reduced capacity for activities of daily 
living (Yeo et al. 2005). The trial design in this thesis excluded participants 
who would be unable to conduct the exercise programme; however, it is likely 
there were a number of other patients who were included who had at least 
one co-morbidity. The capacity for patients with multiple morbidities to 
undertake SPACE FOR COPD may have been restricted; however, this was 
not addressed in this thesis. It is, therefore, not possible to evaluate to what 
extent multiple morbidities may have influenced the outcomes of this trial. The 
EPP is a self-management programme aimed to all chronic diseases, and 
may therefore be better equipped to consider co-morbidities. Evidence to 
date, however, suggests that it does not improve disease-specific behaviours, 
such as exercise capacity or dyspnoea which may be important outcomes for 
people with COPD (Wright et al. 2003; Barlow et al. 2005a). For individuals, 
where the symptoms of COPD are the primary cause of disability, a disease-
specific programme like SPACE FOR COPD might be the most appropriate 
form of self-management support, in order to improve important clinical 
outcomes. Individuals with co-morbidities which are equally disabling might 




Finally, this trial was not sufficiently powered for all of the secondary 
outcomes, and the number of comparisons made was not corrected for. By 
conducting a large number of comparisons there is increased risk of type I 
error. However, methods of correction, such as the Bonferroni adjustment 
increase the risk of type II error. This study is, however, powered on the 
primary outcomes of the CRQ-SR dyspnoea domain, and it is upon that 
measure that the hypothesis of this study is rejected. Secondary outcomes in 
this trial are to be treated cautiously, and are for exploratory purposes only. A 
similar pattern is seen in the data across many of the secondary outcome 
measures, suggesting an improvement in the SPACE FOR COPD group 
compared with usual care. These data provide an adequate enough basis to 
generate hypotheses to inform future studies. 
 
8.3 Areas for Further Research 
Implementation 
This thesis describes the first fully powered RCT designed to establish the 
effectiveness of SPACE FOR COPD. This followed a rigorous development 
procedure and feasibility and pilot testing of the intervention. In line with the 
MRC guidelines for complex interventions (figure 8.2), the next phase is to 
implement the research findings. The aim of the implementation phase of the 
process is to evaluate how well SPACE FOR COPD can be delivered outside 
of the ‘research’ environment described in this trial, and in more of a ‘real-life’ 
clinical setting. A training programme which is comprised of on-line learning 
and a face-to-face workshop has been developed and tested in order to equip 
healthcare professionals with the knowledge and expertise required to deliver 
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and support patients on SPACE FOR COPD. Future research should evaluate 
the effectiveness of SPACE FOR COPD, delivered by healthcare 
professionals who have undertaken the training, on a larger sample of 
patients across multiple sites. The findings from this kind of research would be 
more generalisable to the wider population. 
 




Prior to, or alongside, an implementation project, there may be adjustments or 
modifications to the intervention which should be considered. The findings 
from this study suggest that short-term gains are not wholly maintained in the 
medium-term without any form of on-going support. The chronic care model 
suggests that self-management should sit within a wider system of integrated 
care (Wagner 1998), and that components of the CCM are more effective 
when used in conjunction (Adams et al. 2007). It seems warranted, therefore, 
to evaluate the impact of the addition of longer-term support following SPACE 
This item has been removed due to 3rd Party Copyright. The unabridged version of the thesis can 
be viewed in the Lanchester Library Coventry University.
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FOR COPD beyond the four-week telephone contact. This could be in the 
form of telephone support, which as discussed in section 8.1 has previously 
been reported as advantageous (Walters et al. 2012). Furthermore, if SPACE 
FOR COPD is embedded in primary care, and is provided by the practice 
nurse, there will automatically be regular on-going collaboration between the 
patient and the practice nurse. 
 
Group-based delivery 
There may be some additional benefits to group-based delivery of SPACE 
FOR COPD. Self-management programmes in other diseases which have 
used a group-based approach have had moderate long-term success (Barlow 
et al. 2009; Khunti et al. 2012; Rickheim et al. 2002; Tang et al. 2012a; Tang 
et al. 2012b) and reported that evaluation of the group dynamics has been 
important for its success (Harrison et al. 2011). The Chronic Disease Self-
management Programme (CDSM), or the EPP in the UK, is a group-based, 
lay-led self-management course for a range of chronic diseases. There have 
been a number of studies conducted which have demonstrated that the 
course is moderately effective in improving self-efficacy and is probably cost-
effective also (Barlow et al. 2005a; Kennedy et al. 2007; Wright et al. 2003). 
The evidence so far suggests that benefits from the EPP are largely 
psychological gains, in terms of cognitive management, symptom 
management and self-efficacy (Wilson et al. 2007; Wright et al. 2003). COPD-
specific outcomes, such as exercise performance, dyspnoea or physical 
activity, which are critical to long-term health outcomes, have not been 
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measured objectively, and self-reported data have shown no improvement 
following the EPP (Barlow et al. 2005a; Wright et al. 2003).  
 
Patients have rated the EPP highly, and have reported that group-work 
enhances motivation, is reassuring, and increases confidence and control 
(Barlow et al. 2005b). Social Learning Theory suggests that people will alter 
their behaviour based on the behaviour they observe of other people, or 
‘models’, around them (Bandura 1977b). Group members may make positive 
changes by modelling their own behaviour on that of others in the group who 
they aspire to. However, a recent study which evaluated the impact of social 
comparisons on anxiety in a pulmonary rehabilitation group-setting found that 
making upward social comparisons did not improve anxiety (Peterson et al. 
2012). Downward social comparisons, however, were more likely to increase 
anxiety as patients saw other people who they perceived as ‘worse’ than 
them, and viewed that to be their future (Peterson et al 2012). Additionally,  
group-based self-management may be hampered by ‘problem-patients’ who 
do not engage well with the self-management programme and have been 
identified as disruptive of group dynamics (Wilson et al. 2007). It is indeed 
likely that there are pros and cons to group-based self-management delivery, 
and different approaches will be required to meet the varied learning styles 
and needs of every individual. Indeed, it may be best to shift away from trying 
to identify the ‘ideal’ method of delivery, and move instead towards a menu of 





This shift may be best described as ‘personalised care’. There are now a 
range of approaches for providing self-management support for people with 
COPD (appendix 2/ Wagg 2012). Furthermore, a new web-based version of 
SPACE FOR COPD has also been developed and is currently being 
evaluated. Given the menu of treatments available, and in-line with current 
opinions on individualised care, evaluation of a patient-tailored approach to 
care is warranted. A trial which used a decision-tree to direct patients to 
SPACE FOR COPD, the web programme, pulmonary rehabilitation, or a 
group-based programme would be novel, and would mimic more of a ‘real-life’ 
approach to individualised patient care. It might be anticipated that if the 
method of support has been individualised rather than prescribed as a ‘one 
size fits all’ approach then it may be more effective. 
 
SPACE FOR COPD vs. pulmonary rehabilitation 
The capacity for pulmonary rehabilitation and uptake for the course is low. In 
2008 only 15% of eligible participants in the UK had completed the course 
(The Royal College of Physicians, The British Thoracic Society and The 
British Lung Foundation 2008). Reasons for not attending pulmonary 
rehabilitation, despite its well-known benefits (Lacasse et al. 2006), are 
varied. SPACE FOR COPD might seem like a reasonable alternative to 
pulmonary rehabilitation in the instance that people cannot attend. SPACE 
FOR COPD might be a practical alternative for people who live in rural areas, 
have difficulty with transportation or care for their spouse or other family 
members. While the impact on HRQoL and maximal exercise capacity 
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described in this thesis are not as great as changes documented from 
pulmonary rehabilitation (Sewell et al. 2005; Evans et al. 2010), for those who 
would otherwise receive nothing, it might be the next best alternative. This will 
be evaluated in future research trials. 
 
After First Hospitalisation 
There are substantial financial consequences of hospital admissions 
(Healthcare Commission 2006) and there is extensive pressure on NHS trusts 
to reduce re-admissions. The concern of admissions is also of interest to 
primary care as the median number of visits to GPs in the 12 months prior to 
admission in the 2008 COPD audit was 12 (The Royal College of Physicians, 
The British Thoracic Society and The British Lung Foundation 2008), 
indicating the high usage of primary care prior to admission. 
 
Although the most ideal time to provide self-management might be following 
early diagnosis within primary care, many patients are diagnosed upon their 
first hospital admission for a COPD exacerbation (Bastin et al. 2010).  A 
recent study by Suissa,  Dell'Aniello, and Ernst (2012) suggested that on 
average, there may be around five years between the first and second 
hospitalisation for a COPD exacerbation. Following the second, 
hospitalisations become more frequent. Although post-exacerbation self-
management interventions have not generally been effective (Bucknall et al. 
2012; Fan et al. 2012), the work by Suissa and colleagues suggest that if self-
management might be at all effective post-hospitalisation, then after the first 
episode is likely to be more successful than after several admissions. For 
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some patients who have had their first exacerbation which required 
hospitalisation, it may be an ideal opportunity to address behaviour change as 
this is a time when a patient might be most likely to be motivated to change 
through experience of the negative consequences of their behaviour (Becker 
1974; Rogers 1975). SPACE FOR COPD may be useful in supporting 
patients in behaviour changes, such as smoking cessation, exercise training 
or physical activity uptake, and evaluation of SPACE FOR COPD following 
first hospitalisation due to COPD should be addressed in the future. 
 
Health economics 
It is anticipated that there may be financial gains if an individual who self-
manages resumes a greater responsibility for self-care and becomes less 
reliant upon healthcare services (Department of Health 2012a). Many self-
management studies, therefore, have conducted economic analyses 
alongside clinical effectiveness data (Bourbeau et al. 2006; Khdour et al. 
2011; Monninkhof et al. 2004b). Most healthcare systems around the world 
face considerable financial challenges, and with the current system of 
commissioning in the NHS, interventions that show a cost-effective benefit 
may seem more likely to be implemented into clinical care. There are a 
number of approaches which can be taken to economic analysis and they 
may be to assess cost-effectiveness or cost-utility. Alongside this trial 
healthcare utilisation data and medication usage has been collected directly 
from GP and hospital databases and an accurate account of intervention-
related costs have been kept in order to perform such analyses. A full cost-
effective or cost-utility analysis was deemed too large to fall under the remit of 
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this thesis, however expertise has been sought to assist with these analyses 
and are being conducted by the research team. It is anticipated these data will 
be published following the publication of the clinical findings. 
 
8.4 Final Conclusions 
The aim of this thesis was to test the effectiveness of SPACE FOR COPD as 
an independent self-management intervention for people with COPD in 
primary care. It was anticipated that SPACE FOR COPD would provoke 
changes in health behaviours and lead to improved patient outcomes when 
compared with usual care alone. This study has shown that SPACE FOR 
COPD was not effective in improving dyspnoea over and above usual care at 
six months. Secondary findings suggest that there were short-term gains in 
HRQoL, exercise performance, psychological status, disease knowledge and 
steps when using SPACE FOR COPD. Improvements in exercise 
performance and psychological well-being were maintained after six months. 
Despite the rejection of the study hypothesis, the results of the secondary 
measures suggest that there may be some benefits to SPACE FOR COPD 
above usual care. 
 
SPACE FOR COPD adopts a light-touch approach, which may make it 
favourable for implementation as a self-management strategy for primary care 
in the UK. This is in contrast to many studies which have provided more highly 
supervised programmes. Despite being light-touch, SPACE FOR COPD does 
demonstrate clear benefits, unlike other light-touch interventions such as 
action plans. 
274 
This thesis has focused on patients managed largely in primary care, who 
have previously been under-researched in self-management. Observing this 
group of patients has given unique insights into physical activity levels in 
patients who appear to manage their disease well. The work in this thesis has 
highlighted the need for interventions aimed at improving physical activity and 
promoting self-management in patients who are less functionally limited by 
their disease. 
 
There are numerous opportunities for future research. Some of these relate 
directly to the intervention, such as evaluating group-based delivery, the 
additional benefit of on-going support, effectiveness following first 
hospitalisation and the economic benefits of the programme. Other questions 
relate to the methodology, such as whether there is an effect of a research 
assessment, or conducting an exercise test. It is anticipated that many of 
these opportunities can be explored in the future in order to enhance our 
understanding of the usefulness of SPACE FOR COPD and in improving the 
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A self-management programme for chronic obstructive pulmonary 




You are being invited to take part in research study being conducted by 
Glenfield Hospital and Coventry University.  Before you decide it is 
important for you to understand why the research is being done and what it 
will involve.  Please take time to read the following information carefully and 
discuss it with others if you wish.  Ask us if there is anything that is not clear 
or if you would like more information.  Take time to decide whether or not 
you wish to take part.  Thank you for reading this. 
 
1. What is the purpose of the study? 
 
Over the last year we have developed a self-management manual for 
patients with Chronic Obstructive Pulmonary Disease (COPD).  This has 
been done with enormous help from patients like yourself.  We would now 
like to test the effectiveness of the manual. 
The manual covers issues such as drug and symptom management, 
exercise and nutrition at home. This would give help and advice to manage 
COPD without travelling to the hospital.    
This study is important in order to inform the current delivery of services to 
patient with COPD.  We hope to optimise patient care and support the 
development of new COPD programmes of care. 
 
 
2.  Why have I been chosen? 
As an individual with COPD you have been identified as a suitable 
participant.  It is important to us to see how people in primary care progress 
using the manual we have developed in comparison to those who receive 
standard care from their GP.  It will help us develop and improve future 
services with this knowledge. 
 






Tel: 0116 287 1471 
Fax: 0116 258 3950 
Minicom: 0116 287 9852 
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It is up to you to decide whether or not to take part.  If you do decide to take 
part you will be given this information sheet to keep and be asked to sign a 
consent form. If you decide to take part you are still free to withdraw at any 
time and without giving a reason.   
 
4. What will happen to me if I take part? 
You will be able to take this patient information sheet home with you and 
you will be contacted by telephone to discuss participating in the study. If 
you agreed to take part in the research you will be placed at random into 
either the self-management or usual GP care group.  
 
Once you have provisionally agreed to take part in the research you will be 
contacted to arrange a date and time to discuss the project in more detail.  
We don’t know how effective the self management manual will be. To find 
out, we need to make comparisons between the different treatments. We 
put people into groups and give each group a different treatment; the results 
are compared to see if one is better. To try to make sure the groups are the 
same to start with, each patient is put into a group by chance (randomly). 
The results are then compared. There will be a 50/50 chance of being 
allocated to either group.  
 
Overall your involvement will last for 6 months, although the study will go on 
for much longer.  For the purpose of this study we would ask you to attend 
the hospital on 3 occasions during which time we would measure your 
exercise capacity and ask you to fill in some questionnaires.  
You may also be asked to take part in an interview at these visits.  You do 
not have to complete an interview to be part of this research. 
 
We would, with your permission, inform your General Practitioner that you 
have agreed to take part in this study  
 
 
5. What do I have to do? 
If you are assigned to the GP care group you will continue as normal with the 
treatment you receive from your GP.  You will be requested to complete 
standard assessments of lung function, exercise capacity (walking test), a 
test to measure the strength of the muscles in your thigh and be asked to 
complete some questionnaires about your health status.  You will be 
assessed at the beginning of the study, 6 weeks later and 6 months after.  
These assessments will take place at Glenfield Hospital or Coventry 
University and your travel expenses will be reimbursed. 
 
If you are assigned to the self-management group you will undergo the same 
assessments at the same time points as the GP care group.  This will be at 
Glenfield Hospital or Coventry University. However, you will also be given a 
manual for people with pulmonary disease and invited to a workshop at your 
GP surgery to have your self-management programme explained to you  
Your manual will outline how to manage your condition including information 
on drug and symptom management, exercise and nutrition. Included will be 
some home-based exercises you can carry out in your own time. You will 
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receive 2 phone calls to see how you are progressing with the manual during 
the first 6 weeks.  
 
If you agree to take part in an interview, this will consist of an informal 
interview in which you will be asked some previously agreed questions 
relating to what you think about exercise and self-management.  The 
interview shouldn’t last longer than 1 hour and will be digitally recorded, with 
your permission. 
 
You will also be invited to wear an activity monitor which is worn on your arm. 
This is to be worn for 7 consecutive days (please do not allow the monitor to 
get wet, so please remove if going swimming or you are having a bath etc.). 
You do not need to change your normal activity pattern while wearing this 
monitor. Again this will be assessed before you start your programme and 
also 6 weeks and 6 months after, as is routine. 
 
6. What are the possible disadvantages and risks of taking part? 
There are no foreseeable side-effects of taking part. 
 
7. What are the possible benefits of taking part? 
We hope that the research will aid you in your understanding of exercise 
and COPD and inform both present and future self-management 
programmes therefore benefiting COPD patients.   
 
8. What if something goes wrong? 
If you are harmed by taking part in this research project, there are no 
special compensation arrangement. If you are harmed due to someone’s 
negligence, then you may have grounds for a legal action but you may have 
to pay for it. Regardless of this, if you wish to complain, or have any 
concerns about any aspect of the way you have been approached or 
treated during the course of this study, the normal National Health Service 
complaints mechanisms would be available to you.  
 
9. Will my taking part in this study be kept confidential? 
All information that is collected about you during the course of the research 
will be kept strictly confidential. Any information about you, which leaves the 
medical centre, will have your name and address removed so that you 
cannot be recognised from it. Participants will not be identified in any 
subsequent written material; for example, pseudonyms will be used to refer 
to participants’ names.  Results will be reported in such a way that 
completely preserves confidentiality.  
 
10.  What will happen to the results of the research study? 
The results of the study will be disseminated in peer and lay journals, 
professional publications and presentations made at relevant conferences. 
Results will be reported in such a way that preserves confidentiality. All 
participants will also receive a summary of the results.  
 
11. Who is organising and funding the research? 
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This study is being funded by Astra Zeneca and Research for Patient 
Benefit.  You have been recruited through your GP surgery. 
 
 
12. Who has reviewed the study? 
All research that involves NHS patients or staff, information from NHS 
medical records or uses NHS premises or facilities must be approved by an 
NHS research Ethics Committee before it goes ahead. Approval does not 
guarantee that you will not come to any harm if you take part. However, 
approval means that the committee is satisfied that your rights will be 
respected, that any risks have been reduced to a minimum and balanced 
against possible benefits and that you have been given sufficient 




13. Contact for further information  
If you have any concerns or other questions about this study or the way it 
has been carried out, you should contact the principal researcher (Sally 
Singh Tel: 0116 2502535)  
 
 



























FORM (Version 5 (05/10/2010) 
Identification Number for this study:  
 
A self-management rehabilitation programme for chronic 
obstructive pulmonary disease (COPD) in primary care   
          Please initial box 
 
1. I confirm that I have read and understand the information sheet dated 
04/10/2010 version 4 for the above study and have had the opportunity 
to ask questions.         
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected. 
 
3. I understand that sections of any of my medical notes may be looked at 
by responsible individuals from Coventry University or from regulatory 
authorities where it is relevant to my taking part in research.  I give 
permission for these individuals to have access to my records. 
 
4. I agree to take part in the above study. 
 
 
5. I agree for my GP to be informed of my participation. 
 
6. I agree to take part in taped interviews and for anonymous quotes to be 
used in the final report 
 
7. I understand that all the information I give will be treated in confidence. 
Should I disclose any information that highlights a breach of the law, or 





______________________  _________ ____________ 
Name of Patient         Date   Signature 
 
 
______________________  _________ ____________ 
Name of Person taking consent  Date Signature 
(if different from researcher) 
 
 
______________________  _________ ____________ 
Researcher    Date  Signature 
 






Tel: 0116 287 1471 
Fax: 0116 258 3950 
Minicom: 0116 287 9852 
Appendix 5: Consent Form 
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Appendix 6: Chronic Respiratory 

















HOSPITAL ANXIETY and 
DEPRESSION SCALE (HADS) 
Name:          Date:      
Clinicians are aware that emotions play an important part in most illnesses.  If your clinician knows about these feelings he 
or she will be able to help you more. 
This questionnaire is designed to help your clinician to know how you feel.  Read each item below and underline the reply 
which comes closest to how you have been feeling in the past week.  Ignore the numbers printed at the edge of the 
questionnaire. 
Don’t take too long over your replies, your immediate reaction to each item will probably be more accurate than a long 
out response. 
              
            A          D 
                     I feel tense or ‘wound up’                I feel as if I am slowed down    
  Most of the time         Nearly all the time    3 
  A lot of the time          Very often     2 
  From time to time, occasionally        Sometimes     1 
  Not at all          Not at all     0 
I still enjoy things I used to enjoy    I get a sort of frightened  
  Definitely as much     feeling like ‘butterflies’  
  Not quite as much     in the stomach 
  Only a little        Not at all    0 
  Hardly at all        Occasionally    1 
         Quite often    2 
I get a sort of frightened feeling      Very often    3 
as if something awful is about to    
happen        I have lost interest in my  
 Very definitely and quite badly    appearance  
 Yes, but not too badly       Definitely      3 
1                      A littIe, but it doesn't worry me                            I don’t take as much care as I should  2 
                      Not at all          I may not take quite as much care   1 
          I take just as much care as ever   0 
I can laugh and see the funny side of things 
 As much as I always could    I feel restless as if I have to be on the 
 Not quite so much now     move 
 Definitely not so much       Very much indeed   3 
 Not at all        Quite a lot    2 
           Not very much    1 
Worrying thoughts go through my mind     not at all    0 
  A great deal of the time      
  A lot of the time      I look forward with enjoyment to things 
  Not too often         As much a I ever did    0 
  Very little           Rather less than I used to    1 
         Definitely less than I used to   2 
I feel cheerful          Hardly at all     3 
  Never 
               Not often      I get sudden feelings of panic 
  Sometimes        Very often indeed   3 
  Most of the time       Quite often    2 
           Not very often    1 
I can sit at ease and feel relaxed      Not at all    0 
  Definitely    
  Usually      I can enjoy a good book or radio or 
              Not often                  television programme 
  Not at all          Often      0 
            Sometimes     1 
         Not often     2 
         Very seldom     3 
             
            A        D 
Now check that you have answered all the questions     
        TOTAL   
          
    
Appendix 7: The Hospital Anxiety and Depression 
Scale 
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Appendix 8: Pulmonary Rehabilitation Adapted 
Index of Self-efficacy 
General Self-Efficacy Scale. 
Adapted for Pulmonary Rehabilitation. 
 
 
Please circle where you feel you are now. 
 
Statement Score 
I can always manage to solve difficult problems if I 
try hard enough. 
1 2 3 4 
If someone opposes me, I can find the means and 
ways to get what I want. 
1 2 3 4 
It is easy for me to stick to my aims and accomplish 
my goals. 
1 2 3 4 
I am confident that I can walk for a good distance, 
at my own pace, despite it making me breathless. 
1 2 3 4 
I am confident that I could deal efficiently with 
unexpected events. 
1 2 3 4 
Thanks to my resourcefulness, I know how to 
handle unforeseen situations. 
1 2 3 4 
I feel confident that I will be able to perform the 
exercises asked of me during the course of 
rehabilitation, even if I find them difficult. 
1 2 3 4 
I can solve most problems if I invest the necessary 
effort. 
1 2 3 4 
I feel that I have an adequate amount of knowledge 
about my lung disease, despite it being a complex 
condition. 
1 2 3 4 
I can remain calm when facing difficulties because I 
can rely on my coping abilities. 
1 2 3 4 
When I am confronted with a problem, I can usually 
find several solutions. 
1 2 3 4 
I feel positive that I will be able to complete the 
exercises at home, despite there being no 
supervision from a health professional. 
1 2 3 4 
If I am in trouble, I can usually think of a solution. 1 2 3 4 
I can handle whatever comes my way. 1 2 3 4 
On a day to day basis I feel in control of my lung 
disease and how that affects my lifestyle, even 
when my symptoms become distressing. 
1 2 3 4 
 
Response Format. 
1= Not at all true 
2= Hardly true 
3= Moderately true  
4= Exactly true 
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This item has been removed due to 3rd Party Copyright. The unabridged version of the thesis 
can be viewed in the Lanchester Library Coventry University.
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1. How are you getting on with the manual? 
2. What stage are you at currently?   1 2 3 4 
3. The walking programme:  where are you now? 
a. Frequency ……… per day 
b. Time ……… minutes in total 
c. Provide encouragement to progress to next step 
4. How many days a week do you use the manual?  ……… average 
time 
5. How many A&E visits?   Respiratory…… Non-
respiratory…… 
6. How many hospital vists?  Respiratory…… Non-
respiratory…… 
7. How many visits to GP practice? …….. regular check-ups  
     …….. practice nurse 
……..  GP 
 
8. How many courses of:    ……...  antibiotics 
……...  steroids 
 
Length of Call (mins): 
 
 
 
 
 
 
 
 
Any questions? 
